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I G EN ER A L INTRODUCTION
The growth of the world population and associated increase in life-expectancy 
are demographic factors that have a huge medical impact at present and in the 
near future. Indeed, these factors already individually make that more people will 
suffer from deteriorating, failing or malfunctioning body parts, while their combined 
effect likely surpasses the sum of both. In view of bone tissue, implants can be 
used to replace malfunctioning joints (e.g. total hip replacement) or lost teeth (e.g. 
dental implant). It has been reported that in the US already more than 600,000 
orthopedic joint replacements are performed annually1 whereas the use of dental 
implants has been estimated at 300,000 implants each year2. Such implants have 
specific requirements regarding their optimal performance within the human 
body, which are related to their function and interaction with the biological 
system. Their function relates to load-bearing capacity, which makes that the 
implant material should possess sufficient mechanical properties to withstand the 
forces that act on it. Additionally, bone implants require a stable fixation within
8
the native bone tissue to maintain implant functionality and longevity.
This general introduction will provide an overview of the important aspects of 
load-bearing bone implants and their interaction with the biological surrounding. 
In a comprehensive manner, material aspects (section II), biological aspects 
(section III), and the use of surface modifications to control the biological 
response (section IV) will be outlined. Finally, the objectives of this thesis will be 
delineated.
II B U LK  M A TER IA L A S P EC T S  OF 
LOAD-BEARIN G BONE IM PLA N TS
In medical and dental surgery (e.g. orthopedic and maxillofacial surgery), implants 
need to be made of biomaterials that possess the mechanical requirements for 
load-bearing applications and should induce a life-long secure fixation of the 
implant within the native bone tissue. The requirement of mechanical strength is
a pure bulk material property, whereas the interaction of an implant surface with 
its biological surroundings is related to material surface properties. A  general 
classification of biomaterials is based on biocompatibility, which is defined as 
the property of a biomaterial to perform with an appropriate host response 
in a specific application3. With respect to implant materials, three categories 
of biocompatibility have been classified by Osborn and Newesely, based on 
differences in tissue reaction to different materials:
(i) Biotolerant materials, such as stainless steel, Co-Cr alloys and polymethyl 
methacrylate (PMMA) bone cement. These materials are not necessarily 
rejected when implanted into living tissue, but are characterized by the 
formation of a fibrous tissue layer (capsule) interposed between the implant 
surface and the surrounding bone.
(ii) Bioinert materials, such as titanium (Ti), zirconia and aluminia. These materials 
do not induce the formation of fibrous tissue, but allow close apposition of 
bone to their surface.
(iii) Bioactive materials, such as calcium phosphate (CaP) and glass ceramics.
9
These materials allow direct bone bonding, which is based on a chemical 
interaction that results in the interdigitation of collagen with the active 
surface of the implant4.
The majority of load-bearing implants are nowadays made of commercially pure 
Ti and its alloys (e.g. Ti-6Al-4V)5, as these materials are highly biocompatible and 
possess excellent mechanical properties and corrosion resistance6,7. Mechanical 
properties are important for the long-term performance of the implant. In 
comparison to other materials that have been used for the manufacturing of 
load-bearing bone implants (e.g. stainless steel and cobalt-based alloys), Ti and its 
alloys have the biomechanical advantage of a low elastic modulus (i.e. Young's 
modulus, or stiffness) (Table 1)6,8. A  mismatch in the mechanical properties 
between the implant material and the surrounding bone can result in 'stress 
shielding', a phenomenon that is characterized by peri-implant areas without 
transfer of load from the implant to the bone tissue9. This lack of load transfer 
can lead to atrophy or bone resorption10, which subsequently can cause implant 
loosening and hence implant failure.
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T a b le  1 . C o m p a r is o n  o f Y o u n g 's  m o d u lu s  (G p a ) b e tw e e n  im p la n t  m a te r ia ls  
a n d  b o n e
Material Young's modulus 
(Gpa)
Ref
cpTi 105 (6 )
Ti-6Al-4V 106 -  110 (6 ; 102 )
Stainless steel (316L) 182 -  193 ( 1 02 ; 103 )
Co-Cr alloys 230 ( 102 )
Cortical bone 7 -  30 ( 102 )
Cancellous bone 0.1 -  1 ( 102 )
Despite the fact that Ti and its alloys are the materials of choice for manufacturing 
load-bearing implants, a drawback of their application as implant materials is 
their lack of bioactive behavior. In other words: Ti-metals cannot form a direct 
mechanically stable bond between their surface and the surrounding bone tissue 11. 
To overcome this limitation, research efforts have focused on modifying implant 
surfaces to improve the biological response. For a proper understanding of the
10
interactions that take place at the bone-implant interface, the following section 
(III) will start with a brief description of the biological processes that occur upon 
implantation, followed by an overview of the possibilities to modulate these 
processes (IV).
III B IO LO GICAL A S P EC T S
The long-term clinical success of bone- or teeth replacing implants is based on a 
histological direct bone-to-implant contact, resulting in a strong fixation of the 
implant into the native surrounding bone tissue and thereby preventing the ingrowth 
of fibrous tissue between the implant and bone. The surgical intervention and 
subsequent introduction of an implant into the living human bone tissue initiates 
two types of reactions: (i) those that occur at the interface of the inserted implant, 
and (ii) the biological response of the human body to the implant.
Interface processes upon implant placement
Immediately upon implantation, the implant is surrounded by a zone of necrotic 
bone and a blood clot due to the surgical procedure12. Triggered by the surgery, 
a cascade of events takes place at the bone-implant interface starting with the 
interaction with water. Water molecules will rapidly bind to the implant surface, 
forming a mono- or bilayer of water molecules13. The binding strength of water 
molecules is, however, directly related to the wettability of the implant surface. 
That is, hydrophilic surfaces bind water molecules more strongly than hydrophobic 
surfaces. Hence, it is not surprising that in implantology, Ti and hydroxyapatite 
are the materials of choice, due to their relatively high degree of hydrophilicity14. 
When the water overlayer has formed (within nanoseconds) natural ions, such as 
C l- and Na+, enter the interface and are incorporated into the water overlayer. 
Subsequently, proteins originating from blood and tissue fluids at the wound site, 
will reach the surface and will initially adsorb, desorb (native or denatured) or will be 
replaced by larger proteins at a later stage. When this dynamic layer of proteins has 
been formed, living cells appear on the stage13. Because cells depend on specific 
proteins for anchorage, migration and possibly proliferation, the composition of 
the adsorbed layer is a key mediator of cell behavior, determining which cells 
bind, how they bind and if they become activated. In this manner, the required 
proteins, correctly presented, can stimulate the formation of a newly organized 
tissue at the interface (Figure 1) (vs. e.g. a chronic inflammatory response)13,15. 
In conclusion, when cells approach an implant material, it is unlikely that they will 
make direct contact with that surface. Rather, the rapid adsorption of proteins 
derived from blood and tissue fluids effectively translates the structure and 
composition of the underlying implant surface into a biological language to 
which cells respond. In other words, the fate of implants (from chronic inflamma­
tion or fibrous encapsulation to osseointegration or tissue regeneration) is deter­
mined by the response of cells to the material's surface16.
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Biological response of the human body to an implant
The initial host response after implantation is characterized by an inflammatory 
reaction elicited mainly by the surgical trauma and modified by the presence of 
the implant. This response is very similar to the mechanisms occurring during 
bone fracture repair and involves a cascade of various cellular and extracellular 
events17. During the initial stages of bone healing, devitalized bone is removed by 
osteoclastic activity. At the same time, osteogenic cells deposit a non-collagenous 
matrix layer, similar to the bone cement line and lamina limitans, onto the reab­
sorbed surface of the old bone17. This early calcified afibrillar layer, rich in calcium, 
phosphorus, osteopontin and bone sialoprotein, forms on any type of biomaterial 
implanted, and offers the possibility for optimal 'bonding' between the pre-existent 
bone and the implant, as it is implicated in osteoblast attachment18. A  few days 
after implantation, osteoblasts begin to deposit collagen matrix directly onto the 
early formed cement line, which is followed by the arrangement of the woven 
bone and developing bone trabeculae and marrow spaces.
Consequently, it is hypothesized that peri-implant osteogenesis starts from two
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different directions: (i) from osteogenic cells, that first have been recruited to the 
implant surface and begin secreting bone matrix, towards the pre-existing host 
bone, also known as contact osteogenesis (Figure 2A), and (ii) from the osteogenic 
cells, lined at the remodeling borders of the pre-existent bone tissue, towards the 
implant surface, i.e. distance osteogenesis (Figure 2B)4,19.
For an implant to be considered successfully integrated into bone, it should 
meet certain criteria in terms of function (e.g. ability to chew or to walk), 
tissue physiology (presence and maintenance of stability, absence of pain and 
other pathological processes) and user satisfaction (aesthetics and absence of 
discomfort)20. In some cases however, the performance of an implant drops 
below an acceptable level, which can be caused by biological as well as 
mechanical processes. In healthy patients, dental implant survival rates up to 
99%  have been reported 21,22. However, in aged patients and patients with 
comprised medical conditions (e.g. due to irradiation therapy, bone metabolic 
disorders, such as osteoporosis or diabetes mellitus), it has been observed that 
peri-implant osteogenesis is slower and implant failure rates are substantially
higher compared to those in healthy patients17. The impaired outcome for these 
clinical conditions can be based on a volume deficiency of the recipient bone 
bed, inadequate bone density (e.g. a higher ratio of trabecular to cortical bone) 
or impaired vascularization. As a consequence, the implant will fail to interact 
within the osseointegration process and will loosen over time, allowing the 
ingrowth of fibrous tissue between the implant and bone17. Furthermore, early 
infections (e.g. peri-implant mucositis, peri-implantitis), excessive implant loading 
(leading to bone resorption) and malpositioning of the implant are key factors 
that may lead to implant failure20.
IV  CONTROLLING TH E BIO LOGICAL  
R ESPO N SE TO  BONE IM PLA N TS
As described in the previous section, the sequence of events leading to integration 
of an implant into bone tissue is rather complex and involves numerous factors. 
In the following section, several of these factors will be discussed in more detail.
Implant design
Implant design refers to the three-dimensional structure of the implant, with all 
the elements and characteristics that it is composed of. Over the last few 
decades, many different implant designs have been introduced, which all pursue 
the same goal, i.e. optimization of the anchorage of an implant into bone tissue, 
resulting in a rapid achievement and maintenance of direct bone-implant contact 
and uncomplicated function of the implanted device23,24. Current designs for 
bone implants can be categorized into threaded or non-threaded, and cylindrical 
or conical. Furthermore, additional features, such as vents, grooves, indentations 
or perforations of various dimensions can be introduced to accentuate or replace 
the effect of the threads (Figure 3)25. Nowadays, most implant designs are threaded, 
as the presence of threads offers the surrounding bone a larger surface area 
compared to non-threaded designs26, thereby stimulating the bone healing 
process19. Additionally, during implant placement, a threaded design is able to
C h a p te r 1 G e n e ra l in tro d u c tio n
Hip implant Implant surface events Biological events
Fig 1. Schematic representation of interface processes upon implant placement. A . Operative treatment of a hip fracture w ith a total hip implant. B. Triggered by the surgery, 
a cascade of events takes place at the bone-im plant interface starting w ith the interaction w ith a bioliquid (blood) containing water, solvated ions, and proteins, followed by 
the binding of cells. C. A s a result of the surgery, there is a zone of dam aged tissue around the implant. Once the protective barrier is broken, the process of w ound healing 
is immediately set in motion, w hich is divided in (i) a latent phase, (ii) a proliferative phase, and (iii) a repair phase.
Fig 2. A. Contact osteogenesis: bone formation starts from osteogenic cells, that first have been recruited to the 
implant surface, where they will begin to secrete bone matrix, towards the periphery, that is, the pre-existing host 
bone. B. Distance osteogenesis: bone formation starts from the osteogenic cells, lined at the remodeling borders 
of the pre-existent bone tissue of the surgically created bone cavity, towards the implant surface.
Fig 3. Illustration of different dental implant types.
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transform shear forces into more compressive forces, which will further enhance 
implant stability and fixation, which has been considered as the principal require­
ment for clinical success27. Consequently, threaded-type implants are generally 
recommended for immediate loading regimens28,29, whereas in cases of delayed 
loading cylindrical-type implants can favor the clinical outcome30,31.
Surface roughness / topography
In addition to implant design, implant surface characteristics are of special impor­
tance for successful orthopedic and dental implant fixation. When endosseous 
oral implants were first introduced by Branemark in 1969, these implants had 
turned ('machined') surfaces5. It was not until the beginning of the 1990s that 
surfaces with a certain degree of roughness were introduced, which demonstrated 
to play an important role in orchestrating the biological cascade of early peri-implant 
bone healing32-34. Based on experimental evidence, the majority of commercially 
available implants are nowadays equipped with moderately roughened surfaces, 
i.e. surface roughness of 1-2 |_im (Sa; defined as the arithmetic average of the 3D
16
roughness of a surface)35. Different methods have been developed to alter implant 
surface topography, of which grit- or sandblasting, acid etching, or combinations 
thereof are the most commonly used36,37. The roughening process of implants by 
grit-blasting is based on the projection of ceramic particles of varying sizes onto 
an implant surface, via a nozzle at high velocity by means of compressed air36. As 
a result, irregular surfaces with pits and depressions are formed. Inherent to the 
blasting process is the transfer of blasting medium onto the implant surface. 
Therefore, implants are preferably subjected to an additional cleaning procedure, 
using strong acids, that will wash away and dissolve the adhering particles to 
prevent the occurrence of adverse tissue reactions. These acid treatments will even 
further modify implant surface topography, though on the micro level37. Based 
on positive results obtained in animal and clinical studies, metallic devices with 
grit-blasted and acid-etched surfaces, including dental implants and hip joints, 
are now commercially available for clinical use38-40. Only recently, a new trend was 
introduced concerning the modification of surface roughness at the nanoscale 
level. The interest in the use of nanometer scale surface topographies is based on
the assumption that mimicry of the nanopattern of structural extracellular matrix 
proteins, like collagen, or the nano-crystalline nature of bone mineral, promotes 
protein adsorption and cell adhesion, leading to a faster integration of the implant 
and a reduction in implant failure rates41-43. Although the first results are promising, 
additional experiments are needed to obtain conclusive data on the capacity of 
nanometer scale surface topographies to enhance the osteogenic response.
Surface chemistry
In contrast to the aforementioned subtraction techniques, a more refined approach 
toward the creation of a biologically active implant surface entails the deposition 
of a coating onto the implant surface by means of physicochemical or biochemical 
deposition techniques. The following paragraph will outline the most commonly 
used constituents of such coatings and the available techniques for their deposition.
Inorganic constituents
In the biomedical field, CaPs are still one of the most widely used ceramic
17
materials for functionalization of the non-physiological metallic implant surface.
This particular interest in CaP is based on the chemical similarity to the inorganic, 
mineral phase present in bone and teeth44 (consisting of calcium hydroxyapatite 
or more specifically carbonate apatite (CHA))45. Besides the similarity with 
bone mineral, CaPs are known for their bioactive properties46. In other words,
CaPs have the capacity to form a direct, adherent, and mechanically stable bond 
with bone tissue, without an intervening fibrous tissue layer, also called 
'bone-bonding'47,48. The first clinical attempt to use a CaP compound for bone 
defect repair was reported in 1920 by Albee et al.49. More than 50 years later,
Nery et al. reported the first dental application using a synthetic porous material 
consisting of a mixture of HA and B-TCP50. Many experiments followed, which 
soon showed that despite the excellent properties as a biomaterial, the poor 
mechanical properties of CaPs, specifically their brittleness, low tensile strength, 
and low impact resistance, hinder their use as a bulk material for load-bearing 
situations. Consequently, it was proposed in the early eighties to apply CaP 
ceramics as a coating onto the surface of metallic implants, in order to combine
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the excellent biological properties of CaP ceramics with the mechanical strength 
of metals51. In the past two decades, various coating techniques have been 
developed in order to deposit a dense, uniform, adhesive ceramic coating onto an 
implant surface, among which, plasma-spraying and radiofrequent magnetron­
sputtering are the most successful and therefore still the most widely used 
(Table 2). The popular status of the plasma spraying technique is mainly based on 
its high deposition rates52, but suffers the disadvantage of creating relatively thick 
(> 50|_im) coatings, resulting in a low adhesive strength and the risk of coating 
fragmentation and lamination. Moreover, the density, crystallinity and composition 
of plasma sprayed coatings is not uniform53. In contrast, magnetron sputtering is 
particularly popular for its ability to create thin (0.5 - 5|_im), dense and uniform 
coatings with high adhesive strength. However, the magnetron-sputtering 
process is rather time consuming, owing to its low deposition rates54. Based on 
the limitations related to the above mentioned techniques, studies have been 
undertaken and are still ongoing to explore alternative or complementary 
techniques for the deposition of CaP coatings onto an implant surface. In the
18
1990s, a novel deposition technique, referred to as Electrostatic Spray Deposition 
(ESD) was developed in order to fabricate porous, thin ceramic films with controlled 
morphology55. The basic principle of the ESD technique is the generation of a 
so-called electrospray of organic solvents containing inorganic precursors (e.g. 
Ca, P). Under the influence of a high voltage, the liquid is pumped through a 
nozzle and as a result forms a spray consisting of charged, micro-sized droplets, 
which are attracted towards a grounded and heated substrate. After complete 
solvent evaporation, a thin ceramic layer (nanometer > 30 |_im) is formed on the 
substrate surface56. The advantages of the ESD technique over conventional 
deposition techniques include (i) a high deposition efficiency, since the electric 
field directs charged droplets to the substrate, (ii) control over coating thickness,
(iii) control over coating composition, and (iv) control over coating morphology57,58. 
Leeuwenburgh and co-workers were one of the first to study the feasibility of the 
ESD technique for biomedical purposes, i.e. deposition of CaP coatings onto Ti 
substrates, and reported on the ability of this technique to obtain coatings with a 
wide range of chemical and morphological characteristics59-61. More important, 
electrosprayed CaP coatings were shown to be biocompatible62 and even proved
T a b le  2. O v e rv ie w  o f d if fe re n t  d e p o s it io n  te c h n iq u e s  fo r  th e  fa b r ic a t io n  o f  in o rg a n ic  
an d /o r o rg a n ic  c o a t in g s
Deposition technique Type
Constituents to 
be deposited
Coating
thickness Ref
Plasma spraying line-of-sight Inorganic 50 - 250 pm (51 ;5 4 ; 104 )
RF magnetron sputtering Line-of-sight inorganic 0.5 - 3 pm ( 105 - 108 )
Electrospray deposition Line-of-sight organic-inorganic 0.1 - 5 pm (5 6 ; 57  ;8 4 ; 109 ; 110 )
Layer-by-layer deposition 3-dimensional organic <100 nm ( 1 1 1; 1 12 )
to possess osteoconductive capacity in vivo 63,64. Although the osteoconductive 
and bioactive properties of electrosprayed CaP coatings have been confirmed, 
this deposition technique, as well as the aforementioned coating methods, 
still have important limitations. For instance, all these deposition techniques are 
associated with extremely high temperatures (>500°C) for post-treatment of the 
coatings to transform the as-deposited amorphous coating into a crystalline 
phase, making the incorporation of biologically active compounds (e.g. growth 
factors and enzymes) impossible. Additionally, inherent to the line-of-sight 
deposition of these coating techniques is that only simple 2D objects can be 
provided with a coating, whereas bone implants commonly have 3D dimensions 
and hence require various consecutive runs for complete surface coverage. In 
clinical practice, however, each application demands specific requirements. In this 
respect, the wide range of available deposition techniques offers the possibility to 
select the most appropriate method for each specific implant application.
Organic constituents
Despite the reported beneficial effects on early bone responses due to the 
presence of a CaP-coating, the role of ceramic coatings is relatively passive 
owing to surface restrictions. In other words, CaP-coatings only interact with 
the biological environment via direct contact at the bone-implant interface. 
Consequently, the use of biologically active compounds, such as growth factors, 
or other biomolecules is an emerging area of biomaterials research.
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Growth factors
Growth factors are proteins, which are intimately involved in regulating cellular 
events that occur during repair of bone and other tissues in the body. Growth 
factors function by binding to specific receptors on target cell membranes, 
which induces a cascade of intracellular events, leading to a biological response. 
The most common osteogenic growth factors used for biomedical purposes are 
members of the Transforming Growth Factor-B superfamily, including TGF-Bs, 
bone morphogenetic proteins (BMPs) and other polypeptide factors. At present, 
a total of 15 different BMPs and (in mammals) 3 isoforms of TGF-B are known, of 
which BMP-2, BMP-7 and TGF-B1 are the most promising growth factors for 
improving bone formation in bone defects as well as around orthopedic and 
dental implants 65,67. A  prerequisite for the successful use of osteogenic growth 
factors is a suitable carrier or scaffold material, either from organic (e.g. polymers, 
co-polymers, demineralized bone matrix (DBM) or collagen) or inorganic origin 
(e.g. Ti, CaP-based ceramics)68. Critical to the efficacy of these growth factors, 
however, is the ability of the carrier material to deliver the molecules to the bony
20
site in such a way that they will induce the desired biological response53. That is, 
concentrations of biomolecules must exceed threshold levels for cellular activity 
and biomolecules must interact with local cell populations for a certain period of 
time to initiate cellular events18. The latter consideration is related to the short 
half-life of growth factors, implying the need for a slow release66. Data regarding 
the duration of exposure or concentrations needed for optimal activity of growth 
factors are still lacking. However, many studies have already reported on enhanced 
bone formation due to the loading of bone implants with growth factors, via 
methods of adsorption or covalent immobilization. In particular, growth factors 
immobilized on titanium surfaces pre-coated with collagen or CaP were found to 
be more effective in inducing bone formation compared to untreated titanium 
surfaces69-72. Based on these positive results, the addition of biologically active 
compounds is a promising tool in the optimization of the remodeling process at 
the bone-implant interface.
Deoxyribonucleic acid (DNA)
Another proposed organic constituent, suitable as a coating to modify implant 
surfaces is deoxyribonucleic acid (DNA). DNA is mainly known as the set of 
blueprints, containing the genetic instructions used in the development and 
functioning of all known living organisms. Irrespective of its genetic information, 
the specific three-dimensional structure of DNA gives this unique biomolecule 
also high potential for usage as a biomaterial coating. For instance, functional 
groups of DNA allow the incorporation of molecules (e.g. growth factors) via 
intercalation or groove-binding, making DNA applicable as a drug-delivery system 
(e.g. antibiotics)73. Additionally, due to its natural character and homologous 
composition in vertebrate organisms, DNA is an immunologically interesting 
material, diminishing the incidence of foreign body reactions and/or infections 
associated with implantation procedures74. Finally, the high phosphate content in 
DNA may beneficially affect bone formation, since phosphate groups have a high 
affinity for calcium ions75,76. In view of these properties, Decher and coworkers 
used the process of electrostatic self assembly (ESA) in a layer-by-layer (LbL) 
technique, in order to create multilayered coatings77. The LbL technique is based 
on electrostatic interactions between positively (cationic) and negatively (anionic) 
charged polyelectrolytes. This technique allows the build up of multiple poly­
electrolyte doublelayers. The principle of LbL assembly is very simple and has 
the advantage of being applicable to many different materials, irrespective of 
their geometry. More important, however, is the fact that this technique enables 
the deposition of coatings onto metallic implants under more physiological 
conditions of temperature and pH using organic components. In view of this, 
Van den Beucken and co-workers further explored the possibilities of using 
DNA-based coatings for biomaterial purposes and were the first to successfully 
fabricate and characterize DNA-based coatings as biomedical implant coatings 
using the layer-by-layer (LbL) deposition technique78. The results of these 
experiments have demonstrated that multilayered DNA-coatings are (i) cyto- and 
histocompatible79, (ii) eligible for functionalization with growth factors80, and (iii)
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affect the differentiation of osteoblast-like cells using in vitro immersion studies 
with simulated body fluids81. Regarding the aforementioned beneficial effects on 
cell and tissue responses, DNA-based surface modifications hold promise for 
bone-bonding activities in in vivo situations.
Alkaline phosphatase (ALP)
In addition to the aforementioned substances, another recently proposed implant 
coating material for improving the biological performance of orthopedic and dental 
implants, is the metalloenzyme alkaline phosphatase (ALP). The idea behind using 
ALP-based coatings as an alternative to conventional ceramic coatings is based on 
the important role ALP plays in the physiological biomineralization process82. 
Beertsen et al. already provided evidence for potential beneficial effects of ALP as a 
bone implant coating using collagen matrices in vivo83. However, a clear explanation 
on the exact mechanism behind this process still needs to be obtained. What is 
known on ALP until now is, that it (i) increases the local concentration of inorganic 
phosphate, required for physiological mineralization of hard tissues, by catalyzing
22
the hydrolysis of organic phosphate esters, and (ii) decreases the concentration of 
extracellular pyrophosphate, which is a potent inhibitor of mineralization. Only 
recently, De Jonge et al. fabricated ALP-coatings onto titanium surfaces using a 
modified electrostatic spray deposition technique84. In the conventional set-up, high 
temperatures (>400°C) were necessary for the generation of ceramic coatings and 
even higher temperatures (>700°C) for subsequent crystallization heat-treatments, 
making the preservation of biologically activity in case of incorporating biologically 
active compounds impossible. As a consequence, Morozov et al. modified the ESD 
deposition technique enabling coating deposition at low temperatures (<40°C)85. 
Using this modified technique, De Jonge et al. demonstrated that electrosprayed 
ALP-coatings are able to accelerate mineralization onto titanium surfaces in com­
parison with non-coated implants in in vitro soaking and cell culture studies84,86. 
In other words, the osteogenic potential of Ti can be stimulated by providing implant 
materials with an ALP-containing coating. Nevertheless, true evidence on the in 
vivo bioactivity of ALP-coatings still needs to be obtained.
Combining inorganic and organic constituents
Bone is one of the best examples of a two-phase composite, as it consists of an 
organic phase, represented by a collagen matrix (<30%  wt of bone tissue) and an 
inorganic phase, resembling needle-like crystals of CaP (70% wt of bone tissue) 
located within and around the collagen fibrils87,88. In view of this, research is now 
increasingly focusing on using combinations of different materials (i.e. organic- 
inorganic composites) as promising surface modifications to mimic the unique 
components of bone tissue. Consequently, composite coatings consisting of CaP 
with either collagen, growth factors or other components involved in the bio­
mineralization process, have recently gained a great deal of interest in enhancing 
peri-implant bone formation. Two of the possible composite coatings will now be 
discussed in detail.
Growth factor-CaP composites
As already described, CaP coatings can fulfill a beneficial role in enhancing 
the bone healing response around implants. The same positive effects on bone
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formation and fracture healing have been reported on the use of growth factors, 
such as BMP-2 and TGF-B1. As both constituents play a different role in the 
bone healing process, the idea arose for the concomitant use of CaP and growth 
factors in order to further enhance bone regeneration. Several studies have been 
performed, in which growth factors where immobilized on CaP-coated surfaces, 
resulting in a delayed delivery and a higher stability of the growth factor, and 
consequently an enhanced bone formation compared to untreated surfaces89. A 
few reports, however, have been published, concluding that growth factors, in 
particular TGF-B1, are not capable of promoting clinically relevant osteogenesis90,91.
By now, several factors are known to affect the final outcome of growth factors, 
including dose, application mode and site, follow-up time, and animal species.
Therefore, these factors should be subjected to further investigation, in order to 
optimize the use of growth factors in bone regeneration.
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ALP-CaP composites
It is currently known that biological mineralization is a biphasic process. During 
phase I, which is under tight enzymatic cellular control, ALP is the essential 
component, whereas phase II is a physicochemical process without cellular 
control92. In order to mimic this biphasic process, studies have been proposed in 
which both ALP and CaP in a composite coating are immobilized onto Ti implant 
surfaces. Preliminary studies by De Jonge et al., already showed promising results, 
in that CaP agglomerates were observed together with apatite flakes on the 
surface of Ti discs provided with ALP-CaP composite coatings86. Future research 
will need to elucidated in order to unravel the true value of these composite 
coatings for bone regenerative purposes.
Surgical technique
In the field of implantology, most research efforts are focusing on the importance 
of implant surface modification to improve clinical results. Consequently, the 
influence of the surgical implant procedure on the final outcome is often
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underestimated. Regarding implantation, however, every effort should be made 
to minimize damage to the host tissue, e.g. by contaminants, thermal or surgical 
trauma, as an inadequate surgical technique is one of the main causes of implant 
failure93. For instance, heat generated during drilling without adequate cooling 
of the surgical site, will lead to necrosis of the supporting bone that can endanger 
the formation of a viable bone-implant interface. The threshold temperature for 
osteocyte necrosis has been reported to be 50°C and irreversible damage occurred 
at temperatures exceeding 70°C94. Therefore, to reduce the risk of surgical trauma, 
particular emphasis must be placed on avoiding excessive heating of the bone, 
for instance by using serial drills, relatively low drilling speeds, abundant irrigation, 
light hand pressure, and sharp instruments95. Besides the fact that a gentle surgical 
technique is a key element for implant success, differences in surgical technique 
itself can also be of paramount importance for clinical success. Most endosseous 
implants are either threaded or cylindrical and therefore screwed or tapped into 
position, according to differences in implant geometry and the concomitant vari­
ation in insertion modality (e.g undersized, equalsized, or oversized approach).
Multicenter studies on screw and cylindrical implants have shown high long-term 
survival rates for both implant types21,22,96, however, a number of studies also 
demonstrated failure rates for cylindrical-type implants97. Whether these differences 
are due to design or insertion modality is not yet clear and needs to be further 
explored.
Evaluation of implants and surface modifications in animal models
In order to determine whether a newly developed implant or surface modification 
matches the requirements of compatibility to the biological surroundings, and 
above all, safety, it must undergo thorough testing prior to clinical use. In vitro 
studies can provide the first basic information, however, are unable to mimic the 
true tissue response. Therefore, the use of animal models is inevitable. In clinical 
settings, dental and orthopedic implants are subjected to functional loading.
Therefore, specific animal models can be chosen that reflect well the complex 
environment in clinical applications, such as intra-oral implantation models98,99.
It should also be realized that healing responses within different animals and
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tissues can vary significantly, as well as factors like implantation site and local 
bone conditions. For instance, it is known that metabolic and bone healing prop­
erties in rats as well as in rabbits are significantly different from those in human 
bone, making the extrapolation of the obtained results rather difficult (Table 3). 
Furthermore, it should be realized that the available bone for implantation in for 
example femoral bone in rats is rather limited compared to that in goats. Not to 
mention the differences in bone quality and related physical support between 
cortical and trabecular bone. Several studies demonstrated higher failure rates for 
maxillary implants compared to mandibular implants21,100, which are attributed 
to differences in bone density. Therefore, it is desirable to prepare the recipient 
site so as to include at least part of it within cortical bone, thereby ensuring a 
higher primary implant stability as compared to trabecular bone95. For evaluation 
of the bone responses and hence the influence of implant parameters, qualitative 
as well as quantitative analysis techniques have been developed. The conventional 
approach and still the most widely used method to qualify bone responses to 
implants is light microscopical observation of histological sections. This method,
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however, entails several drawbacks as it is: (i) time consuming, (ii) destructive, (iii) 
offers only a limited number of histological sections and (iv) provides only two­
dimensional information on the samples101. Consequently, research has focused 
on imaging techniques that do not entail these limitations. One promising new 
technique is micro-computed tomography, which can be applied to visualize and 
quantify bone in three dimensions. However, as micro-CT is still a relatively new 
technique, studies still need to be undertaken to validate this technique as a 
possible alternative to the conventional evaluation techniques. Finally, for an 
accurate judgment of the obtained results regarding peri-implant osteogenesis, 
animal experiments should be designed in a correct way and statistical analysis 
should be comparative.
T a b le  3 . O v e rv ie w  o f c o m p o u n d s  fo r  c o a t in g  d e p o s it io n  w ith  p o te n tia l to  be a p p lie d  fo r  
b io m im e tic  p u rp o s e s  a n d  th e ir  o ste o in d u c t iv e / o s te o c o n d u c t iv e  p ro p e rt ie s/ e ffe c ts
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Biomimetic agents Osteoinductive Osteoconductive
Bioceramics Hydroxyapatite (HA) No Yes
Calcium phosphate phases No Yes
Biologically active 
compounds
Growth factors (Bone 
Morphogenetic Proteins 
(BMPs), Transforming 
Growth Factor Beta (TGF-B)
Yes No
Enzymes (Alkaline 
phosphatase (ALP) No Yes
Extracellular matrix 
components
Collagen,
glycosaminoglycans (GAGs), 
bone sialoprotein
No Unknown
Ions Fluoride No No
V  O B JECTIV ES OF TH IS  TH ESIS
The work described in this thesis is based on the collaboration between the 
Department of Biomaterials and the Department of Plastic and Reconstructive 
Surgery of the Radboud University Nijmegen Medical Center and is part of the 
DPTE-project 'Osteotropic biomolecule spraying'. The overall aim of this thesis is 
to optimize the biological healing response after implant placement. The interaction 
of an implant surface with its biological surroundings is related to material sur­
face properties and can therefore be significantly improved by modifying implant 
surfaces through the application of different biologically active coatings. Within 
the project, a close collaboration was established with Dr. L.T. de Jonge, whose 
research efforts focused on the development of such novel biologically active 
coatings by using the ESD technique, for the modification of implant surfaces in 
order to improve the biological response. In the present thesis, the newly developed 
coatings are evaluated using different animal models in order to determine the in 
vivo bioactivity and find evidence that justifies their applicability for future clinical
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applications. Consequently, the following sub-aims were specified:
- Evaluate effects of implant geometry on peri-implant bone responses using 
two geometrically different implant types
- Evaluate potential beneficial effect of an electrosprayed CaP coating, either 
or not enriched with TGF-B1 on the osteogenic response
- Investigate the quantitative assessment of peri-implant bone responses using 
two analysis techniques: histomorphometry and micro-computed tomography
- Evaluate the potential in vivo bioactivity of DNA-based coatings
- Evaluate the in vivo bone response to electrosprayed ALP- and ALP-CaP 
composite coatings
- Evaluate the validity of a novel implantation model for evaluation of bone 
healing responses: the goat iliac crest
- Evaluate the mechanical properties as well as the in vivo bone response of 
electrosprayed CaP-nanoparticle coatings
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INTRODUCTION
For decades, an uneventful healing period for several months has been advocated 
for oral implants to avoid fibrous tissue formation, which should result in an 
appropriate fixation of the implant within the native bone tissue1. As during this 
healing period the implants should be prevented from any form of loading, patients 
experience this 'waiting period' as very inconvenient15. Therefore, despite the 
high clinical success rates of oral implants43,3,6. optimization of the initial bone 
healing response after implant placement is still an important issue. In addition, 
the desire to use oral implants in more challenging clinical situations drives the 
need for continuing refinements in implant design, surface characteristics, and 
optimization of the biological healing response following implant placement8. 
Over the last few decades many different implant designs have been introduced 
to optimize the anchorage of an implant in bone tissue, i.e. the rapid achievement 
and maintenance of direct bone-implant contact33. Implant designs range from 
threaded to non-threaded, cylindrical or conical, either or not combined with ad-
38
ditional features, such as vents, grooves, indentations or perforations38,31,42,39. 
Despite the available data on the effect of single implant designs, the number of 
studies that directly compare different implant geometries is limited.
In addition to implant design, implant surface properties are an important factor 
in the biological healing response. Consequently, surface modifications represent 
a tool to enhance the biological response into a desired direction. The main 
consequences of the available surface modification techniques can be reduced to 
effects on surface topography (roughness or texture) or surface chemistry (or a 
combination thereof)34. It has been claimed that a certain degree of roughness 
leads to an increased mechanical stability through surface enlargement and 
mechanical interlocking with the surrounding bone35,13. In addition, some studies 
indicate that rougher surfaces increase the degree and rate of peri-implant bone 
formation 34.
Regarding surface chemistry, beneficial effects on bone response have been 
ascribed to the deposition of ceramic materials, such as calcium phosphates 
(CaP)19,11 and bioglass44,48. These so-called 'bioactive' materials have the ability
to bond bone directly, without an intervening layer of soft tissue, thereby making 
them suitable as coatings onto bone anchored implants12,11. Various techniques 
have been used to deposit CaP coatings onto an implant surface, among which 
plasma spraying and magnetron sputtering are the most widely used. Although 
the osteoconductive and bone-bonding behaviour of plasma-sprayed and magne­
tron sputter coatings has been confirmed by numerous studies20,10,18,22,23,16, still 
some important limitations there are related to these techniques. Plasma-sprayed 
coatings are relatively thick (> 30 |_im), which may result in coating delamination 
and fragmentation, thus in time influencing the long-term stability of the implants41.
Moreover, the crystallinity, composition, and thickness of the coatings are not uni­
form. By using the magnetron sputter technique, thinner (< 5 |_im), more dense 
and adherent coatings can be obtained20, but it is still challenging to vary the 
coating composition. These problems can be overcome using the Electrostatic 
Spray Deposition (ESD) technique, which is a simple and versatile technique that 
allows deposition of thin (2-3 |_im) CaP coatings with a wide variety of chemical 
and morphological characteristics26,25 .
39
Bone healing responses can be further stimulated using appropriate growth 
factors14. Among these factors, members of the TGF-B superfamily appear to 
play the most critical role in bone healing17. For example, TGF-B1 has been 
shown to stimulate bone healing in several animal models21,5. Moreover, previous 
studies have reported on the ability of TGF-B1 to enhance bone healing around 
ceramic-coated implants in unloaded gap-healing models40,28,29,27.
In view of the described effects of implant design, surface properties, and enrich­
ment with biologically active factors, the present study aimed at evaluating these 
parameters in a comparative study design. Therefore, two geometrically different 
dental implants (screw-type (St) and push-in type (Pi)) were used in an implantation 
study in goats. Additionally, these implants were modified using an electrosprayed 
CaP coating, either enriched or not with the osteoinductive growth factor TGF-B1.
Implants were inserted into the trabecular bone at the medial side of both 
femoral condyles for 12 weeks. Evaluation consisted of qualitative (histology 
and fluorochrome labeling) as well as quantitative (histomorphometry) analyses 
of the peri-implant bone response.
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M ATERIALS AND M ETHODS
Materials
Prototypes of two geometrically different oral implants, made of Ti-6AL-4V alloy, 
and with a smooth surface (Figure 1) were provided by Dyna Dental Engineering 
BV (Bergen op Zoom, the Netherlands):
• Cylindrical, Screw-type (St) implant (diameter: 4.2 mm; length: 10 mm)
• Cylindrical, Push-in (Pi) implant with grooves (diameter: 3.6 mm; length:
10 mm)
Recombinant human TGF-B1 was obtained from R&D Systems Inc. (Minneapolis, 
USA). Fluorochromes Alizarin (Alizarin Complexon dehydrate), Calcein (Fluorexon), 
and Tetracycline were acquired from Acros Organics (Geel, Belgium).
Electrostatic spray deposition (ESD) process
Prior to CaP coating deposition, implants were cleansed ultrasonically in nitric 
acid 10%  (15 min), acetone (15 min) and ethanol (15 min), successively. For CaP
40
coating deposition, a vertical ESD set-up (Advanced Surface Technology, Bleiswijk, 
the Netherlands) was used, as described previously by Leeuwenburgh et al.24. 
In brief, the basic principle of ESD is the generation of a so-called electrospray 
of organic solutions containing the inorganic precursors Ca and P This is 
accomplished by pumping this solvent through a nozzle, which is connected to 
a high voltage supply. As a result of the applied potential difference, a spray 
consisting of charged, micron-sized droplets is formed, which are attracted 
towards a grounded and heated substrate. Consequently, the droplets impinge 
onto the heated substrate, where they lose their charge. After complete solvent 
evaporation, a thin layer (2-3 |_im) consisting of the inorganic product is left on 
the substrate surface.
In this study, implants were coated in 3 runs (in turns of 120°) of 45 minutes each 
, at a substrate holder temperature of 475°C, a nozzle-to-substrate distance of 20 
mm, and a precursor liquid flow rate of 2.0 ml/h. Coatings were prepared using 
precursor solutions with a Ca/P ratio of 1.8 (Ca(NO3)2. 4H2O and H3PO4 were
precursors for Ca and P respectively). Subsequently, all coated implants were 
subjected to an additional heat-treatment for 2 hours at 700°C in order to 
transform the amorphous coatings into crystalline carbonated hydroxyapatite 
(CHA) coatings37. The morphology of the CaP-coatings was characterized using 
Scanning Electron Microscopy (SEM, Jeol, SEM6310, Tokyo, Japan). In addition,
X-ray diffraction (XRD) using a thin film Philips X-ray diffractometer (PW3710,
Almelo, The Netherlands), and Fourier Transform Infrared Spectrometry (FTIR;
Perkin Elmer Instruments, Zoetermeer, the Netherlands) were used in order to 
characterize the crystal structure and the molecular structure of the deposited 
coatings, respectively.
TGF-B1 loading
For growth factor loading, TGF-B1 was dissolved in sterile 4 mM HCl containing 
1 mg/ml bovine serum albumin (BSA; Sigma Aldrich, Zwijndrecht, the Netherlands). 
Administration was achieved by direct adsorption of the growth factor onto the CaP 
coated implants. Aseptic conditions were maintained throughout the adsorption
41
process. A volume of 6 |_il of the HCl/BSA solution (containing 1.0 |jg TGF-B1) was 
pipetted onto each implant. After loading, implants were immediately stored at 
- 80°C for 1 hour, and placed in a 24-well plate for overnight lyophilisation.
Experimental animal groups
In the animal study, a total of 6 different experimental groups were used:
1. St (Screw-type), non-coated
2. St + CaP (Screw-type with CaP coating)
3. St + CaP + TGF-B1 (Screw-type with CaP coating loaded with TGF-B1)
4. Pi (Push-in type), non-coated
5. Pi + CaP (Push-in type with CaP coating)
6. Pi + CaP + TGF-B1 (Push-in type with CaP coating loaded with TGF-B1)
Sterility was obtained through autoclavation of non-coated and CaP-coated 
implants. TGF-B1 enrichment of CaP-coated implants was performed after 
autoclavation under aseptic conditions.
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Fig. 1. Representation of implant designs used in this 
study: Screw-type (St; left) and Push-in (Pi; right).
Surgical procedure
All in vivo work was conducted in accordance with ISO standards, and protocols 
of the University Medical Center, Nijmegen, the Netherlands. National guidelines 
for the care, and use of laboratory animals were observed, and approval of the
42
Experimental Animal Ethical Committee was obtained. A total of 54 implants (9 
implants of each experimental group; n=9) were implanted into 9 female Saanen 
goats (2-4 years of age), with a mean body weight of about 50 - 60 kg. Surgery 
was performed under general inhalation anesthesia and sterile conditions. To re­
duce the peri-operative infection risk, the prophylactic antibiotic Albipen® was 
administered subcutaneously (Albipen 15% , 3 ml/50 kg pre-operative and Albi­
pen LA, 7.5 ml/50 kg for 3 days post-operative, Intervet BV, Boxmeer, the Nether­
lands). Anesthesia was initiated by an intravenous injection of Pentobarbital® 
(AUV Wholesale, Cuijk, the Netherlands). Subsequently, the goats were intubated 
and connected to an inhalation ventilator with a constant volume of a mixture of 
nitrous oxide, isoflurane, and oxygen. Before the insertion of the implants, each 
animal was immobilized on its back and the hind limbs were shaved, washed, and 
disinfected with povidone-iodine. For implantation of the implant in the femur, a 
longitudinal incision was made on the medial surface of the left and right femur. 
Subsequently, landmarks were placed in the femoral condyle, and a radiographic 
image was made to localize the trabecular bone. After exposure of the femoral
c o n d y le ,  a  2 .0  m m  p ilo t  h o le  w a s  d r il le d , w h i c h  w a s  g r a d u a l ly  w id e n e d  w i t h  d r ills  
o f  in c r e a s in g  s iz e  u n t il t h e  f in a l d ia m e t e r  w a s  r e a c h e d .  T h e  f in a l d rill f o r  b o th  th e  
St-  a n d  P i- im p la n ts  h a d  a  d ia m e t e r  o f  4 .0  m m . T h e  b o n e  d e f e c t  p r e p a r a t io n  w a s  
p e r f o r m e d  w i t h  a  g e n t le  s u rg ic a l  t e c h n iq u e ,  u s in g  lo w  r o t a t io n a l  d rill s p e e d s  
(8 0 0 - 1 2 0 0  rp m ), a n d  c o n t in u o u s  e x te rn a l  c o o l in g  w i t h  s a lin e . In  th is  w a y ,  3 h o le s  
w e r e  m a d e  o n  t h e  m e d ia l s id e  o f  t h e  c o n d y le  (p ro x im a l,  m e d ia l ,  a n d  d is ta l w i t h  a n  
in t e r  im p la n t  d is t a n c e  o f  1 .0  c m ) . A f t e r  p r e p a r a t io n ,  t h e  h o le s  w e r e  i r r ig a te d  a n d  
t h e  im p la n ts  in s e r te d .  In e a c h  fe m u r ,  3 im p la n t  s ite s  w e r e  lo c a t e d ,  r e s u lt in g  in 6  
s ite s  p e r  g o a t  ( F ig u re  2 ). To e n s u re  c o m p le t e  r a n d o m iz a t io n ,  t h e  im p la n ts  w e r e  
p la c e d  a c c o r d in g  t o  a  b a la n c e d  s p lit- p lo t  d e s ig n .  H o w e v e r ,  t o  a v o id  c ro s s - o v e r  
e f f e c t s ,  a ll im p la n t s  c o n t a in in g  T G F - B 1  w e r e  g r o u p e d  t o g e t h e r  a n d  p la c e d  in 
le f t  f e m u r s  o n ly . A f t e r  in s e r t io n  o f  t h e  im p la n ts ,  t h e  s o f t  t is s u e s  w e r e  c lo s e d  in 
s e p a r a t e  la y e rs ,  a n d  t h e  s k in  w a s  c lo s e d  t r a n s c u t a n e o u s ly  u s in g  r e s o rb a b le  V ic r y l®
4-0  s u tu re s  (E t h ic o n  P ro d u c ts ,  A m e r s fo o r t ,  t h e  N e th e r la n d s ) .  To r e d u c e  p a in  a f t e r  
s u rg e r y ,  a ll g o a t s  r e c e iv e d  F in a d y n e ®  ( A U V  W h o le s a le ,  C u ijk ,  t h e  N e th e r la n d s )  
f o r  2 d a y s  p o s to p e r a t iv e ly .  P o s t o p e r a t iv e  r a d io g r a p h s  w e r e  c o n d u c t e d  t o  c h e c k
43
im p la n t  p la c e m e n t .  To v is u a liz e  t h e  d y n a m ic s  o f  b o n e  g r o w t h ,  4  g o a t s  re c e iv e d  
s e q u e n t ia l  f lu o r o c h r o m e  la b e ls  a t  1, 6 , 9 , a n d  11 w e e k s  p o s t o p e r a t iv e  ( T a b le  1 ).
A ll  la b e ls  w e r e  a d m in is te re d  s u b c u ta n e o u s ly  a t  2 5  m g /k g  b o d y  w e ig h t .  A t  3 m o n th s  
p o s t- im p la n ta t io n ,  e u t h a n a s ia  w a s  p e r f o r m e d  w i t h  a n  o v e r d o s e  o f  N e m b u ta l® ,  
a n d  th e  im p la n ts  w i t h  s u r ro u n d in g  t is s u e  w e r e  re t r ie v e d  fo r  h is to lo g ic a l e v a lu a t io n .
Right fomur Left femur
I_____________________I Fig. 2. Location of implant sites in the medial
femoral condyle. The black bars represent the 
Medial condyle implants.
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Table 1. Schem e fo r subcutaneous fluo rochrom e adm inistration at 
tim ed intervals
Weeks before sacrifice Fluorochrome marker Color Dose
11 Tetracycline Yellow 2 5 mg/kg
9 Calcein Green 25 mg/kg
6 Alizarin complexon Red 25 mg/kg
1 Calcein blue Blue 25 mg/kg
Histological preparations
After the animals were sacrificed, the femoral condyles were retrieved, excess 
tissue was removed, and, using a diamond circular saw, the condyles were divided 
into smaller specimens suitable for histological processing. Finally, each specimen 
contained only 1 implant with surrounding bone. Subsequently, the tissue blocks 
were fixed in 10%  neutral buffered formalin solution, dehydrated in a graded 
series of ethanol (70-100%), washed with acetone, and embedded in methyl
44
methacrylate (M M A) for 4 weeks. After polymerization, non-decalcified thin 
longitudinal sections (10-20|_im) of the implants were prepared (at least 3 of each 
implant), using a modified sawing microtome technique45, and stained with 
methylene blue and basic fuchsin. Specimens from the 4 goats that received 
fluorochromes were processed to obtain both unstained and stained sections.
Histological and histomorphometrical evaluation
To evaluate the trabecular bone response to the implants, histological as well as 
histomorphometrical analysis were performed. Histological evaluation using a 
light microscope DMRD (Leica Microsystems AG, Wetzlar, Germany) consisted of 
a concise description of the observed tissues reaction, including the structure and 
arrangement of cells, implant, and tissue-implant interface. In addition, a computer- 
based image analysis technique (Leica Qwin Pro-image analysis software; Leica 
Imaging Systems, Cambridge, UK) was used for histomorphometrical evaluation. 
The quantitative measurement was performed for 3 different sections per implant, 
on each side of the 2D histological image. The average of these 6 measurements 
was used for statistical analysis. The quantitative parameter as assessed was the
bone-implant contact (at magnification 25x). Therefore, the amount of bone 
contact was defined as the percentage of implant length at which there is direct 
bone-to-implant contact without intervening soft tissue layers. Measurements 
were performed along the length of the implant; for the St-implant, starting at 
the first coronal screw thread, and for the Pi-implant, starting at the beginning 
of the first concave thread (total standardized distance of interest 4000 |_im).
Fluorochrome labeling
For fluorochrome labeling analysis, a reflectant fluorescence microscope was 
used (Leica Microsystems AG, Wetzlar, Germany). In addition, a Zeiss filter No. 05, 
consisting of a 395 - 440 nm band-pass excitation filter, was used for visualization 
of the different fluorochromes.
Statistical analysis
Measurements were statistically evaluated using SPSS 14.0 (SPSS Inc., Chicago,
USA). Data obtained with histomorphometry regarding bone-implant contact were
45
analyzed using a linear regression model. The dependent variable was represented 
by 'bone contact', whereas the independent variables were represented by, 'implant 
design', 'presence of CaP' and 'presence of TGF-B1. By using this model the effect 
of the independent variables on bone-implant contact could be evaluated. The 
significance level was set at a probability (p) value smaller than 0.05.
RESULTS
Coating characterization
SEM observations showed a uniform surface coverage of the implant. The electro­
sprayed CaP coatings revealed a porous, reticular surface morphology (Figure 3).
Heat treatment increased coating crystallinity and resulted in a CHA structure as 
confirmed with XRD and FTIR (data not shown). Additionally, XRD measurements 
showed reflection peaks of TiO2 at 27.6 and 36.2° 20 for heat treated CaP coatings, 
which were absent in non-heat treated CaP coatings. The coatings were crack 
free after the heat treatment at 700°C.
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Fig. 3. Scanning electron micrograph of 
the porous CaP coating as deposited using 
Electrostatic Spray Deposition.
General observations experimental animals
All 9 goats remained in good health during the experimental period without any 
postoperative wound healing complications. At sacrifice, no signs of inflammation 
or adverse tissue reaction could be seen around the implants. Table 2 depicts 
46 the number of implants placed, retrieved after implantation, and included in the
histological and histomorphometrical analyses. Of the 54 installed implants, a total 
of 53 implants could be retrieved. One implant was not found during retrieval. 
Throughout histological processing, 5 implants were damaged, and hence not 
included for analyses. A total of 48 implants were used for analyses.
Table 2. N um ber o f implants placed, retrieved and used fo r histological and 
histom orphom etrical analyses
# implants used for
# implants placed # implants retrieved analyses
St Non-coated 101 10 93
CaP 9 9 9
CaP + TGF-^1 8 1 8 73
Pi Non-coated 9 82 8
CaP 9 9 83
CaP + TGF-^1 9 9 73
1 During implantation one St + CaP + TGF-p1 implant was lost, and replaced by one non-coated St- 
implant
2 During explantation one non-coated Pi-implant could not be retrieved
3 During histological preparation one non-coated St-implant, one St + CaP + TGF-p1, one Pi + CaP, and 
one Pi + CaP + TGF-p1 implant were damaged
Descriptive histological evaluation
Light microscopic examination of the methylene blue/basic fuchsin-stained 
sections of the implants and its surrounding tissue demonstrated that one of the 
implants (non-coated Pi) was inserted very close to the growth plate cartilage, but 
no contact between the implant and the growth plate was seen. Also, for another 
implant (St + CaP + TGF-B1), inflammatory cells were observed at the implant 
surface. Generally, in all sections, bone apposition, bone remodeling, and ingrowth 
of newly formed bone into the threads of the implants were observed.
In all St-implants, except for one, an intimate contact between the implant and 
surrounding bone was observed. The screw threads were almost completely 
filled with bone (Figure 4, St-implants), but around one non-coated St-implant, 
an intervening fibrous tissue layer was present at the crestal area of the implant.
In the sections of 4 Pi-implants (3 non-coated, and 1 CaP coated), a gap was 
observed between the surrounding bone and implant surface (Figure 4, Pi-implants), 
resulting in no implant-bone contact at all. In all other Pi-implants a close bone- 
to-implant contact was observed.
47
For all St- and Pi-implants, except for one, the CaP coated equivalents, whether 
or not enriched with TGF-B1, showed a close bone-to-implant contact (Figure 4,
CaP coated implants). In these sections the presence of bone on top of the thread, 
and conducting over the implant surface into the threads was observed.
Non-coated CaP CaP ♦ TGF-U1
Fig. 4. Representative histological sections of Screw-type (St) and Push-in (Pi) implants after 12 weeks of implantation 
in the femoral condyles of goats.
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Fluorescence microscopy
The consecutive fluorochrome markers, laid down in the form of bands, were 
observed around the implants in the sequence of their administration (Figure 5A 
and 5B). In contrast to the labels, alizarin complexon (red), calcein (green) and 
tetracycline (yellow), the presence of the calcein blue label, administered 1 week 
after implantation, could not be clearly identified.
Detailed observation of the images showed the yellow line very close to the 
implant surface and bone marrow spaces in the trabecular bone, and the green 
and red line more towards the peripheral areas (away from the implant surface) 
with about equal distances between the lines. This band formation was absent in 
images of the non-coated groups.
Fluorochromes in the non-coated groups of both implant types, i.e. St and Pi, 
showed a less intense fluorescence signal compared with the surface modified 
groups, i.e. CaP coated, enriched with TGF-B1 or not (Figure 6A and 6B). In general, 
a more pronounced signal was seen at sites were new bone was formed.
Histomorphometrical analysis
The results of the bone-implant contact measurements and the outcome of the 
statistical analyses are depicted in Figure 7 and Table 3, respectively. Considering 
geometry, a significantly higher (12 .5% ) bone-implant contact was observed for 
St-implants compared to Pi-implants (p = 0.004). Furthermore, surface modification 
using the electrosprayed CaP coating showed a significantly higher (19 .7% ) bone 
contact (p < 0.001) compared with their non-coated equivalents. The enrichment 
of CaP coated implants with TGF-B1, however, was not statistically significant 
(8 .0% ; p = 0.147) compared to CaP-coated implants.
Fig. 5. Fluorescence microscopy images of histological sections of fluorochrome-administered experimental animals. 
Colors indicate bone formation at 1 (blue; calcein blue), 6 (red; alizarin-complexon), 9 (green; calcein green), and 
11 (yellow; tetracycline) weeks post-implantation.
49
Fig. 6 . Fluorescence microscopy images of histological sections of fluorochrome-administered experimental animals. 
The colour indicates bone formation at 9 weeks post-implantation (green; calcein green). Images indicate bone 
formation predominantly in the implant vicinity.
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Fig. 7. Results of histomorphometric analyses of Screw-type (St) and Push-in (Pi) implants in femoral condyles 
of goats. Bone-implant contact of St- and Pi-implants after 12 weeks of implantation is displayed for the different 
experimental groups. Bars represent the mean + standard deviation. No interaction between the experimental 
variables was found. # Significantly higher bone implant contact fot St-implants compared with Pi-implants.
* Significantly different compared with non-coated controls.
Table 3. Bone  contact percentages and statistical testing o f the experimental 
variables
Bone-implant contact 95%  Confidence Interval
Effect Lower Upper p-value
Intercept 60,1 44,2 76,1 < 0 ,1%
Implant Design (Pi = 1, St = 0) -12,5 -20,9 -4,2 0,4%*
CaP (with = 1, without = 0) 19,7 10,4 28,9 < 0 ,1% *
TGF-/T7 (with = 1, without = 0) 8,0 -2,9 18,9 14,7%
CaP, calcium phosphate; TGF-^1, transforming growth factor beta-1
* Indicates statistically significant effect (p < 0.05).
DISCUSSION
The aim of this study was to evaluate the effect of implant geometry on 
bone healing responses in an in vivo goat femoral condyle model. Furthermore, 
the potential beneficial effect of an electrosprayed CaP coating, enriched with 
TGF-B1 or not, on bone healing was evaluated. The results of this study showed 
a significant effect on bone healing response of both implant geometry and CaP 
coating, whereas additional enrichment of CaP coated implants with TGF-B1 did 
not further enhance peri-implant bone response.
A prerequisite for successful orthopedic and dental implant placement is to 
obtain a good primary stability of the implant in the surrounding bone2. The 
establishment of such a mechanically stable interface prevents the development 
of an intervening layer of fibrous tissue35. In view of currently available implant 
systems, it needs to be emphasized that the degree of primary stability, besides 
bone quality, largely depends on implant design and insertion modality. For this 
reason, the current study included two geometrically different implant designs
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(Screw-type, St; Push-in, Pi). W ith respect to implant geometry, the results of this 
study indicate that bone-implant contact is superior for St- over Pi-implants.
This observation corroborates published data of other experiments, in which 
different animal models were used39,47. An explanation for the higher implant- 
bone contact for St-implants is that, relative to their length, St-implants offer the 
surrounding bone a larger surface area compared to Pi-implants. Moreover, the 
manufacturer's recommendations for insertion of the St-implants actually involve 
screwing implants into an undersized defect, whereas the advise for Pi-implants 
is to push the implants into an oversized defect. Consequently, the placement of 
St-implants is associated with shear forces at the interface, hence loosening small 
bone fragments. These bone fragments are likely to be pressed in between the 
trabecular voids and in between the screw threads during implant placement, 
enhancing new bone formation35. In addition, during implant placement a degree 
of compression will take place along the implant-bone interface, which further 
enhances implant stability32. When such an undersized approach is used for 
cylindrical Pi-implants, there may be an increased risk of (i) failing to place the
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implant fully into the drill hole, and (ii) detrimental effects of bone tissue 
compression, potentially causing local cellular damage, resulting in cell death, 
necrosis and ultimately bone resorption32. Due to the visco-elastic properties 
of bone, an oversized bone cavity is always drilled for cylindrical implants, 
implicating less primary stability as compared with St-implants.
To improve bone-implant contact, bioactive materials, such as CaP ceramics, have 
been used successfully. These materials are characterized by their potential to 
form a very tight, chemical bond with the surrounding bone, i.e. 'bone-bonding'12. 
Due to their favorable biological behavior, bulk CaP ceramics have been widely 
used in the orthopedic and dental field. As bulk materials, however, the mechan­
ical properties of CaP ceramics are too weak, limiting their use in load-bearing 
situations. Consequently, CaPs are applied as coatings onto mechanically strong 
(metallic) implants. Numerous studies have already confirmed the osteoconductive 
and bone-bonding behavior of CaP coatings19,18. Similar positive data were ob­
tained in an animal gap-study, showing that gaps of 1.0 mm can only be bridged 
by bone if a CaP coating is applied, whereas uncoated implants demonstrated no 
bone contact at all7.
Various deposition methods have been proposed to apply CaP coatings onto 
implants, among which plasma-spraying, and magnetron sputtering are the most 
widely used. A major drawback of both coating techniques is the lack of control 
over the final coating composition and morphology. Consequently, promising CaP 
phases, like carbonate apatite, which comprise a chemical composition closest 
to bone and teeth, cannot be deposited20,26. To overcome these problems, the 
ESD technique was used in the present study to deposit carbonated apatitic CaP 
coatings. Leeuwenburgh et al.24 already confirmed the feasibility of the ESD tech­
nique for the deposition of thin CaP coatings with a defined surface morphology, 
by varying the deposition parameters. Moreover, by varying the Ca/P precursor 
solution ratio, and applying an additional heat treatment, this technique is able 
to control coating composition and crystallinity26. Despite the improved mechanical 
strength and interfacial adhesion, no data are available yet, that can provide 
information regarding whether the coating remains stable after implantation.
However, the observed biological response in the present study proves that during 
the initial bone healing process, the CaP coating exposed its biological effect by 
enhancing the bone formation around the implanted materials. Additionally, as 
a result of the heat treatment oxidation of the titanium substrate occured, which 
was demonstrated through XRD-analysis. Though, the authors are aware of effects 
of heat treatment on the mechanical properties of titanium, the current study did 
not evaluate this parameter.
In addition to the deposition of a CaP coating, the potential beneficial effect of 
TGF-B1 on the peri-implant bone response was also evaluated in this study. It is 
recognized that TGF-B1 might have effects in the vicinity of the implant, however 
thorough histological observations did not support this suggestion. With respect 
to the study design, the combination of TGF-B1 with a non-coated implant was 
not included. It should be realized that most growth factors, including TGF-B1, 
are very expensive. Only a significant extra effect, beyond the effect of a CaP 
coating alone, may value these high costs. To prove such an effect, only the 
combination of CaP-coated implants and TGF-B1 was selected. Over the last
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decade, several studies have been performed to evaluate the effects of TGF-B1 
in vitro and in vivo, which obtained rather mixed results. For example, 2.0 |jg 
TGF-B1 applied in a 3 %  methylcellulose gel was able to regenerate a critical 
size defect in a rabbit skull within 28 days; 0.1- and 0.4 |jg showed less bone 
formation4. In a non-critical size rabbit skull model the combination of a Ti fiber 
mesh implant with 2.0 |jg TGF-B1 induced orthotopic bone formation46. Further, 
in a canine model, porous coated implants showed a more effective bone ingrowth 
with a dose of 120 |jg TGF-B1, compared with a dose of 335 |jg TGF-B140. In the 
present study, no significant effects of TGF-B1 on bone healing were observed.
The reason for this lack of beneficial effects of TGF-B1 remains unclear. A possible 
explanation may be the dose-responsive effect for TGF-B1. However, as shown 
in the available literature higher doses do not necessarily generate more bone 
formation, as there is an optimum dose. Therefore, in the present study it was 
decided to load the implants with 1.0 |jg TGF-B1. In addition to the dose­
responsive effect, data have been published suggesting a positive correlation
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between the in vivo osteoinductive activity of TGF-B1, and the amount of protein 
retained at the site of implantation. Consequently, if less growth factor is retained, 
a higher dose is needed for the same osteoinductive response. Although growth 
factor retainment was not assessed in this study, the amount of TGF-B1 remaining 
on the implants in the present study might have been below the optimal osteoinduc­
tive level. Several in vitro studies have been performed to determine the release 
characteristics of TGF-B1. For instance a burst release of 7 0 %  of TGF-B1 was 
observed from a titanium fiber mesh implant46. Lind et al. found a burst release 
of 80%  of TGF-B1 adsorbed onto tricalcium phosphate coated implants29. Loading 
an electrosprayed B-tricalcium phosphate coating with TGF-B1 also resulted in a 
burst release of > 90%36. Analogue to this relatively fast and almost complete 
in vitro release of TGF-B1, the release in the current study may have resulted in 
suboptimal amounts of TGF-B1 both spatially and temporarily. Therefore, the 
need for a slow and more gradual release still exists and has to be investigated. A 
possible solution can be found by the incorporation of the growth factor into the 
carrier material, as proposed by Liu et al.30, who incorporated BMP-2 during the
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deposition of a biomimetic CaP coating onto a titanium implant by co-precipitation. 
Future research is needed to find a suitable technique for the incorporation of 
biologically active compounds in order to create a more gradual release, or an 
optimized combination of a burst and sustained release profile.
In summary, this study demonstrates that the peri-implant healing response 
following implant placement is dependent of both implant design and surface 
modification. W ith respect to implant design, Screw-type (St) implants show an 
overall better biological healing response over Push-in (Pi) implants. Considering 
surface modification, the deposition of an electrosprayed CaP coating onto 
implants significantly increased the amount of bone-implant contact. Further, 
enrichment of the CaP coating with the osteoinductive growth factor TGF-B1 did 
not show an additional effect on peri-implant bone response. The results of this 
study consequently indicate that a substantial improvement of the osteogenic 
response to titanium implants can be obtained by the deposition of an electro­
sprayed CaP coating. The enrichment of the coating with 1.0 |jg TGF-b1 has only 
a marginal effect.
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INTRODUCTION
In oral implantology, the most important research goal is to design implants that 
induce predictable, controlled, guided, and rapid healing at their bone-implant 
interface. Obtaining such an optimal bone-implant interface depends on numerous 
factors, including implant-related factors (e.g. material, design, surface character­
istics), biomechanical factors (e.g. mechanical loading), surgical factors (e.g. 
surgical technique, experience, implantation location) and patient variables (e.g. 
bone quantity and quality)1-3. Years of fundamental and applied research have 
led to the development and commercial exploitation of more than 1300 implant 
designs4, each with their specific surface modification, some of them claiming 
success rates up to 9 9 % 5-7. Nevertheless, despite these high clinical success 
rates8-10 user demands drive the need for continuing refinements. For instance, in 
patients with a compromised medical condition (e.g. due to irradiation therapy 
or bone metabolic disorders, such as osteoporosis), implant failure rates are still 
substantially higher compared to those in healthy patients11,12.
Immediately upon implantation, the cascade of events at the bone-implant 
interface starts with the adsorption of proteins, originating from blood and 
tissue fluids at the wound site, onto the implant surface1. Consensus exists on 
the pivotal role this 'conditioning film of adsorbed proteins' plays in the 
host response13. Simultaneously, cellular responses are initiated through the 
infiltration of inflammatory and connective tissue cells. Subsequently, osteogenic 
cells deposit a non-collagenous matrix layer onto the implant surface, similar to 
the bone cement line and lamina limitans12. This early calcified afibrillar layer, rich 
in calcium, phosphorus, osteopontin and bone sialoprotein, forms regardless 
of the type of biomaterial implanted and provides a mechanism for optimal 
'bonding' between native hard tissue and a biomaterial3. Consequently, it is 
presumed that peri-implant osteogenesis starts from two different directions:
(i) from the cement line structure initially formed at the implant surface towards 
the host bone (contact osteogenesis), and (ii) from the cement lines at the 
remodeling borders of the surgically created bone cavity towards the implant 
surface (distance osteogenesis)14,15. In view of the afore mentioned, three
separate peri-implant zones can be discerned; the inner zone (0 - 500 jm ) 
correlating with the area of contact osteogenesis, the middle zone (500 - 1000 |jm) 
in which distant osteogenesis takes place and the outer zone (1000 - 1500 jm ) 
indicative for the 'unattached' preexistent bone.
A prerequisite for peri-implant bone formation is the continuous recruitment 
around, and migration of osteogenic cells to the implant surface. Consequently, 
much effort is being devoted to methods of modifying design and surfaces of 
implants to provoke the desired biological healing response. Beside the availability 
of implants in many shapes (e.g. screws, cylinders), sizes and lengths16-19, also a 
wide variety of surface modifications have been tested, ranging from relatively 
smooth surfaces to those roughened by grit blasting, acid etching, or combinations 
of these techniques7,20-23. Regarding surface chemistry, it has been heavily 
documented that the deposition of ceramic materials onto implant surfaces, 
such as calcium phosphates (CaP), favors early bone responses24. The last decade, 
the interest in the use of biological molecules (e.g. growth factors) to further 
stimulate bone-healing responses, has grown substantially. Among these factors,
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members of the TGF-B super-family appear to play a critical role in bone healing25, 
i.e. stimulating osteogenesis in orthotopic sites26-28 or even enhancing bone 
healing around ceramic-coated titanium implants in gap-healing models29-31. 
Nevertheless, despite all positive data of different implant designs and their 
surface modifications inducing a certain degree of bone healing around implants, 
there is no uniform strategy about the optimal implant yet.
To evaluate bone responses and hence the influence of implant parameters both 
qualitatively as well as quantitatively, different analysis techniques have been 
developed. The conventional approach, which still is the most widely used method 
to qualify bone morphology and architecture, entails microscopic observations of 
thin histological sections. Although this method offers high resolution and image 
contrast, it is time consuming, involving substantial preparation of the specimens, 
including embedding in methylmethacrylate followed by sectioning. Consequently, 
unfavorable changes or damages to the tissues during preparation and sectioning 
of the specimens can occur. Particularly limiting is the destructive nature of the 
procedure, preventing the specimen from being used for other measurements32.
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Another important drawback of histological sectioning is the loss of material 
that occurs during sawing, due to the thickness of the sawing blade (± 300 jm), 
resulting in a rather limited number of histological sections per implant33. Finally, 
this methodology provides only two-dimensional information and is based on the 
assumption that the section(s) of the sample selected for analysis, are representative 
for the entire specimen.
To overcome important limitations related to this conventional method of analysis, 
research has focused on imaging techniques that are able to visualize complex 
three-dimensional structures. One promising new technique is micro-computed 
tomography (micro-CT), which is an approach that can be applied to image and 
quantify cortical and trabecular bone in three dimensions. This technique offers 
some major advantages: (i) it gives full 3D information, (ii) samples require only 
limited preparation, (iii) it is non-invasive and non-destructive, and (iv) it has a 
broad application field on different materials33. However, as micro-CT is still 
relatively new, the procedures utilized to assess and analyze bone structure 
quantitatively are not yet fully standardized.
Considering the afore mentioned, the present study aimed at evaluating the 
effects of implant design and surface properties on the peri-implant bone response 
in a comparative study design. Additionally, the interchangeable value of two 
analysis techniques, i.e. conventional histomorphometry versus micro-CT was 
studied. In brief, two geometrically different dental implants (Screw type (St) and 
Push-in (Pi)), either or not surface modified (non-coated, CaP-coated, or CaP- 
coated+TGF-B1) were inserted in the medial femoral condyles of 9 goats for 12 
weeks. To evaluate the peri-implant bone response adequately, three different 
zones (inner: 0 - 500 jm ; middle: 500 - 1000 jm ; and outer (1000 - 1500 jm ) 
were defined around the implant.
M ATERIALS AND M ETHODS
Materials
Prototypes of two geometrically different oral implants, made of Ti-6AL-4V alloy, 
with a smooth surface (Figure 1) were provided by Dyna Dental Engineering BV 
(Bergen op Zoom, the Netherlands): conical, Screw type (St) implants (diameter:
4.2 mm; length: 10 mm) and cylindrical, Push-in (Pi) implant with grooves (diameter:
3.6 mm; length: 10 mm).
Recombinant human TGF-B1 was obtained from R&D Systems Inc. (Minneapolis,
USA).
Electrostatic spray deposition (ESD) process
In the current study, a commercially available vertical ESD set-up (Advanced 
Surface Technology, Bleiswijk, the Netherlands) as described previously34 was 
used to deposit CaP coatings. Prior to CaP coating deposition, implants were 
cleaned ultrasonically in nitric acid 10%  (15 min), acetone (15 min) and ethanol
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(15 min), successively. The basic principle of ESD is the generation of a so-called 
electrospray of organic solutions containing the inorganic precursors Ca and P.
This is accomplished by pumping this solution through a nozzle, which is connected 
to a high voltage supply. As a result, a spray consisting of charged, micron-sized 
droplets is formed, which are attracted towards a grounded and heated substrate. 
Consequently, the droplets impinge onto the heated substrate, the solvent 
evaporates, and a thin layer (2-3 jm ) consisting of the inorganic product is left on 
the substrate surface.
In this study, implants were coated in 3 runs (i.e. turning the implant 120° 
for each run) of 45 minutes each, at a substrate holder temperature of 475°C, a 
nozzle-to-substrate distance of 20 mm, and a precursor liquid flow rate of 2.0 
ml/h. Ca and P precursor solutions were prepared by dissolving Ca(NO3)2 • 4H2O 
(5 mM, Merck Chemicals Ltd, Nottingham, UK) and H3PO4 (3.57 mM, 85w t% , 
Mallinckrodt Baker B.V., Deventer, the Netherlands) in butyl carbitol (Sigma Aldrich, 
Zwijndrecht, the Netherlands) at a fixed Ca/P ratio of 1.8. After deposition, all
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coated implants were subjected to an additional heat-treatment for 2 hours at 
700°C in a chamber furnace (UAF, Lenton, Hope Valley, England), in order to 
transform the amorphous coatings into crystalline carbonated hydroxyapatite (CHA) 
coatings35. The morphology of the CaP coatings was characterized using Scanning 
Electron Microscopy (SEM, Jeol, SEM6310, Tokyo, Japan). Additionally, CaP coatings 
were subjected to X-ray Diffraction analysis (XRD) using a thin film Philips X-ray 
diffractometer (PW3710, Almelo, The Netherlands) and Fourier Transform Infrared 
Spectrometry (FTIR; Perkin Elmer Instruments, Zoetermeer, the Netherlands) to char­
acterize the crystal and molecular structure of the deposited coatings, respectively.
TGF-B1 loading
For growth factor loading, TGF-B1 was dissolved in sterile 4 mM HCl containing 1 
mg/ml bovine serum albumin (BSA; Sigma Aldrich, Zwijndrecht, the Netherlands). 
Administration was achieved by direct adsorption of the growth factor onto the 
CaP-coated implants. Aseptic conditions were maintained throughout the adsorp­
tion process. A volume of 6 |_il of the HCl/BSA solution (containing 1.0 |jg TGF-B1) 
was pipetted onto each implant. After loading, implants were immediately stored 
at -80°C for 1 hour, placed in a 24-well plate, and lyophilized overnight.
Experimental groups
In the animal study, a total of 6 different experimental groups were used:
3. St, non-coated
4. St + CaP
5. St + CaP + TGF-B1
6. Pi, non-coated
7. Pi + CaP
8. Pi + CaP + TGF-B1
Sterility was obtained through autoclavation of non-coated and CaP-coated 
implants. TGF-B1 enrichment of CaP-coated implants was performed after 
autoclavation under aseptic conditions.
Surgical procedure
All in vivo work was conducted in accordance with ISO standards and protocols 
of the University Medical Center, Nijmegen, the Netherlands. Approval of the 
Experimental Animal Ethical Committee was obtained (RUDEC 2006-018) and
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national guidelines for care and use of laboratory animals were obeyed. A total of 
54 implants (nine implants of each experimental group; n = 9) were implanted 
into nine female Saanen goats (2-4 years of age), with a mean body weight of 
about 50-60 kg. Surgery was performed under general inhalation anesthesia and 
sterile conditions. To reduce the peri-operative infection risk, the prophylactic 
antibiotic Albipen® was administered subcutaneously (Albipen 15% , 3 ml/50 kg 
pre-operative and Albipen LA, 7.5 ml/50 kg for 3 days post-operative, Intervet BV,
Boxmeer, the Netherlands). Anesthesia was initiated by an intravenous injection 
of Pentobarbital®. Subsequently, the goats were intubated and connected to 
an inhalation ventilator with a constant volume of a mixture of nitrous oxide, 
isoflurane, and oxygen. Before the insertion of the implants, each animal was 
immobilized on its back. Subsequently, the hind limbs were shaved, washed, and 
disinfected with povidone-iodine. For implantation of the implant, a longitudinal 
incision was made on the medial surface of the left and right femur. After exposure 
of the femoral condyle, a 2.0 mm pilot hole was drilled, which was gradually 
widened with drills of increasing size until the final diameter was reached. For
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both the St and Pi implants the final drill diameter used was 4.0 mm. Drilling was 
performed with a gentle surgical technique, using low rotational drill speeds 
(800-1200 rpm) and continuous external cooling with saline. In this way, three 
bone cavities were created on the medial side of the condyle (proximal, medial, 
and distal with an inter-implant distance of about 1.0 cm). After preparation, the 
cavities were irrigated and the implants inserted. In each femur, three implant 
sites were located, resulting in six implantation sites per goat (Figure 2). To ensure 
complete randomization, the implants were placed according to a balanced 
split-plot design. However, to avoid cross-over effects, all implants containing 
TGF-B1 were grouped together and placed in left femurs only. After insertion of 
the implants, the soft tissues were closed in separate layers, and the skin was 
closed transcutaneously using resorbable Vicryl® 4-0 sutures (Ethicon Products, 
Amersfoort, the Netherlands). To reduce pain after surgery, all goats received 
Finadyne® for 2 days postoperatively. To check the implant position, postoper­
atively radiographs were taken. After an implantation period of twelve weeks, 
the goats were sacrificed by an overdose of Nembutal®. Subsequently, the 
implants with surrounding tissue were retrieved for histological evaluation and 
histomorphometrical- and micro-CT analysis.
A B
Figure 2. A (left): Location of implant sites in the medial femoral condyle. The black bars represent the implants. 
B (right): Three dental implants inserted in the medial femoral condyle of a goat.
Micro-computed tomography
After the animals were sacrificed, the femoral condyles including the implants 
were harvested; excess tissue was removed and immediately fixed in 10%  neutral 
buffered formalin solution. Using a diamond circular saw, the condyles were 
divided into smaller specimens suitable for micro-CT scanning and histological 
processing. Prior to scanning, bone blocks containing only one implant each, 
were dehydrated in ethanol 70%  and wrapped in Parafilm® (SERVA Electrophoresis 
GmbH, Heidelberg, Germany) to prevent drying during scanning. For a quantitative 
3D analysis, the specimens were placed vertically onto the sample holder of a 
micro-CT imaging system, Skyscan 1072 desktop X-ray Micro-tomography System 
(SkyScan, Kontich, Belgium), with the long axis of the implant perpendicular to 
the scanning beam. Subsequently, a high-resolution scan was recorded at a 30-|_im- 
voxel resolution. Then, using Nrecon V1.4 (SkyScan, Kontich, Belgium), a cone 
beam reconstruction was performed on the projected files. Finally, by using 3D 
creator software, a 3D-reconstruction of the implant could be obtained.
Prior to analysis, all implants were digitally filled using ImageJ (ImageJ 1.38x,
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National Institutes of Health, Bethesda, Maryland, USA) software in order to 
exclude the interior of the implants. Subsequently, a constant region of interest 
(ROI) was set along the length of the implant, using CTAn, V1.8 (Skyscan, Kontich,
Belgium). The ROI started at the first coronal screw thread for the St implants, and 
at the beginning of the first concave thread for the Pi implants (total standardized 
distance of interest of 4000 |_im). Thereafter, for all images a threshold was 
manually selected to isolate bone tissue and preserve its morphology, while 
excluding the implant material. To determine the amount of bone volume (BV) in 
three different zones around the implant, i.e. inner (0 - 500 |_im), middle (500 - 
1000 |_im) and outer (1000 - 1500 |_im), the implant was digitally enlarged three 
times, increasing the diameter with 1000 |_im (2 x 500 |_im) per dilatation-step, 
resulting in 0 - 500 |_im, 0 - 1000 |_im and 0 - 1500 |_im. Subtraction of these data, 
that is (0 - 1500 minus 0 - 1000) and (0 - 1000 minus 0 - 500) resulted in the 
aimed data per zone . By digitally enlarging the implants, the specific designs 
of both implant types were taken into account for the measurements (Figure 3).
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Per implant, the parameters bone volume (BV) and tissue volume (TV) were 
measured, after which the amount of bone volume per zone was calculated.
Figure 3. A (left): 3D micro-CT image showing the top view of an implant placed in bone and representing the 
quantification of bone volume (% ) in three different zones: 1: inner (0 - 500 pm), 2: middle (500 - 1000 pm) and 
3: outer (1000 - 1500 pm) B (right): 3D micro-CT image of a St implant, showing how the specific implant design 
is taken into account during digital enlargement of the implant for analysis (1: inner, 2: middle and 3: outer zone).
Histological preparations
Subsequent to micro-CT scanning, the specimens were dehydrated in a graded 
series of ethanol (70-100%), washed with acetone, and embedded in methyl 
methacrylate. After polymerization, non-decalcified thin longitudinal sections 
(10 - 20 pm) of the implants were prepared (at least three of each implant), using 
a modified sawing microtome technique36 and stained with methylene blue and 
basic fuchsin.
Histomorphometrical evaluation
To evaluate the bone response around the implants, histomorphometrical analyses 
were performed using a computer-based image analysis technique (Leica Qwin 
Pro-image analysis software; Leica Imaging Systems, Cambridge, UK). Quantitative 
measurements were performed for 3 different sections per implant, on each 
side of the 2D histological image (at magnification 25x). The average of these 6 
measurements was used for statistical analysis. The quantitative parameter as
assessed was the peri-implant bone volume. Therefore, the amount of bone 
was determined in rectangular regions along the length of the implant; for the St 
implant starting at the first coronal screw thread, and for the Pi implant, starting 
at the beginning of the first concave thread. In accordance with micro-CT analysis, 
an inner, middle and outer zone were marked, with a standardized length of 
4000 pm and a width of 500 pm, resulting in an area of interest of 2 mm2 per 
zone. The amount of peri-implant bone volume was defined as the percentage of 
the total area of interest in which bone was present.
Statistical analysis
Statistical analyses of the bone volume values (BV) were performed using SPSS, 
version 16.0 (SPSS Inc., Chicago, IL, USA). Paired t-tests were used to determine 
differences in the amount of bone volume. Statistical comparisons of bone 
volume measurements for different zones (inner, middle and outer) were exe­
cuted at 3 different levels: 1) overall data, 2) corrected for implant design and 
3) corrected for surface modification. Additionally, statistical comparisons of bone
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volume data of St vs. Pi implants, regarding design (overall; inner, middle, outer) 
and surface modification (non-coated, CaP-coated, CaP-coated + TGF-B1; inner, 
middle, outer) were performed, using paired t-tests and regression analysis, re­
spectively. Differences were considered significant at probability (p) values smaller 
than 0.05.
RESULTS
Coating characterization
SEM observations showed a uniform surface coverage of the implant with the 
electrosprayed coating. The electrosprayed CaP coatings revealed a porous, reticular 
surface morphology. Heat treatment increased coating crystallinity and yielded a 
carbonated apatite structure as confirmed with XRD and FTIR (data not shown).
The coatings appeared crack free after heat treatment at 700°C.
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General observations experimental animals
All 9 goats remained in good health during the experimental period and did not 
show any postoperative wound healing complications. At sacrifice, no signs of 
inflammation or adverse tissue reactions were seen around the implants. Table 1 
depicts the number of implants placed, retrieved after implantation, and included 
for micro-CT and histomorphometrical analysis. Of the 54 installed implants, a 
total of 53 implants could be retrieved. During processing of the specimens, 3 
implants were damaged and could not be used for micro-CT or histomorpho­
metrical analysis. Finally, for micro-CT 46 out of 50 implants were analyzed, as 
the amount of bone surrounding another 4 implants was not sufficient to 
perform bone volume measurements. For histomorphometry, 49 out of 50 
implants were included, as one implant was damaged during sectioning.
Table 1. Number of implants placed, retrieved and used for histological, 
histomorphometrical and micro-CT analyses
No. of implants 
placed
No. of implants 
retrieved
No. o f im 
Micro-CT
iplants used for analysis 
Histomorphometry
St Non-coated 10a 10 9c 9c
CaP 9 9 8d 9
CaP + TGF- 1 8a 8 7d 7e
Pi Non-coated 9 8b 8 8
CaP 9 9 7c,d 8c
CaP + TGF- 1 9 9 7c,d 8c
a During implantation one St+CaP+TGF- 1 implant was lost, and replaced by one non-coated St-
implant
b During explantation one non-coated Pi-implant could not be retrieved 
c During processing one non-coated St, one Pi+CaP, and one one Pi+CaP+TGF- 1 implant were 
damaged and could not be used for micro-CT or histomorphometry
d During scanning it appeared that around 4 implants: one St+CaP, one St+CaP+TGF- 1, one Pi+CaP, 
and one Pi+CaP+TGF- 1 not enough bone w as present to perform micro-CT analysis 
e During histological preparation one St+CaP+TGF- 1 w as damaged
Descriptive histological evaluation
Light microscopic examination of methylene blue/basic fuchsin stained sections of 
the implants and surrounding tissue demonstrated that generally all sections 
showed bone apposition, bone remodeling, and ingrowth of newly formed bone 
into the threads of the implants. All bone trabeculae were oriented in a vertical 
direction from the host bone to the implant surface (Figure 4).
Figure 4. Histological representation of St and Pi implants with different surface modifications (non-coated, CaP- 
coated, CaP-coated+TGF-B1) after a 12-week implantation period.
St implants: in all St implants, the peripheral pitch of the threads was in close 
contact with the surrounding bone tissue. Moreover, particularly in the surface 
modified St implants (CaP; CaP + TGF-B1), it was observed that the bone present 
at the pitch was more or less conducting over the implant surface into the threads. 
At the crestal part of one non-coated St implant an intervening fibrous tissue 
layer was present. Another non-coated St implant was partially placed in the 
epiphytical plate and around one surface modified St implant (CaP + TGF-B1), an 
inflammatory reaction was observed.
Pi implants: in the sections of 4 Pi implants (3 non-coated, and 1 CaP-coated), 
a gap was observed between the surrounding bone and the implant surface. In 
the remaining Pi implants, conduction of the bone along the surface into the 
threads was observed, particularly in the surface-modified Pi implants.
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Micro-CT analysis
Mean data regarding bone volume measurements and the outcome of statistical 
analyses between the inner, middle and outer zone at different levels (overall 
data, implant design, and surface modification) are depicted in Figure 5 and Table 2, 
respectively.
For all levels, data showed the highest bone volume in the inner zone. Additionally, 
statistical comparisons showed significant differences in bone volume in the inner 
zone compared to the middle and outer zone, except for the CaP-coated Pi 
implants. In this group only the inner zone showed a significant higher amount 
of bone volume compared to the middle zone.
Histomorphometrical analysis
Mean data regarding bone volume measurements and the outcome of statistical 
analyses between the inner, middle and outer zone are depicted in Figure 6 and 
Table 2.
Overall data: Data showed a significantly higher amount of bone volume in the 
middle zone compared to the inner (7 .7% , p < 0.01) and outer zone (6 .8% , p <
0.001) (Figure 6A).
Implant design: St implants (Figure 6B) showed a significantly higher bone volume 
in the middle zone compared to the outer zone (9 .7% , p < 0.001). No differences 
were seen between the middle and the inner zone. The opposite was observed 
for the Pi implants (Figure 6C); a significantly higher bone volume was observed 
in the middle zone compared to the inner zone (11,8%, p < 0.01), whereas no 
differences were observed between the middle and outer zone.
Surface modification: Regarding surface modification, it was observed that 
non-coated as well as CaP-coated St implants showed a significant higher bone 
volume in the middle zone compared to the outer zone (St non-coated: 12,9%, 
p < 0.001; St + CaP: 8 ,1% , p < 0.05) (Figure 6D-F). For Pi implants (Figure 6G-I), 
the CaP-coated group demonstrated a significantly higher bone volume in the 
middle zone compared to the inner zone (15,4%, p < 0.05).
Figure 5. Results of micro-CT and statistical analysis of bone volume for Screw-type (St) and Push-in (Pi) implants 
displayed for the different zones: inner, middle and outer. A. Overall bone volume (% ), B. Implant design: St, and 
C. Implant design: Pi. D. Surface modification St: non-coated, E. CaP-coated, F. CaP-coated+TGF-ß1. G. Surface 
modification Pi: non-coated, H. CaP-coated, and I. CaP-coated+TGF-ß1. Bars represent the mean + standard deviation. 
Differences were considered significant at values : ap < 0.05, bp < 0.01, and cp < 0.001.
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Table 2. Mean difference and the outcome of the statistical analyses between the 
three zones: inner, middle and outer
Micro-CT_________ Histomorphometry
Overall Bone volume
Mean
difference P-value
Mean
difference P-value
inner vs. middle 15,83 P < 0,001 -7,73 p < 0,01
inner vs. outer 26,94 P < 0,001 -0,97 P = 0,760
middle vs. outer 11,10 P < 0,001 6,76 P < 0,001
Implant design
St inner vs. middle 15,87 P < 0,001 -4,79 P = 0,077
inner vs. outer 27,70 P < 0,001 4,87 P = 0,211
middle vs. outer 11,84 P < 0,001 9,66 P < 0,001
Pi inner vs. middle 15,78 P < 0,001 -11,77 P < 0,05
inner vs. outer 25,85 P < 0,001 -8,97 P = 0,086
middle vs. outer 10,07 P < 0,001 2,80 P = 0,222
Surface modification
St
Non-coated inner vs. middle 15,66 P < 0,001 -6,36 P = 0,166
inner vs. outer 27,04 P < 0,001 6,52 P = 0,295
middle vs. outer 11,38 P < 0,001 12,88 P < 0,01
CaP inner vs. middle 16,95 P < 0,001 -9,08 P = 0,128
inner vs. outer 30,97 P < 0,01 -0,96 P = 0,910
middle vs. outer 14,01 P < 0,001 8,12 P < 0,05
TGF-ß1 inner vs. middle 14,52 P < 0,001 1,81 P = 0,577
inner vs. outer 25,95 P < 0,01 9,57 P = 0,113
Pi
Non-coated
middle vs. outer 11,43 P < 0,01 7,76 P = 0,064
inner vs. middle 16,97 P < 0,001 -13,37 P = 0,177
inner vs. outer 27,55 P < 0,01 -7,53 P = 0,538
middle vs. outer 10,58 P < 0,01 5,84 P = 0,152
CaP inner vs. middle 13,88 P < 0,01 -15,36 P < 0,05
inner vs. outer 18,11 P = 0,211 -8,71 P = 0,249
middle vs. outer 4,23 P = 0,199 6,66 P = 0,111
TGF-ß1 inner vs. middle 16,27 P < 0,01 -6,29 P = 0,355
inner vs. outer 28,64 P < 0,01 -10,91 P = 0,168
middle vs. outer 12,38 P < 0,01 -4,61 P = 0,203
Statistical analyses of bone volume values of the inner, middle and outer zone, using paired t-tests 
were performed at three different levels: overall data, implant design, and surface modification.
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Inner Middle Outer
G H I
Figure 6 . Results of histomorphometrical and statistical analysis of bone volume for Screw-type (St) and Push-in (Pi) 
implants displayed for the different zones: inner, middle and outer. A. Overall bone volume (% ), B. Implant design: 
St, and C. Implant design: Pi. D. Surface modification St: non-coated, E. CaP-coated, F. CaP-coated+TGF-B1. G. Surface 
modification Pi: non-coated, H. CaP-coated, and I. CaP-coated+TGF-B1. Bars represent the mean + standard deviation. 
Differences were considered significant at values : ap < 0.05, bp < 0.01, and cp < 0.001.
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DISCUSSION
The present study was initiated to evaluate the effect of implant design (screw-type 
vs. push-in) and surface modification (non-coated, CaP-coated, either enriched or 
not with TGF-B1) on the peri-implant bone response in a comparative study design. 
Furthermore, the interchangeable value of two different analysis techniques (i.e. 
2D histomorphometry and 3D micro-CT) was evaluated.
A prerequisite for successful implantation of orthopedic and dental implants is to 
obtain a sufficient primary stability of the implant within the host bone37. The 
degree of primary implant stability is, besides bone quality and quantity, affected 
by implant design and insertion modality (undersized drilling, self-tapping or 
press-fit)38,39. In the present study, two geometrically different implant designs,
i.e screw-type (St) and cylindrical (Pi), were implanted, using different surgical 
protocols. In accordance with the manufacturer's guidelines, recommendations for 
the insertion of St-implants actually involve screwing implants into an undersized 
defect (diameter 4.0 mm), whereas those for Pi-implants involve the placement of 
implants into an oversized defect (diameter 4.0 mm). Consequently, a degree of 
compression will take place along the bone-implant interface during St implant 
placement, which further enhances the peri-implant bone volume and stability39. 
Moreover, undersized placement of St-implants is associated with shear forces at 
the interface, hence loosening small bone fragments. These bone fragments are 
likely to be pressed in between the trabecular voids and screw threads during 
implant placement, not only enhancing the peri-implant bone volume, but also 
stimulating new bone formation40. When such an undersized approach is used 
for cylindrical Pi-implants, there may be an increased risk of (i) failing to place 
the implant fully into the drill hole and (ii) detrimental effects of bone tissue 
compression, potentially causing local cellular damage, resulting in cell death, 
necrosis, and ultimately bone resorption39. Therefore, due to the visco-elastic 
properties of bone, an oversized bone cavity is always drilled for cylindrical Pi 
implants, implicating less compression of the peri-implant bone as compared to 
screw type implants.
Interchangeable value of histomorphometry vs. micro-CT
For the evaluation of the peri-implant bone response around St- and Pi implants 
two different analysis techniques, i.e. conventional histomorphometry and micro-CT 
were used. Observation of the results showed that the micro-CT data were in 
sharp contrast to the histomorphometrical outcome. For all implant types, the 
highest bone volume was observed in the inner zone around the implant.
Although the bone trabeculae were clearly visible on the micro-CT image, during 
analysis it appeared that bone in close contact with the implants could not be 
detected accurately, due to a thin layer of noise present around the whole implant 
of both implant types. A possible explanation for this noise is the geometry of the 
implants and the scattering of titanium. As a consequence, bone volume data in 
the inner zone around both implant types were overestimated and should therefore 
be excluded from evaluation. This observation corroborates published data by 
Stoppie et al.33, in which a blurring border of 60 |_im was found around screw­
shaped titanium implants inserted into the femoral condyles of goats.
Regarding the bone volume percentages in the middle and the outer zone similar
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trends were observed for micro-CT and histomorphometrical analysis. The middle 
zone showed higher bone volumes compared to the outer zone. However, the 
percentages as measured with micro-CT were 5-30% higher compared to those 
obtained with histomorphometry. This mismatch in absolute values might be 
explained by the definition of the threshold procedure for micro-CT analysis.
Starting the analysis, the micro-CT images were first divided into ROI's (trabeculae) 
and objects that need to be excluded (the implant). Several studies use a fixed 
threshold for this segmentation, which implicates that the threshold is kept constant 
for all bone specimens. In the present study, however, adaptive thresholding was 
performed. This methodology implies setting a new threshold for each image 
based on the histogram of the image. By using this method and adjusting the 
black and white pixels with the histogram, the exact contour of the trabeculae 
per image was determined. A drawback of this method is that adjustments are 
defined visually, resulting in a high variability between one observer and the other.
The results of this study clearly indicate that, due to the limitations of scanning at the 
tissue-implant interface, micro-CT analysis in its current application, is not the first
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technique of choice. More research is needed to optimize or even fully standardize 
the procedures utilized to assess and analyze bone structure with micro-CT and 
therefore, the following part on effects of implant design and surface modification 
on peri-implant bone responses will only concern data obtained with histomorpho- 
metrical analysis.
Effects of implant design and surface modification
With respect to implant design, the histomorphometrical measurements in this 
study showed that in all zones around the implant the bone volume for St implants 
was significantly higher than for Pi implants (Table 3; Figure 6B,C) As previously 
mentioned, this observation can be explained by the difference in surgical protocols 
used for the insertion of both implant types, i.e. an undersized approach for St 
implants and a press-fit approach for Pi implants.
Afore mentioned mechanisms are also responsible for differences between the 
three peri-implant zones for each implant type. With respect to St implants, the 
highest bone volume was present in the inner and middle layer around the implant, 
compared to the outer zone. The opposite was seen for the Pi implants: in the 
middle and outer peri-implant zones the highest bone volume was registered, 
whereas in the inner zone a significant lower bone volume was measured.
For the Pi-implants the concepts of contact and distant osteogenesis are recog­
nizable. Bone formation started from two frontiers: from the implant surface to 
the periphery, bridging the gap as generated by the oversized drilling (contact 
osteogenesis). Synchronically, from the walls of the created bone cavity, bone 
formation was directed toward the implant surface (distantosteogenesis). For the 
St implants, in our opinion the zones of contact and distant osteogenesis are 
more or less 'pushed' together. Others already stated, that the bone implant 
cavity surgically created, should be compared to a bone wound with heating 
injuries, including death of osteocytes, extending 100 - 500 |_im into the host 
bone41,42. In case of a screw type implant and undersized drilling, already during 
implantation, this 100 - 500 |_im zone is filled via (i) compression and (ii) by loosened 
bone particles pressed in between the trabecular voids and screw threads during 
implant placement. The present study also showed that bone formation in the
outer zone was significantly higher for St than for Pi implants, implicating that 
above mentioned mechanisms, linked specifically to screw type implants, also 
stimulate the preexistent original bone towards extra bone formation.
With respect to both surface modifications (CaP-coated, CaP-coated+TGF-B1), 
comparative data with non-coated controls for each zone did not show significant 
differences (Table 4). It needs to be emphasized, however, that these results on 
peri-implant bone volume around CaP-coated implants, either or not enriched 
with TGF-B1 cannot be interpreted as evidence for the absence of biological effects 
of the applied surface modifications: previously reported experimental work with 
these surface modifications43 clearly indicated significant improvements on the 
bone-implant contact for CaP-coated implants, which underlines evidence for the 
biological benefit of this surface modification.
It was hypothesized that the addition of TGF-B1 should improve at least the bone 
volume at the inner zone. Lind et al.44 demonstrated, that the addition of as little 
as 0.3 |jg TGF-B1 can increase the volume of newly formed bone in a gap model 
around tricalciumphosphate-coated implants. However, on the surrounding pre-
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existing trabecular bone around the gap, TGF-B1 had little effect. Also Sumner et 
al.31 evaluated the effects of local TGF-B1 released from ceramic coatings on bone 
remodeling around implants. They found increased amounts of bone trabeculae, 
increased trabecular thickness and bone volume fraction, not only in the gap 
around the implant, but also in the surrounding trabecular bone. This might be 
explained by the high dose of TGF-B1, i.e. 120 |jg, used in their study. Although 
in the present study the addition of 1.0 |jg TGF-B1 improved the bone volume in 
the inner zones for both implant types, these data were not statistically significant.
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Table 3. M ean , m ean d ifference and the outcom e of the  statistical analyses of 
im plant design (S t versus Pi im plants) regard ing overall b on e  vo lum e and the three 
zones: inner, m iddle and outer
Histomorphometry
Mean
Mean
difference P-value
Overall St 60,50
Pi 43,96 16,53 P = 0,001
Inner St 60,52
Pi 37,05 23,47 P < 0,001
Middle St 65,31
Pi 48,81 16,49 P < 0,001
Outer St 55,65
Pi 46,02 9,64 P < 0,05
Table 4. M ean  d ifference and the outcom e of the statistical analyses o f surface 
m odification (non-coated, CaP-coated, C aP  coated+TGF-p1) regarding the three 
zones: inner, m iddle and outer
Histomorphometry
Mean
Zone difference P-value
St
Non-coated vs. CaP inner -3,64 p = 0,642
middle -0,91 p = 0,881
outer 3,85 p = 0,557
Non-coated vs. TGF-ß1 inner 4,44 p = 0,582
middle -3,732 p = 0,555
outer 1,39 p = 0,836
Pi
Non-coated vs. CaP inner 1,52 p = 0,896
middle 3,51 p = 0,610
outer 2,69 p = 0,689
Non-coated vs. TGF-ß1 inner 8,67 p = 0,458
middle 1,59 p = 0,816
outer 12,05 p = 0,087
CONCLUSION
Regarding the analysis techniques, the results of the present study consequently 
indicate, that bone volume measurements in a zone ranging from 0 - 500 |_im 
around the implants, as calculated with micro-CT, are not reliable. Also, for the 
middle and outer peri-implant zones this technique produced elevated bone 
volume numbers. On the other hand, micro-CT images show 3D information, 
which cannot be obtained using 2D histomorphometry. Consequently, conven­
tional histological- and histomorphometrical analysis and micro-CT are neither 
interchangeable, nor independent techniques, but need to be considered as 
complementary techniques. W ith respect to the histomorphometrical data, the 
present study showed that in all peri-implant zones the bone volume for St 
implants was significantly higher than for Pi implants. Moreover, for St implants 
no differences in bone volume between the inner and middle zone could be 
observed, while for the Pi implants the bone volume in the inner zone was 
significantly lower than in the middle. Both findings can be explained by implant
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design and its specific surgical implantation protocol. Inherent in their concept 
cylindrical implants do not allow undersized placement. As such, a gap is 
introduced, that needs to be regenerated with bone tissue formed from both 
the implant surface (contact osteogenesis) as from the borders of the surgically 
created defect (distantosteogenesis). In contrast, undersized drilling can be used, 
when installing screw type implants. Such an approach prevents gap formation by 
compression of the peri-implant bone. Furthermore, due to the shear stresses at 
the interface, loosened bone fragments are pressed into the voids between 
the peri-implants trabeculae. Both features cause that for screw type implants 
the zone for contact and distant osteogenesis are 'pushed' together, thereby 
improving the peri-implant bone quality significantly.
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INTRODUCTION
In the field of implantology, a wide variety of materials are used to generate 
biomedical devices with satisfactory properties to replace body parts that have been 
damaged or lost. Many types of metals (or metallic alloys), ceramics, and polymers, 
or combinations thereof, have been used for the construction of medical and 
dental implants1. Commercially pure titanium (Ti) is one of the most widely used 
materials for manufacturing load-bearing implants. The use of titanium for bone 
implants is based on the combination of mechanical properties and corrosion 
resistance2. However, as metals usually do not show bioactive behavior, that is, 
they do not form a direct bond between the implant and the surrounding 
bone tissue, methods have been sought to improve the biological contact at 
the implant/tissue interface. Consequently, bioactive materials, such as calcium 
phosphate (CaP) ceramics, have been routinely applied as thin coatings onto 
metallic substrates in order to combine the mechanical properties of the metal 
with the excellent biological properties of CaP ceramics3,4.
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Various deposition techniques have been used to apply CaP coatings onto 
implants, of which plasma-spraying and magnetron sputtering are the most widely 
used. Although the osteoconductive and bioactive properties of CaP coatings 
derived with these techniques have been confirmed by numerous studies5,6, these 
coating methods still have important limitations. For instance, both techniques 
are associated with extremely high temperatures for post-treatment of the coatings 
to transform the as-deposited amorphous coatings into a crystalline phase. This 
makes the incorporation of biologically active compounds (e.g. growth factors) 
impossible. In addition, inherent to both line-of-sight techniques is that only 
simple (nonporous) 2D objects can be provided with a CaP coating. In the field 
of regenerative medicine, for example, in craniofacial skeletal reconstructions, 
however, scaffolds must fit very complex three-dimensional (3D) anatomic defects7. 
To overcome these limitations, studies have been undertaken to find methods to 
increase surface bioactivity. As proposed by Kokubo and Takadama8, immersion of 
materials in simulated body fluids (SBF), which are solutions that are compositionally 
similar to human blood plasma, is a well-defined method to obtain predictive
information on the materials in vivo bone-like apatite formation on the implant 
surface. W ith the use of SBF in in vitro experiments, in which in vivo apatite 
formation can be mimicked, it has been demonstrated that negatively charged 
groups, that is, phosphate-containing groups in particular, are the most potent 
inducers of the CaP nucleation process9.
In view of the aforementioned findings, a recently proposed implant coating 
with deoxyribose nucleic acid (DNA) as its main component has shown favorable 
CaP nucleation in comparison with titanium control10. The idea behind the DNA- 
based coatings is that, irrespective of its genetic information, DNA has beneficial 
biomaterial properties, which include non- or low immunogenicity, capability to 
bind other biologically active compounds (e.g. proteins or antibiotics), and a high 
phosphate content. In view of these properties, van den Beucken et al. fabricated 
and characterized multilayered DNA-based coatings for biomaterial purposes, 
whose generation is based on the layer-by-layer (LbL) deposition technique11. This 
technique has been used previously for the generation of various biomedical coat­
ings which have been tested in rat animal models12-14. The results of these in vivo
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experiments have demonstrated prolonged stability (up to 3 months) at different 
implantation sites. The multilayered DNA-based coatings further demonstrated to 
be cyto- and histocompatible15, and eligible for functionalization with growth 
factors16,17. The earlier mentioned positive effect of phosphate-containing groups 
on the CaP nucleation process, was also observed for DNA-based coatings in 
comparison with titanium in an SBF-soaking experiment. In addition, SBF-pretreated 
DNA-based coatings affected the differentiation of osteoblast-like cells through 
an increased deposition of osteocalcin10. The results of this in vitro study are 
indicative for bone-bonding capacities of DNA-based coatings, though conclusive 
data on in vivo bioactivity are lacking.
In the present study, originally used cationic polyelectrolytes for the generation of 
DNA-based coatings were replaced by Bis-Ureido-Surfactant (BUS). This surfactant 
molecule functions by the formation of strong hydrogen bonds resulting in well- 
defined highly ordered ribbon-like bilayer aggregates18, ensuring the presence of 
DNA at the surface.
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Consequently, the present study aimed at evaluating the potential in vivo bioactivity 
of BUS/DNA coatings, either or not pre-treated in SBF. For this purpose, BUS/DNA 
coatings were prepared on titanium cylinders. Noncoated titanium cylinders 
served as negative controls, whereas titanium cylinders with a CaP-sputter coating 
served as positive controls. The surfaces of all implant types were evaluated morpho­
logically and physicochemically before initiation of the in vivo implantation study. 
For the in vivo experiment, the four types of implants were inserted into the lateral 
femoral condyle of rats for 1 and 4 weeks to determine the osteogenic response, 
which consisted of qualitative (histology) as well as quantitative (histomorphometry) 
analyses.
M ATERIALS AND M ETHODS
Materials
Polyanionic salmon DNA (± 300 bp/molecules; sodium salt) was kindly provided
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by Nichiro Corporation (Kawasaki-city, Kanagawa prefecture, Japan). BUS (Bis- 
Ureido-Surfactant) was kindly provided by Dr. Nico Sommerdijk and Dr. Matthijn 
Vos (Laboratory for Macromolecular and Organic Chemistry, Eindhoven University 
of Technology, the Netherlands).
Implant preparation and cleaning
Eighty cylindrical titanium implants (diameter: 1.75 mm; length: 3.5 mm; commer- 
cially-pure titanium) were used. Prior to coating deposition, implants were cleaned 
ultrasonically in nitric acid 10%  (15 min), acetone (15 min), and isopropanol (15 
min), respectively. Subsequently, the implants were air-dried.
Coating generation
The implants were left uncoated or provided with either a multilayered DNA-coating 
or a CaP sputter coating.
Layer-by-layer (LbL) deposition of multilayered DNA coatings 
Multilayered DNA coatings were generated using the LbL deposition technique 
with BUS18 as the cationic component and DNA as the anionic component. Briefly, 
the cleaned implants were immersed in an aqueous solution of BUS (5 mg/ml) 
for 30 min, thereby allowing sufficient time for the adsorption of BUS (the first 
cationic polyelectrolyte layer) onto the implants. Subsequently, implants were 
washed in ultra-pure water. Thereafter, substrates were immersed alternately in 
an anionic aqueous DNA solution (1 mg/ml), and a BUS solution (1 mg/ml) for 7 
min each, with intermediate washing in ultra-pure water (5 min; continuous 
water flow). The build-up of the multilayered DNA-coatings was continued until 
a total of 5 double-layers was reached with a final coating architecture of [BUS/
DNA]5 (the number indicates the total number of double layers).
Deposition of CaP sputter coatings
Prior to CaP coating deposition, implants were grit-blasted with Al2O3 (Ra = 0.8-1.0 
l_im). Subsequently, the CaP coatings were deposited using a commercially available
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RF magnetron sputter unit (Edwards ESM 100) as described previously by Wolke 
et al.19. The process pressure was 5 x 10-3 mbar and the sputter power 400 W.
Resultant coating thickness was approximately 2.0 |_im. After deposition, all coated 
implants were subjected to an additional heat treatment for 2 hours at 550°C in 
a chamber furnace (UAF, Lenton, Hope Valley, England).
SBF pretreatment of DNA-based coatings
The recipe for the preparation of SBF was adopted from Kokubo and Takadama8. 
Pre-treatment of the DNA-coated implants was performed with SBF containing a 
2-fold increased calcium- and phosphate-ion concentration (SBF2) compared to 
human blood plasma. Briefly, chemicals were dissolved in sequence into distilled 
water, one by one in order to prevent precipitation in the solution during prepara­
tion. After complete dissolution of the reagents, pH-value was set at 7.4. Immersion 
studies were performed in 15 ml tubes (Greiner Bio-One B.V., Alphen aan de Rijn, 
the Netherlands), using 1 implant per tube in 4 ml SBF. Tubes were placed in a water
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bath at 37 °C  under continuous shaking. The SBF solution was refreshed on a 
weekly basis. After an immersion period of 2 weeks, implants were thoroughly 
rinsed (3 times) with ultra-pure water, and air-dried.
Surface morphology
Scanning Electron Microscopy (SEM) was performed in order to examine the 
surface morphology of the implants. Therefore, the substrates were sputter coated 
with gold and examined using a Jeol 6310 scanning electron microscope at an 
acceleration voltage of 10-15 kV (SEM; Jeol 6310, Tokyo, Japan).
Surface analysis
The crystallographic structure of depositions on the substrates was characterized 
using a Philips thin film X-ray diffractometer with CuK -radiation (XRD; PW3710, 
Almelo, The Netherlands). In addition, average surface roughness values (Ra) were 
determined using a Universal Surface Tester (UST; Innowep, Wurzburg, Germany).
Experimental animal groups
In the animal study, a total of four different experimental groups were used:
1. Ti, non-coated
2. Ti + [BUS/DNA]5
3. Ti + [BUS/DNA]5 + SBF
4. Ti + CaP
Sterility was obtained through autoclavation of non-coated and CaP-coated 
implants. Generation of the DNA-coating was performed under aseptic conditions 
after autoclavation of cleaned implants.
Surgical procedure
All in vivo work was conducted in accordance with ISO standards, and protocols 
of the Central Animal Facility (CDL; Radboud University Nijmegen Medical Center, 
Nijmegen, the Netherlands). National guidelines for the care and use of laboratory 
animals were observed, and approval of the Experimental Animal Ethical Committee 
was obtained. A total of 80 implants (10 implants per experimental group for
each implantation period; n = 10) were implanted unilaterally into 80 male Wistar 
rats (1 implant per rat), with a mean body weight of about 250 g. Surgery was 
performed under general inhalation anesthesia, and sterile conditions. To reduce 
the postoperative pain, Rimadyl® (5.0 mg/kg) and Morphine® (1.0 mg/kg) were 
administered subcutaneously pre-operative. Before the insertion of the implants, 
each animal was immobilized on its back, and the hind limbs were shaved, 
washed, and disinfected with povidone-iodine. For implantation of the implant in 
the femur, a longitudinal incision was made over the patella. By flexion of the 
knee joint, and shifting aside of the patellar ligament, both femoral condyles 
were fully exposed. After exposure of the condyles a hole with a diameter of 1.75 
mm was drilled using a dental bur (Elcomed 100, W&H Dentalwerk Burmoos,
Austria) in the lateral femoral condyle of either the right or the left limb, according 
to statistic randomization. The bone defect preparation was performed with a 
gentle surgical technique, using low rotational drill speeds (800-1200 rpm), and 
continuous external cooling with saline. In this way, one hole was made on the 
lateral side of the condyle, resulting in one implant site per rat. After preparation,
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the hole was irrigated and the implant inserted (Figure 1). After insertion of the 
implants, the soft tissues were closed with resorbable sutures (Vicryl® 4-0; Ethicon 
Products, Amersfoort, the Netherlands), and the skin with skin staples (Agraves;
InstruVet, Cuijk, the Netherlands). To reduce post-operative pain, all rats received 
one subcutaneous injection with Temgesic® (20|jg/kg) and Rimadyl® for 2 
days postoperatively. After both 1 and 4 weeks post-implantation, 40 rats were 
euthanized by an overdose of CO2, and the implants with surrounding tissue 
were retrieved for histological evaluation.
Histological preparations
After the animals were sacrificed, the femoral condyles were retrieved, excess tissue 
was removed, and using a diamond circular saw, the condyles were divided into 
smaller specimens suitable for histological processing. Subsequently, the tissue 
blocks were fixed in 10% neutral buffered formalin solution, dehydrated in a 
graded series of ethanol (70-100%), washed with acetone, and embedded in 
methyl methacrylate (M M A) for 4 weeks. After polymerization, non-decalcified
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thin sections, cross-sectional to the axis of the implants, were prepared (at least 3 
of each implant), using a modified sawing microtome technique20 and stained 
with methylene blue and basic fuchsin.
Histological and histomorphometrical evaluation
To evaluate the trabecular bone response to the implants, histological and 
histomorphometrical analyses were performed. Histological evaluation using a 
light microscope DMRD (Leica Microsystems AG, Wetzlar, Germany) consisted of 
a concise description of the observed tissues reaction, including the structure and 
arrangement of cells, implant, and tissue-implant interface. In addition, a computer- 
based image analysis technique (Leica Qwin Pro-image analysis software; Leica 
Imaging Systems, Cambridge, UK) was used for histomorphometrical evaluation. 
The quantitative measurement was performed for three different sections per 
implant. The average of these three measurements was used for statistical 
analysis. The quantitative parameters assessed were bone-implant contact and 
bone volume (at magnification 25x). The amount of bone contact was defined
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as the percentage of implant length at which there is direct bone-to-implant 
contact. In cross-sectional histological sections, the implant edge was selected 
manually after which the bone in direct contact with the implant edge was 
determined as a percentage of the circumference of the implant. To determine the 
amount of bone volume, a circle with a diameter of 2.25 mm (ROI) was centered 
over the implant. Subsequently, the implant area was measured (IA), which was 
subtracted from the ROI, yielding the area of interest (AOI). Thereafter, the amount 
of bone tissue in the AOI was selected manually and defined as the percentage of 
the AOI, yielding the definite amount of bone volume per implant.
Statistical analysis
Statistical analyses of the surface roughness values (Ra), bone-implant contact 
and bone volume measurements were performed using SPSS, version 16.0 (SPSS 
Inc. Chicago, Illinois, USA). Statistical comparisons for roughness, bone implant 
contact and bone volume of the 4 different experimental groups were performed 
using a one-way ANOVA, combined with a post-hoc Tukey-Kramer Multiple
Comparisons Test. Additionally, statistical comparisons for each experimental 
group between the two implantation periods (week 1-week 4) were performed 
using an unpaired t-test. Differences were considered significant at a probability 
(p) value: p < 0.05.
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Figure 1. A (left): Location of implant site in the lateral femoral condyle. The black bar represents the implant. B 
(right): Titanium cylinder inserted in the lateral femoral condyle of a rat.
RESULTS
Surface analysis and morphology
The XRD analyses of the heat treated (550 °C ) sputter coating revealed a crystalline 
CaP coating with mean diffraction peaks of apatitic calcium phosphate at 20 = 25.9°
(002), 31.9° (211), 32.4° (112), 33.2° (300) and 34.0° (202). Analyses of the [BUS/ 
DNA]5 + SBF substrates revealed a poorly crystalline apatitic nature with diffraction 
peaks at 20= 25.9° (002) and 31.9° (211) (data not shown).
The results of the surface roughness measurements and the outcome of the statis­
tical analyses are depicted in Table 1. The surfaces of the different experimental 
implants had an average surface roughness value (Ra) of 0.16, 0.21, 0.25, and 1.47
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for non-coated controls, [BUS/DNA]5, [BUS/DNA]5 + SBF, and CaP, respectively. In 
comparison with the non-coated controls, statistically significant differences were 
observed for [BUS/DNA]5 + SBF (p < 0.05) and CaP (p < 0.001). Additionally, the 
surface roughnaess of CaP was significantly higher compared to both [BUS/DNA]5 
and [BUS/DNA]5 + SBF (p < 0.001).
Scanning electron micrographs of the different experimental implant surfaces, 
showed apparent differences between all experimental groups (Figure 2). Images 
of the non-coated controls showed the original surface morphology of as-machined 
Ti. Observation of the [BUS/DNA]5 coated surfaces with low magnification did not 
show the presence of the deposited DNA-based coating. At higher magnification 
(7500x), however, a uniform surface layer was observed on the implant surface. 
Immersion in SBF for 2 weeks resulted in granular depositions of different sizes 
(ranging from ~1-3 |_im) over the entire surface of the [BUS/DNA]5 + SBF-coated 
implants. High magnification SEM images revealed that each granule consisted of 
a large number of tiny flake-like crystals. SEM observations of the magnetron 
sputter-coated CaP implants showed a continuous surface coverage with a rough
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appearance compared to the other surface modifications.
Table 1. D eterm ination o f surface roughness
Experimental surface Ra (^m) ± Stdev
Non-coated (Titanium) 0.16 ± 0.01
[BUS/DNA]5 0.21 ± 0.02
[BUS/DNA]5 + SBF 0.25 ± 0.01*
CaP 1.47 ± 0.07***
Ra , surface roughness
Statistical analyses were performed using a one-way ANOVA, combined with a post hoc 
Tukey-Kramee multiple comparisons test.
* Significantly increased surface roughness compared to the noncoated controls (p < 0.05).
***  Significantly increased surface roughness compared to the noncoated controls, [BUS/DNA^ 
and [BUS/DNA]5 + SBF (p < 0.001).
Figure 2. Scanning electron micrographs of cylindrical Ti implants with different surface modifications before 
implantation. Ti, noncoated control, [BUS/DNA]5, [BUS/DNA]5 + SBF, and CaP. Note the flake-like crystals at the 
surface of the [BUS/DNA]5 + SBF coated implants at the high magnification image.
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Implant retrieval
All 80 rats remained in good health during the experimental period without any 
postoperative wound healing complications. At sacrifice, no signs of inflammation 
or adverse tissue reaction could be seen around the implants. Table 2 depicts the 
number of implants placed, retrieved after implantation, and included in the histo­
logical and histomorphometrical analyses. Of the 80 installed implants, a total of 
79 implants could be retrieved. One implant ([BUS/DNA]5 + SBF) was not found 
during retrieval.
Table 2. N um ber o f implants p laced, retrieved and used fo r histological and 
histom orphom etrical analyses
No. of No. of No. of implants used for
implants implants histomorphometrical analysis
placed retrieved bi C BV
wk 1 wk 4 wk 1 wk 4 wk 1 wk 4 wk 1 wk 4
Non-coated 10 10 10 10 6 8 6 8
[BUS/DNA]5 10 10 10 10 7 8 7 6
100 [BUS/DNA]5 + SBF 10 10 10 9* 8 7 8 8
CaP 10 10 10 10 6 6 5 5
*One [BUS/DNA]5 + SBF implant was lost after retrieval.
Descriptive histological evaluation
After an implantation period of 1 week, light microscopic examination of the 
methylene blue/basic fuchsin-stained sections of the implants and their surrounding 
tissue demonstrated variable amounts of new bone formation between implants 
from different experimental groups (Figure 3). In general, little or no inflammatory 
cells, such as macrophages and foreign body giant cells were observed and only 
occasionally an intervening fibrous tissue layer was present between the bone 
and the implant. In most sections, the drilling procedure appeared to have been 
accurate. In addition, damage caused by the drilling procedure was only limited, 
evidenced by the absence of drilling debris and/or fractured bone chips. In 1 implant 
(CaP), the remains of a haemorrhage were present. Several implants showed the
presence of bone marrow or growth plate at the original defect site limiting the 
amount of bone surrounding the implant. Furthermore, the diameter of the implant 
bed was occasionally oversized in relation to the implant diameter, resulting in little 
or no bone-to-implant contact. In all other implants a close bone-to-implant contact 
was observed.
After 4 weeks of implantation, the histological sections generally demonstrated 
an increase in new bone formation. Similarly to week 1, little or no inflammatory 
cells were observed. Additionally, in several sections bone marrow or growth plate 
was present and again in a few sections the diameter of the implant bed was 
oversized in relation to the implant diameter. In all other implants a close bone- 
to-implant contact was observed.
Figure 3. Representative histological sections of cylindrical implants surrounded by bone after 1 and 4 weeks of 
implantation in the femoral condyles of rats. A1-4 weeks: non-coated controls ; B1-4 weeks: [BUS/DNA]5 ; C1-4 
weeks: [BUS/DNA]5 + SBF ; D1-4 weeks: CaP
Histomorphometrical analysis
The number of implants used for histomorphometrical analyses is depicted in 
Table 2. Several implants were excluded for histomorphometrical analyses for 
different reasons: the presence of bone marrow or growth plate at the defect site, 
or an oversized implant bed.
Bone-to-implantcontact: the results of the bone-to-implant contact measurements 
and the outcome of the statistical analyses are depicted in Table 3. A total of 56
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implants were used for bone-to-implant contact measurements. The data illustrate 
that after an implantation period of 1 week, the non-coated controls showed the 
statistically significant lowest bone-to-implant contact (13.1 ± 2 .4% ), whereas 
[BUS/DNA]5 , [BUS/DNA]5 + SBF and CaP coated implants showed similar bone- 
to-implant contact (21.3 ± 6 .8% , 24.5 ± 5 .3% , and 23.5 ± 5 .0% , respectively). 
After an implantation period of 4 weeks, statistically higher bone-to-implant 
contact values were found for both [BUS/DNA]5 + SBF and CaP coated implants 
(41.2% ± 13.0, and 49.6% ± 13.3) compared to non-coated controls as well as 
[BUS/DNA]5 coated (23.8% ± 8 .3% , 21.8% ± 3.2) implants. Additionally, statistical 
comparisons between week 1 and week 4 showed significantly increased bone- 
to-implant contact values for non coated controls, [BUS/DNA]5 + SBF and CaP 
coated implants compared to 1 week, whereas bone-to-implant contact for the 
[BUS/DNA]5 group remained constant.
Bone volume: for the bone volume measurements, a total of 53 implants were 
used, of which the results and statistical outcomes are depicted in Table 3. The 
amount of bone volume was determined in a zone of 0.50 mm (2.25 mm (ROI) - 
1.75 mm (implant0). The results showed that after 1 week the amount of bone 
volume was significantly higher for CaP-coated implants compared to non-coated 
controls (64.7% ± 7.1). After 4 weeks the percentage of bone volume ranged 
from 60.5% to 67.6%. Statistical testing did not show any significant differences 
between the individual experimental implant groups for week 4.
Table 3. Bone-im plant contact ( % )  and Bone vo lum e ( % )  (M ean  ± SD)
Bone-implant contact (% )________________ Bone volume (% )
Week 1 Week 4 Week 1 Week 4
Non-coated 13.1 ± 2.4 23.8 ± 8.3’ 53.7 ± 4.0 60.5 ± 10.2
[BUS/DNA]5 21.3 ± 6.8 b 21.8 ± 3.2 57.8 ± 4.0 63.4 ± 6.8
[BUS/DNAL+SBF 24.5 ± 5.3c 41.2 ± 13.0' ,b d 59.0 ± 3.7 61.4 ± 12.0
CaP 23.5 ± 5.0b 49.6 ± 13.3 e 1 g 64.7 ± 7.1c 67.6 ± 9.5
Statistical analyses within week 1 and week 4 were performed using a one-way ANOVA, combined 
with a post-hoc Tukey-Kramer Multiple Comparisons Test. Between week 1 and week 4 analyses 
were performed using an unpaired T-test.
Significantly different compared to non-coated controls at each implantation period; b p < 0.05, c p 
< 0 .01, e p < 0 .001 .
Significantly different compared to [BUS/DNA]5 at each implantation period; d p < 0.01, f p < 0.001. 
Significant difference within experimental group between week 1 and week 4; a p < 0.05, g p < 0.01.
DISCUSSION
This study was initiated to evaluate the potential in vivo bioactivity of DNA-based 
coatings, either or not pre-treated in SBF, in a rat femoral condyle model. 
Non-coated titanium implants and CaP sputter coated titanium implants served 
as negative and positive controls, respectively. After implantation periods of 1 
and 4 weeks, the bone-to-implant contact and amount of bone volume were 
determined histomorphometrically. The results of this study showed that DNA- 
based coatings, either or not pre-treated in SBF, and CaP coatings increased the 
bone-to-implant contact after 1 week compared to non-coated controls. Four weeks 
of implantation further increased the bone-to-implant contact for non-coated 
controls, SBF pre-treated DNA-coatings, and CaP coatings, whereas no additional 
increase in bone-to-implant contact was observed for the DNA-coated implants. 
Bone volume measurements did not show any significant differences between the 
individual experimental implant groups at both 1 and 4 weeks post-implantation. 
Previous studies by van den Beucken et al. demonstrated the feasibility of the use 
of multilayered DNA-based coatings for biomaterial purposes, using poly-D-lysine 
(PDL) and poly(allylamine hydrochloride) (PAH) as cationic components11. Chemical 
characterization of these [PDL/DNA] and [PAH/DNA] films, using XPS and contact 
angle measurements, showed that the layers in the multilayered coating are not 
completely separated, but can be regarded as partly mixed11. Several authors 
stated that the mixing process is a consequence of diffusion of the polyelectrolytes 
'in' and 'out' of the film during build up of the multilayered coating, and has 
some important limitations21,22. In view of the current study, the major limitation 
of polyelectrolyte diffusion is the presentation of DNA at the surface of the coating. 
Because of the diffusion and mixing process, the amount of DNA in the DNA- 
terminated layer decreases. Consequently, the beneficial properties of DNA as a 
functional biomaterial, that is, an optimal availability of the phosphate groups at 
the implant surface, cannot be fully exploited. Additionally, in the absence of 
discrete layers, the process of incorporation of proteins, drugs or other biologicals 
in predetermined layers will be hampered. To overcome these problems, physical 
barriers can be placed between the various components within a single film, in order 
to control the interlayer diffusion23. In the present study, Bis-Ureido-Surfactant
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(BUS) was used to function as a barrier for the formation of a multi-compartment 
coating. This surfactant molecule functions by the formation of strong hydrogen 
bonds resulting in well-defined highly ordered ribbon-like bilayer aggregates18, 
ensuring the presence of DNA at the surface. Apart from acting as a stabilizing 
unit, bis-urea units can also be used as an anchor for functional molecules, such 
as growth factors. By using a spacer, these functional molecules will be able to 
penetrate the surface layer of DNA and become exposed on the surface18. There­
fore, by generating multilayered [BUS/DNA]-coatings the functional properties of 
both the anionic DNA molecule as well as the cationic counterpart, BUS, can be 
optimally used.
In the present study, histological data demonstrated that titanium implants 
deposited with multilayered [BUS/DNA]-coatings and implanted in the femoral 
condyles of rats, did not show any adverse tissue reactions after 1 and 4 weeks of 
implantation. These results indicate that [BUS/DNA]-coatings can be regarded 
as histocompatible. This observation corroborates published data of other 
experiments, in which DNA-coated implants or DNA-based biomaterials did not 
show any unfavorable tissue responses after subcutaneous implantation in the 
back of rats15,24.
With respect to histomorphometry, the results of this study indicated that the 
presence of a multilayered [BUS/DNA]-coating favored the initial bone-implant 
contact. After 4 weeks of implantation, however, no additional effect on the 
peri-implant bone response was observed. The reason for the absence of an 
additional response in the DNA-coated group remains unclear. In contrast, SBF 
pre-treated DNA-coatings and CaP coatings showed both early as well as a late 
positive effect on bone response compared to non-coated controls. It can be 
hypothesized that this observation might be partly due to the differences in 
surface roughness between the individual experimental groups. Numerous studies 
demonstrated effects of surface roughness on the peri-implant bone response25-31 
and in vitro studies have shown that on microrough surfaces, osteoblasts create 
a microenvironment favorable for new bone formation via a decrease in osteoblast 
proliferation, and an increase in differentiation and secretion of osteogenesis 
promoting factors (such as TGF-B1)30,31. A systematic review on animal studies by
Shalabi et al., investigating the effects of implant surface roughness on bone 
response and implant fixation after 12 weeks of implantation, provided evidence 
for a positive relationship between bone-to-implant contact and surface rough- 
ness32. In the present study, the positive controls, that is, the CaP-coated implants, 
had a significantly increased roughness due to the necessity of grit-blasting prior 
to CaP coating deposition through RF magnetron sputtering for coating adhesive 
reasons. However, it needs to be emphasized that this experimental group, which 
has demonstrated superior bone responses in previous animal experiments33,34, 
served as positive control. To maximally diminish potential effects of differences 
in roughness on bone responses, the remaining three experimental groups 
(non-coated controls, [BUS/DNA] and [BUS/DNA] + SBF) received no conventional 
treatment to roughen the surface. Regarding the relationship between bone-to- 
implant contact and surface roughness, as described by Shalabi et al., a positive 
correlation was found for SBF pre-treated DNA-coated implants and CaP-coated 
implants. Both groups showed a statistically higher surface roughness and 
increased bone-to-implant contact compared to non-coated controls. The 
DNA-coated implants did not show a positive correlation, though SBF pre-treated 
implants were only slightly, but not significantly rougher. Therefore, it is not likely 
that the increased osteogenic response to SBF pretreated DNA-coatings is solely 
due to variations in surface roughness26. It can be further hypothesized that this 
observation might be due to the presence of CaP depositions on the DNA-coated 
implant surfaces after immersion in SBF (Figure 2). After all, the presence of a 
biologically active bone-like apatite layer on an implant surface enhances the 
formation of a tight chemical bond between the bone apatite and surface 
apatite, favoring the osteogenic response35,36.
Beside focusing on the importance of altering implant surfaces in order to 
improve implant stability and bone healing, another essential feature that needs 
attention is the surgical implant procedure in relation to the animal implantation 
model. Although the rat femoral condyle model is easy to perform, requires little 
operation time and most important, has a low inconvenience score for the 
animals, still some important limitations are related to this model. Histological 
evaluation showed that in several sections the implant diameter resembled the
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medio-lateral diameter of the lateral condyle, resulting in little or no bone tissue 
surrounding the implant. Due to the limited dimension of the lateral condyle, 
implants were placed in, or in contact with, the growth plate or bone marrow 
cavity. In addition, with respect to the small implant diameter, the defect was 
easily drilled slightly oversized in relation to the implant diameter, resulting in 
little or no bone-to-implant contact, or the presence of an intervening fibrous 
tissue layer. To overcome these problems, a suggestion would be to decrease the 
implant diameter, to switch to a bigger animal model, or to place the implants in 
a different implantation location, such as the intramedullary cavity37 or different 
implant orientation, that is, from medial to lateral [38] (instead of from distal to 
proximal as performed in the present study).
In summary, this study demonstrates that DNA-based coatings are histocompatible 
and favor the early bone response. SBF-pretreated DNA-based coatings were 
found to increase both the early as well as the late peri-implant bone response.
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INTRODUCTION
During the last decades, a variety of materials have been used for the fabrication 
of orthopedic and dental implants. Of these materials, titanium (Ti) and its alloys 
have been proven to be most suitable and consequently are the materials of 
choice for manufacturing load-bearing implants. However, a drawback of the 
usage of Ti and its alloys as implant materials, is their lack of bioactive behavior. 
To overcome this limitation, the non-physiological metallic implant surface can be 
functionalized using biologically active coatings. One of the bioactive, ceramic 
biomaterials that have been investigated intensively, are calcium phosphates 
(CaPs). CaP ceramics show close resemblance to natural bone and teeth and have 
the ability to form a mechanically stable bond between the implant surface and 
surrounding bone tissue. However, due to their brittle nature, CaP ceramics are 
not suitable for load-bearing applications but are frequently applied as thin coatings 
onto metallic substrates1. Various studies already demonstrated a beneficial effect 
on the early bone responses due to the presence of a CaP-coating on bone- 
anchored implants2-4. The role of ceramic coatings, however, is relatively passive 
owing to their surface-restriction, which only allows interaction with the biological 
environment via direct contact at the bone-implant interface.
In view of the aforementioned, the metalloenzyme alkaline phosphatase (ALP) 
was recently proposed as an implant coating material in order to improve the 
biological performance of orthopedic and dental implants. Evidence for potential 
beneficial effects of ALP as a bone implant coating material, was provided by 
Beertsen et al, who observed that ALP can induce mineralization of collagenous 
matrices in vivo5. The idea behind using ALP-based coatings as an alternative to 
conventional ceramic coatings is supported by the assumption that ALP is closely 
involved in the physiological biomineralization process6. Although the exact 
mechanism of this process is still not fully understood, it is currently known that 
biological mineralization is a biphasic process. Phase I is initiated inside so-called 
matrix vesicles, that serve as a site for Ca2+ and PO43- accumulation. In developing 
bone, these matrix vesicles are strictly positioned within the newly formed osteoid 
(i.e. the area in which mineralization starts). The local increase in Ca2+ and PO43- ions
will result in the deposition of CaP precipitation complexes that finally convert 
into needle-like hydroxyapatite (HA) crystals7. The second phase of mineralization 
starts with the breakdown of matrix vesicles membranes, exposing the preformed 
HA crystals to the extracellular fluid, enabling further crystal proliferation to take 
place8,9. Several studies have provided evidence that ALP plays an important role 
in Phase I of the bone mineralization process, as ALP catalyzes the hydrolysis of 
organic phosphate esters, generating an excess of free inorganic phosphate species. 
This increased level of inorganic phosphate species appears to be a crucial event 
in the initiation of mineralization5,6.
In view of these properties, De Jonge et al. fabricated and characterized ALP-based 
coatings for biomaterial purposes, using the electrostatic spray deposition tech­
nique10. This technique has proven to be particularly successful for the deposition 
of biomolecules to preserve functionality11,12. The results of the experiments 
performed by De Jonge et al. have demonstrated that ALP-coatings accelerate 
mineralization onto titanium surfaces in comparison with non-coated controls in 
an in vitro study. To further mimic the biphasic mineralization process, De Jonge 
et al. performed another in vitro study in which composite coatings, consisting of 
both the enzyme ALP and calcium phosphate nanoparticles were immobilized 
onto Ti discs using the ESD technique13. In vitro soaking experiments revealed 
that mineral deposition initially proceeded faster on pure CaP-coatings compared 
to ALP-containing coatings (i.e. either pure ALP-coatings or composite coatings). 
However, after 12 days, ALP-containing coatings reached equal amounts of 
mineral deposition on their surfaces as did CaP-coatings. The results of these in 
vitro studies hold promise for the bone-bonding capacity of electrosprayed ALP- 
based coatings, although conclusive data on in vivo bioactivity still needs to be 
obtained.
Consequently, the present study aimed at evaluating the in vivo bone response to 
electrosprayed coatings, containing ALP, CaP or a combination thereof (composite 
coating: ALP + CaP) compared to non-coated controls (gritblasted and acid 
etched; GAE). The four types of implants were inserted intramedullary into femurs 
of rats for 1 and 4 weeks to determine bone response. Evaluation consisted of 
qualitative (histology) as well as quantitative (histomorphometry) analysis.
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Materials
Bovine intestinal ALP (specific activity: 42500 U/mg, P7640) was obtained from 
Sigma (Sigma Aldrich, Zwijndrecht, the Netherlands). Cylindrical implants (Ti-6AL- 
4V, grade 5; diameter: 2.5 mm; length: 10.0 mm) with a gap (length: 6.0 mm, 
depth: 1.0 mm (Figure 1)) were provided by Jansen BV (G. Jansen BV, Valkenswaard,
Diaphyseal side 
Epiphyseal side — - 
Gap '
Base -----
Total Gap — 1 J
Total implant 1 =
Figure 1. Schematic representation of the quantification of bone volume (BV) and bone contact (BC) for histomor- 
phometrical analysis. The amount of BV in the gap was determined by setting of a region of interest (ROI = area 
in the gap beneath the dashed line) for each individual sample. BV was defined as the percentage of bone area 
in the ROI. BC was measured for 4 different areas: (1) diaphyseal side, (2) epiphyseal side, (3) base of the gap, (4) 
base of the implant. BC was defined as the percentage of implant surface at which bone is in direct contact with 
the implant. Additionally, the parameters representing the total bone contact area in the gap (Total Gap) and that 
of the implant (Total implant) were calculated.
Implant preparation and cleaning
Eighty cylindrical titanium implants were used as substrates for coating deposition. 
Prior to coating deposition, all implants underwent surface treatment using grit- 
blasting (Cam Bioceramics BV, Leiden, the Netherlands) and acid etching, and 
were thereafter cleaned ultrasonically in nitric acid 10% (15 min), acetone (15 min), 
and isopropanol (15 min), respectively. Subsequently, the implants were air-dried.
Coating deposition
The implants were left non-coated (controls, GAE), or provided with either an 
electrosprayed coating: ALP, CaP nano-apatite, or a combination thereof (ALP+CaP 
nano-apatite composite).
ALP-coatings
Deposition of the ALP-coatings was performed at room temperature, to preserve 
the biological activity of the ALP enzyme, and from aqueous solutions (1 mg/ml in 
10:90 vo l.%  ethanol:ddH2O). Ethanol was added to the ALP solution to overcome 
the high surface tension of ddH2O, thereby enabling stable spray modes. In previous 
experiments, no negative effects on the secondary structure of ALP molecules 
were observed due to the addition of 10 vo l.%  of ethanol, using Circular Dichroism 
(CD) spectroscopy (unpublished data).
CaP-coatings
For deposition of the CaP-coatings at low temperatures, CaP suspensions
115
containing nano-sized crystalline carbonate apatite particles were used as 
described previously13. The CaP suspension was prepared by a precipitation 
reaction of calcium hydroxide (Ca(OH)2, Acros organics, Geel, Belgium) and 
orthophosphoric acid (H3PO4, Acros organics, Geel, Belgium) at a Ca/P ratio 
of 1.6714. Under continuous stirring (350 rpm, Teflon upper stirrer) at room 
temperature, 0.3 M  H3PO4 solution was added drop wise to 0.5 M  Ca(OH)2 
solution, and was stirred overnight after complete addition of the Ca(OH)2 
solution. Finally, the suspension was centrifuged (60 min at 5000 rpm in 50 ml 
tubes) and thereafter ready to be used for electrospraying.
ALP-CaP composite coatings
For deposition of composite coatings, ALP (0.5 mg/ml) was dissolved in a 
two-fold diluted CaP suspension (0.18 mg/ml). This two-fold dilution was 
necessary to avoid CaP agglomeration within the suspension used for composite 
coating deposition.
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Electrostatic spray deposition (ESD) process
In the present study, a commercially available vertical ESD set-up (Advanced 
Surface Technology, Bleiswijk, the Netherlands), as described previously by De 
Jonge et al.13, was used to deposit the ALP, CaP and composite coatings. Implants 
were coated under standardized conditions: relative humidity 15%, substrate 
holder temperature of 40°C, nozzle-to-substrate distance of 40 mm, liquid flow 
rate of 0.15 ml/h, applied voltage of 8-10.5 kV, and a deposition time of 15 min.
Coating characterization
Alkaline phosphatase activity
The activity of deposited ALP was measured according to a previously described 
method15 with modifications. In brief, a volume of 200 |_il ultra-pure water, 50 |_il 
of buffer solution (5mM MgCl2, 0.5 M 2-amino-2-methyl-1-propanol) and 250 
l_il of substrate solution (5 mM para-nitro-phenyl-phosphate) was added to 
ALP-coated implants in a 24-wells plate and incubated for 1 hour at 37°C, after 
which 100 |_il solution was pipetted out of each well into a 96-well plate. Then, 
the reaction was stopped by adding 100 |_il 0.3 NaOH and the enzyme activity was 
read in an ELISA reader at 405 nm. Serial dilutions of freshly-dissolved ALP (0-250 
ng) were used for the standard curve.
In vitro cell culture medium (CCM) soaking experiment
To investigate the biological activity of the deposited ALP-coatings, implants were 
immersed in 1 ml of CCM in 24-well plates under static conditions. Non-coated 
controls (GAE) were also immersed in CCM and served as negative controls. CCM 
consisted of alpha minimal essential medium (Gibco) supplemented with 10 
vo l.%  fetal calf serum (FCS, Gibco), 50 |jg ml-1 ascorbic acid (Sigma), 10-8 M 
dexamethasone (Sigma Aldrich, Zwijndrecht, the Netherlands), 10 mM sodium 
B-glycerophosphate (Sigma), and 50 |jg ml-1 gentamycin (Gibco). Substrates were 
immersed in CCM for 6 days (n = 2) at 37°C and refreshed once. After 6 days, the 
substrates were removed from the CCM, washed thoroughly with ultra-pure 
water and dried at 50°C.
Coating morphology
Surface morphology of the different electrosprayed coatings, as well as the 
substrates immersed in CCM, was examined using a Jeol 6310 scanning electron 
microscope (SEM; Jeol 6310, Tokyo, Japan).
Experimental groups
In the animal study, a total of 4 different experimental groups were used:
1. Ti, non-coated (GAE)
2. Ti + ALP
3. Ti + CaP
4. Ti + CaP+ALP
Sterility of non-coated and CaP-coated implants was obtained through auto- 
clavation. ALP- and composite-coated implants were lyophilized overnight and 
stored at -20°C until further use.
Surgical procedure
All in vivo work was conducted in accordance with ISO standards and protocols 
of the University Medical Center, Nijmegen, the Netherlands. National guidelines 
for care and use of laboratory animals were obeyed and approval of the Experi­
mental Animal Ethical Committee was obtained (RUDEC 2008-073). A total of 80 
cylindrical implants were implanted in 40 male Wistar rats (mean weight: 250 g; 
10 implants per experimental group for each implantation period; 2 implants per 
animal). Surgery was performed under general inhalation anesthesia, and sterile 
conditions. Pre-operative, Rimadyl® (5.0 mg/kg) and Morphine® (1.0 mg/kg) were 
administered subcutaneously, to reduce postoperative pain. Subsequently, each 
animal was immobilized supine with the knee joint in a maximally flexed position 
and the hind limbs were shaved, washed and disinfected with povidone-iodine. 
For implantation of the implant into the femur, a mid-line longitudinal parapatellar 
incision was made. The knee joint capsule was incised longitudinally, and by lifting 
the patellar ligament gently and moving it laterally, the knee joint became fully 
exposed. This maneuver was facilitated by a slight extension of the knee. At the 
femoral intercondylar notch, a cylindrical hole (2.5 mm in diameter) was prepared
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in the femoral medullary cavity, parallel to the long axis of the femur, using a dental 
bur (Elcomed 100,W&H Dentalwerk Burmoos, Austria) with low rotational drill 
speeds (1200 rpm) and continuous external cooling with saline. According to 
statistic randomization, the implants were inserted bilaterally into the predrilled 
holes, resulting in two implants per rat. After insertion of the implants, the soft 
tissue layers were closed with resorbable sutures (Vicryl® 4-0, Ethicon Products, 
Amersfoort, the Netherlands), and the skin with skin staples (Agraves). To reduce 
post-operative pain, Temgesic® (0.02mg/kg) was administered subcutaneously 
for 2 days postoperatively. After both 1 and 4 weeks of implantation, 40 rats 
were euthanized by CO2-suffocation, and the implants with surrounding tissue 
were retrieved for histological evaluation.
Histological preparations
After euthanasia of the animals, the femora were harvested, excess tissue was 
removed and the specimens were fixed in 10%  neutral buffered formalin solution 
and dehydrated in graduated ethanol solutions from 70 to 100%. Subsequently, the 
specimens were embedded in methyl methacrylate (MMA). After polymerization, 
non-decalcified thin longitudinal sections of the implants were prepared (3 of 
each implant, parallel to the gap), using a modified sawing microtome technique16 
and stained with methylene blue and basic fuchsin.
Histological and histomorphometrical evaluation
To evaluate the bone response in the gap and around the implants, histological as 
well as histomorphometrical analysis were performed. Histological evaluation was 
carried out using a light microscope (Axio Imager Microscope Z1, Carl Zeiss Micro 
imaging GmbH, Gottingen, Germany), whereas a computer-based image analysis 
system (Leica Qwin Pro-image analysis software; Leica Imaging Systems, Cambridge, 
UK) was used to perform the histomorphometrical analysis. Quantitative measure­
ments were performed for 3 different sections per implant (at magnification 31.5x 
(5x-10x-0.63)), and the parameters as assessed were bone-implant contact (BC) 
and bone volume (BV) in the gap. The amount of BC was calculated in the gap, 
as well as along the long axis of the implant ('implant base'). To obtain
additional information on the process of osteoconduction in the gap, the gap was 
divided in 3 different parts: (1) diaphyseal side, (2) epiphyseal side, and (3) base 
of the gap. Additionally, the parameters representing the total bone contact area 
in the gap (Total Gap) and that of the implant (Total implant) were calculated. BC 
was defined as the percentage of implant surface at which bone is in direct contact 
with the implant, without fibrous tissue interposition.
Bone volume (BV) in the gap was determined by setting of a region of interest 
(ROI) for each individual sample. This ROI was individually set by determining the 
spacers of the gap and placing a quadrangle. BV was defined as the percentage 
of bone area in the ROI-quadrangle (Figure 1).
Statistical analysis
Statistical analyses of the bone-implant contact and bone volume measurements 
were performed using SPSS, version 16.0 (SPSS Inc., Chicago, Illinois USA). Statis­
tical comparisons of BC and BV measurements of the 4 different experimental 
groups were performed using a one-way ANOVA. If groups were significantly 
different, regression analysis was performed to analyze how factors contribute to 
the differences between the groups. The BC data were determined at 4 
different sites: (1) diaphyseal side, (2) epiphyseal, (3) base of the gap and (4) base 
of the implant. As a result, statistical comparisons were not only performed for 
the aforementioned sites, but also for the variables 'total gap' (the sum of 1+2+3) 
and 'total implant' (the sum of 1+2+3+4). Paired t-tests were used 
to detect BC differences between the diaphyseal and epiphyseal side of the 
gap. For all variables, statistical comparisons were performed between the two 
implantation periods (week 1 vs. week 4). Differences were considered significant at 
a probability (p) value: p < 0.05.
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RESULTS
Electrosprayed coatings
Coating characterization
Analysis of the ALP activity assay, performed to determine the retention of enzym­
atic activity of the deposited ALP on the implants, showed per implant an ALP 
activity corresponding to ~ 1000 ng (range: 857 - 1033) of freshly-dissolved ALP. 
The morphological appearance of the electrosprayed coatings and the non-coated 
implants were evaluated using SEM. Similar to the results described by De Jonge 
et al.13, non-coated controls showed a rough surface appearance in accordance 
with the surface pre-treatment (i.e. GAE), which was less pronounced for ALP­
coatings. CaP- and composite coatings showed granular depositions of different 
sizes homogeneously distributed over the entire implant surfaces, which for 
composite coatings revealed ALP-spots on top of and between the granules at 
higher magnification (data not shown).
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After soaking in CCM for 6 days, ALP-coated substrates demonstrated flake-like 
depositions of different sizes distributed over the entire surface (Figure 2B-C). 
These flake-like depositions were not observed for non-coated controls (GAE) 
(Figure 2A).
Figure 2. Scanning electron microscopy 
images of the substrates after immersion 
in cell culture medium (CCM) for 6 days: 
non-coated implant surface (A), ALP- 
coated implant surface (B-C). At the high 
magnification image (C), the ALP-coated 
substrates demonstrate flake-like deposi­
tions distributed over the entire surface. 
These flake-like depositions were not 
observed for non-coated controls (A). 
Original magnifications: 10.000x (A-B); 
30.000x (C).
In-vivo implantation experiment
General observations experimental animals
During the experiment all rats appeared to be in good health. However, after 
retrieval it was observed that 2 rats had a simple closed femoral fracture. For the 
remaining animals, no inflammatory signs or adverse tissue reactions were 
observed. After histological evaluation, it appeared that the inclusion of implants 
for analysis was affected, due to either a femoral fracture (2 .5% ), an inaccurate 
implantation procedure (32,5%), or a hematoma (2.5%). The numbers of implants 
placed, harvested and included in the histological and histomorphometrical analysis 
are depicted in Table 1.
Table 1. Num ber o f implants placed, retrieved and used fo r histom orphom etrical 
analyses
Implants used for analysis*
Implants placed Implants retrieved Bone volume Bone contact
week 1 week 4 week 1 week 4 week 1 week 4 week 1 week 4
Non-coated 10 10 10 10 3 8 3 8
ALP 10 10 10 10 7 8 7 7
CaP 10 10 10 10 5 8 5 8
ALP + CaP 10 10 10 10 5 7 6 7
* The number of implants used for histomorphometrical analysis is less than the number of implants 
placed, due to the following observations: presence of a femur fracture, inaccurate implantation 
procedure, hematoma formation
121
Descriptive histological evaluation
One week specimens (Figure 3A-D)
Light microscopic analysis of the histological sections demonstrated variable 
amounts of callus tissue formed in the gap area. No differences between the dif­
ferent experimental groups were apparent. Furthermore, it was observed that the 
callus tissue was predominantly present at the drill margins of the pre-existent 
surrounding host bone tissue, where it was extending from the old bone towards 
the gap (Figure 3E-H). The original margins of the drill hole were clearly visible
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Figure 3. Histological representation of 
gap-implants of the 4 experimental 
groups (non-coated, A; ALP, B; CaP, C; 
ALP+CaP, D) implanted in the femora 
of rats for 1 week. Higher magnifica­
tions, showing callus tissue in the gap 
area, are presented in the right panels 
(E-H).
due to the disrupted architecture of the trabecular bone and the difference in 
staining intensity of the bone tissue. Generally, the pre-existent bone stained less 
intensively in comparison with the young, newly formed bone tissue. Regarding 
bone contact, in all groups little or no bone tissue was present at the implant 
surface in the gap. In many cases, mostly in the non-coated group (GAE), fibrous 
tissue was interposed between the implant surface and the bone tissue.
Four weeks specimens (Figure 4A-D)
In contrast to the 1 week group, no bone tissue was present inside the gap area 
for all experimental groups after four weeks. In most cases, the majority of the 
gap area was filled with fatty marrow. Bone contact, however, was considerably 
more apparent than in the one week specimens and was observed for all 
experimental groups. It was clearly visible that the bone was conducting from the 
spacers on the diaphyseal and epiphyseal sides of the gap into the base of the 
gap (Figure 4E-H), in the course of which more bone contact was apparent at the
Figure 4. Histological representa­
tion of gap-implants of the 4 
experimental groups (non-coated, 
A; ALP, B; CaP, C; ALP+CaP, D) 
implanted in the femora of rats 
for 4 weeks. Higher magnifications, 
showing osteoconduction from the 
spacers into the gap, are presented 
in the right panels (E-H).
diaphyseal side (Figure 5). Generally, bone contact was more apparent for coated 
implants than for non-coated controls (GAE). W ith higher magnification it was 
observed that bone present on the surface of non-coated implants (GAE) was 
frequently interposed by a thin fibrous tissue layer. This phenomenon was not 
observed for the coated groups.
Figure 5. Histological representation showing the diaphyseal and epiphyseal side of a gap-implant coated with 
an ALP-coating implanted for 4 weeks. An apparent difference in bone contact between both sides of the gap 
can be observed.
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Histomorphometrical analysis
Mean data of the BC measurements and the outcome of statistical analyses 
regarding the 4 different sites: (1) diaphyseal side, (2) epiphyseal side, (3) base 
of the gap and (4) base of the implant are depicted in Table 2 and Figure 6. The 
outcomes of the variables 'total gap' (the sum of 1+2+3) and 'total implant' (the 
sum of 1+2+3+4), together with the statistical comparisons 1 vs. 2 are depicted in 
Table 2 and Figure 7A-B and 8, respectively. Mean data regarding BV measurements 
and the statistical outcomes of these analyses are depicted in Table 2 and Figure 9.
Table 2. M ean  d ifference and the outcom e of the statistical analyses of bone contact 
and bone vo lum e m easurem ents.
Bone contact (% )
Bone volume
(% )
Diaphyseal Epiphyseal Gap Base Total Gap
Total
implant
W eek 1
Non-coated 0.6 ± 1.1 3.9 ± 3.8 0 ± 0 4.8 ± 1.8 4.6 ± 4.8 9.4 ± 4.7 11.3 ± 2.3
ALP 11.6 ± 9.8 5.1 ± 7.7 0.4 ± 0.5 11.3 ± 6.9 17.1 ± 15.7 28.3 ± 17.8 13.2 ± 5.3
CaP 15.5 ± 19.6 6.0 ± 6.6 1.9 ± 2.6 7.3 ± 8.5 23.4 ± 23.7 30.7 ± 31.6 11.4 ± 4.4
ALP+CaP 9.8 ± 13.4 9.4 ± 10.3 0.9 ± 1.3 7.5 ± 5.2 20.1 ± 22.5 27.6 ± 27.1 10.6 ± 3.6
W eek 4
Non-coated 57.8 ± 13.9 35.5 ± 11.2 26.3 ± 12.9 46.2 ± 21.0 119.8 ± 31.0 168.7 ± 37.6 3.9 ± 2.0
ALP 66.2 ± 16.3 54.7 ± 14.6a 46.2 ± 12.4a 61.8 ± 14.9 166.8 ± 19.8b 228.1 ± 25.7c 5.8 ± 3.3
CaP 79.7 ± 11.0b 54.1 ± 11.4a 43.2 ± 17.0a 54.0 ± 9.6 177.0 ± 22.9c 231.0 ± 24.3c 4.2 ± 2.6
ALP+CaP 74.5 ± 11.4 53.3 ± 18.0 38.1 ± 15.8a 52.0 ± 13.8 165.9 ± 35.2b 217.9 ± 33.0b 4.6 ± 2.4
Statistical analyses of bone contact (BC) and bone volume (BV) values. Regarding BC values, no significant differences 
were observed between the experimental groups after 1 week. After 4 weeks substantially higher BC values were 
measured, which are represented in the table. Statistical comparisons between BC data of the diaphyseal vs. the 
epiphyseal side showed significantly higher BC values for the diaphyseal side (p < 0.001).
Statistical testing of BV measurements showed significant differences between the 1-week and 4-week group (non­
coated c, ALPb , CaPb, ALP+CaPb), whereas no significant differences were observed between the experimental groups 
at each individual implantation period. Statistical differences are indicated: a p < 0.05, b p < 0.01, and c p < 0.001.
Bone contact
Only limited BC values were measured for all experimental groups after an 
implantation period of 1 week, revealing no significant differences between the 
experimental groups. After an implantation period of 4 weeks, substantially higher 
BC values were measured for all experimental groups. Below, the detailed descrip­
tion of the BC measurements can be found.
Diaphyseal side: data obtained from the diaphyseal side of the gap showed a 
significantly higher amount of BC for the CaP-coated group compared to the 
non-coated controls (22.0%, p < 0.01) (Figure 6A).
Epiphyseal side: on the epiphyseal side of the gap, both the ALP-coated (19.2 % ,  
p < 0.05) and the CaP-coated implants (18.6%, p < 0.05) showed significantly 
higher BC values compared to the non-coated controls (Figure 6B).
Base of the gap: regarding the base of the gap, all coated experimental groups 
showed significantly higher BC values compared to non-coated controls (ALP: 
19.8%, p < 0.05; CaP: 16.9%, p < 0.05; ALP+CaP: 11.8%, p < 0.05 (Figure 6C). 
Base of the implant: data obtained from the long axis of the implant did not show 
any significant differences between the 4 experimental groups (Figure 6D).
Total gap: regarding the total gap area, all coated experimental groups showed 
significantly higher BC values compared to non-coated controls (ALP: 47 .0% , p < 
0.01; CaP: 57.2%, p < 0.001; ALP+CaP: 46.1% , p < 0.01) (Figure 7A).
Total implant: regarding the total implant, it was observed that all coated experi­
mental groups showed significantly higher BC values compared to non-coated 
controls (ALP: 59 .4% , p < 0.001; CaP: 62 .3% , p < 0.001; ALP+CaP: 49 .2% , 
p < 0.01 (Figure 7B).
Diaphyseal side vs. epiphyseal side: irrespective of implant surface, statistical 
comparisons between BC data of the diaphyseal vs. the epiphyseal side showed 
significantly higher BC values for the diaphyseal side of the implants ( 28.1%, 
p < 0.001). (Figure 8).
Bone volume
Bone volume measurements in the gap area showed that after 1 week the percent­
age of BV ranged from 10.6 to 13.2%, whereas after 4 weeks the BV ranged from 
3.9 to 5 .8%  (Table 2). Statistical testing revealed significant differences between 
the 1-week and 4-week BV values for each experimental group (non-coated: p < 
0.001, ALP: p < 0.01, CaP: p < 0.01, ALP+CaP: p < 0.01), whereas no significant 
differences were observed between the experimental groups at each individual 
implantation period.
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Figure 6 . Results of histomorphometrical and statistical analyses of bone contact percentages measured at 4 dif­
ferent locations: diaphyseal side (A), epiphyseal side (B), base of the Gap (C), base of the Implant (D). Data are 
displayed for the different experimental groups (non-coated, ALP, CaP, ALP+CaP) and implantation periods (1 
week, 4 weeks). Bars represent the mean + standard deviation. Significant differences are indicated: a p < 0.05, 
b p < 0 .01 , and c p < 0 .001 .
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Figure 7. Results of histomorphometrical and statistical analyses of bone contact percentages for: Total Gap (A), 
Total Implant (B). Data are displayed for the different experimental groups (non-coated, ALP, CaP, ALP+CaP) and 
implantation periods (1 week, 4 weeks). Bars represent the mean + standard deviation. Significant differences are 
indicated: a p < 0.05, b p < 0.01, and c p < 0.001.
Figure 8 . Representation of bone contact 
data of the diaphyseal vs. the epiphyseal 
side, irrespective of implant surface. Sta­
tistical difference is indicated: c p < 0 .001 .
Figure 9. Results of histomorphometrical 
and statistical analyses of bone volume 
percentages for the different experimental 
groups (non-coated, ALP, CaP, ALP+CaP) 
and implantation periods (1 week, 4 
weeks). Bars represent the mean + stan­
dard deviation. Statistical differences are 
indicated: b p < 0 .01 , and c p < 0 .001 .
DISCUSSION
The present study was initiated to evaluate the in vivo bone response to ALP-, CaP-, 
and ALP+CaP coated implants in a rat intramedullary gap-model, using non-coated 
implants (gritblasted and acid-etched; GAE) as controls. Bone contact and bone 
volume were determined histomorphometrically after implantation periods of 1 and 
4 weeks. The results of this study show that all three electrospray coated groups 
(i.e. ALP, CaP, and ALP+CaP) significantly improve the bone response compared to 
non-coated controls (GAE) after 4 weeks of implantation.
Material-related effects
Prior to implantation all coatings were sterilized using either autoclavation (non­
coated and CaP-coated implants) or lyophilisation (ALP-containing coatings). In 
an in vitro study by De Jonge et al.13, using lyophilisation as a sterilization method
• Ncwcoatoc
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for ALP- and ALP+CaP-coatings, no contamination was observed in osteoblast-like 
cell culture experiments. These results indicate that lyophilisation seems to be 
sufficient as sterilization method for ALP-containing coatings. However, in order 
to be used safely for clinical applications, sterilization methods need to be used 
that are well-accepted and standardized and preserve the biological activity of 
proteinaceous coating components. Future research needs to be carried out to 
determine which of the established sterilization methods (lyophilisation, gamma 
irradiation, ethylene oxide, immersion in alcohol aqueous solutions) is most 
appropriate for sterilization of ALP-containing coatings for clinical use17-19. 
Regarding the histomorphometrical analysis, observation of the bone contact as 
well as the bone volume measurements showed that no significant differences 
were found after 1 week of implantation. Except for the variable 'base of the 
implant', all statistical comparisons performed for the different bone contact 
variables ('diaphyseal side', 'epiphyseal side', 'base of the gap', 'total gap', and 
'total implant') showed significantly higher bone contact for the coated experi­
mental groups compared to the non-coated controls. The significantly lower bone 
contact values for the surface treated (GAE) non-coated group in this gap-healing 
model is quite a remarkable observation. Previous studies stated, that implant 
surface roughening (blasted and acid-etched) results in a substantial increase in bone 
contact, and more particularly to a comparable extent as observed for CaP coat­
ings20-22. However, it needs to emphasized that in these studies implants were placed 
using an undersized implantation technique. An undersized approach, results in 
loosening of small bone fragments, which are, upon implantation, pressed in be­
tween the trabecular voids and screw threads enhancing new bone formation23,24. 
In the current study, removal of bone chips during implant installation did not occur 
as the implant bed was equal-sized compared to the implant diameter.
Generally, for all coated experimental groups (i.e. ALP, CaP, and ALP+CaP) a similar 
bone response was observed. These results indicate that ALP-coatings are able 
to improve the bone response to a comparable extent as CaP-coatings or a 
combination thereof (ALP+CaP). For CaP-coatings, it is known that these can 
provide a mechanism for direct bonding with native hard tissue without intervening 
soft tissue layers, a property generally known as bioactivity1. With respect to ALP-
coatings, the mechanism to achieve direct bone bonding is not clear. The authors 
hypothesize that either a-cellular or cellular mechanisms (or their combination) are 
responsible for the observed effects on osteoconductivity. A-cellularly, surface-immo­
bilized ALP might induce CaP-nucleation in the presence of organic phosphate 
esters in vivo similar to that in vitro, as demonstrated by De Jonge et al. using a cell- 
deficient model, in which as soon as 4 days after soaking in cell culture medium 
(CCM) CaP-depositions on the surface of ALP-coated substrates were observed13. 
The resulting CaP-layer formed on the implant surface might subsequently evoke 
similar effects as do CaP-coatings. On the other hand, surface-immobilized ALP 
catalyzes the enzymatic conversion of organic phosphate species, thereby increasing 
inorganic phosphate levels in the direct vicinity of the implant. These elevated levels 
of phosphate-ions can subsequently affect signaling pathways responsible for 
osteoblastic differentiation and matrix mineralization, and hence biological respons­
es25. More fundamentally oriented experimental work is required to identify 
potential in vivo effects on interface physics and intracellular signaling pathways. 
Thorough histological evaluation of the implants demonstrated variable amounts 
of osteoconduction into the gaps between the different experimental groups. At 
higher magnification, however, non-coated controls (GAE) showed the presence 
of thin fibrous tissue layers interposed between the implant surface and the newly 
formed bone tissue. Consequently, no or only limited actual bone contact was 
present in most of the cases for the non-coated implants. In contrast, all coated 
implants, i.e. ALP, CaP and ALP+CaP, showed direct bone contact without an 
intervening fibrous tissue layer. This observation corroborates published data of 
other experiments, in which, similarly, the presence of an interposing fibrous tissue 
was observed for non-coated controls, but not for ceramic coated implants26-29.
Clinical-related effects
The current study set-up also revealed clinical-related effects regarding gap­
design and the orientation of the implant, which are not related to the surface 
modifications.
Histological evaluation clearly showed that bone was extending from the pre­
existent surrounding bone and conducting along the implant surface of the
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spacers into the gap of the coated implants. This phenomenon was also observed 
for the non-coated (GAE) implants, however, to a lesser extent compared to the 
coated implants.
Because of the gap-design and the small diameter of the implants, it was not 
feasible to section all samples perfectly cross-sectional. In the few samples that 
were not 100% cross-sectional, it was incidentally observed that the amount of 
bone contact was higher at the lower part of the spacer, which spatially is closest 
to the pre-existent bone. The available literature on gap-healing models underline 
this observation. Carlsson et al., for example, found evidence that for non-coated 
titanium implants, the critical gap size is 0.35 mm between bone and implants30. 
Regarding CaP-coated implants, numerous studies have demonstrated new 
bone formation and gap bridging despite gaps of 1.0 mm26,28,31. It needs to be 
emphasized, however, that the studies by Clemens et al. and Manders et al. used 
a goat femoral condyle model for implantation of the gap-implants. Consequently, 
the obtained results in those experiments concern implants placed in trabecular 
bone, whereas in the current study the implants were placed in or close to cortical 
bone. This difference in type of bone is likely the reason for observed differences 
in bone volume observed in the gap area, which were substantially lower in the 
current study compared to the previously mentioned reports of gap-implants 
placed in trabecular bone.
In clinical situations, it is often impossible to meet perfect operative fit of the 
implant in the drilled hole. The present study involved a press-fit approach, which 
inevitably introduced a limited void between the implant and the bone. Regarding 
the base of the implant, no significant differences were observed in bone contact 
between the experimental groups. In contrast, for the base of the gap, all coated 
experimental groups showed significantly higher bone contact values compared 
to non-coated controls. The authors hypothesize that, as the void at the base of 
the implant was below the critical gap size of 0.35 mm, coated as well as 
non-coated implants were able to bridge the gap. The significant differences in 
bone contact observed within the gap are in contrast with those from the base of 
the implant. Undoubtedly, the higher bone contact within the gap for all coated 
specimens are the result of surface modifications.
Regarding the orientation of the implant, statistical comparisons between the 
diaphyseal and the epiphyseal side of the gap revealed a significant higher bone 
contact at the diaphyseal side of the gap, irrespective of implant surface. The 
observed higher bone contact for the diaphyseal side is likely to be explained by 
the implantation model used. In an intramedullary model, the diaphyseal side of 
the gap is in close contact with the endosteal marrow. The authors hypothesize, 
that upon implantation, the endosteal marrow, which is rich in ostoprogenitor 
cells, is activated and stimulates new bone formation from the diaphyseal side. 
A previous study by Feighan et al., who implanted Ti-plugs intramedullary into 
the femora of rabbits, corroborates our findings, as they demonstrated a signifi­
cantly increased total bone area and length of the bone implant interface at the 
diaphyseal level of the femur in comparison with the proximal and distal part of 
the metaphysic32.
Besides the obtained results regarding bone contact, the present study also eval­
uated data regarding the bone volume in the gap area. Statistical comparisons 
revealed a significantly higher amount of bone volume after 1 week compared 
to 4 weeks of implantation, whereas no significant differences were observed 
between the experimental groups at each individual implantation period. 
Histological observations showed that in the implants after 1 week of implantation, 
a considerable amount of callus tissue was present in the gap area. After 4 weeks 
however, the majority of the gap area was filled with fatty marrow and hardly 
any bone tissue was present. This bone resorption pattern occurred independent 
of the different implant surfaces. A similar change in bone volume pattern 
was observed in a in vivo extraction socket model by Cardaropoli et al.33, who 
observed that after 2 months of healing the extraction socket was filled with 
woven bone, while after 6 months the defect was mainly characterized by 
bone marrow. An explanation for the observed bone resorption can be the 
lack of mechanical stimuli at the implantation location. In the present study, the 
intramedullary model was chosen, as in this model implants are placed at a site 
of minimal direct cyclic loading, so that the interactions between the material 
properties and the biological properties of the host site could be distinguished. 
However, it is known from the currently available literature that in bones, whose
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predominant function is load-bearing (e.g. femur), the particular features on which 
structural competence depends, all require a certain degree of physiological 
loading34'35.
CONCLUSION
In the current study design, electrosprayed ALP, CaP and ALP+CaP-coatings were 
able to improve the biological response, more particularly osteoconduction, in 
comparison with non-coated (gritblasted, acid-etched) controls. Moreover, ALP­
coatings were found to favor the osteogenic response to a comparable extent as 
CaP-coatings or a combination thereof (ALP+CaP). Consequently, the current 
study proofs that ALP-coatings have potential as bone implant coatings, though 
long-term data remain to be obtained. From a clinical perspective, it was observed 
that the process of osteoconduction is related to positional determinants, which 
needs to be taken into account when analyzing data on bone responses from 
implantation studies in long bones.
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INTRODUCTION
Over the last forty years, the use of dental and orthopedic implants has become 
increasingly widespread, and still continues to expand. For successful clinical 
employment, implants should be designed in such a way that a controlled, guided 
and rapid healing at the bone-implant interface is induced upon implantation, 
resulting in stable anchorage of the implant in bone. Although excellent clinical 
results have already been claimed for a number of implant designs and surfaces, 
the optimization of implant characteristics remains a continuous process. Further­
more, the production and marketing of new brands persists and evolves at such 
a high pace that new companies enter the implant market without extensive 
preclinical and clinical testing1. In some cases, this attitude has resulted in the 
marketing of unsuitable implants and unnecessary failures1. To avoid such pitfalls, 
in-depth research still needs to be carried out prior to marketing of new implants, 
in order to obtain fundamental scientific information and data on the biological 
performance regarding a new or optimized product.
In order to determine whether a newly developed implant matches the requirements 
of compatibility to the biological surroundings, mechanical stability and, above 
all, safety, it must undergo thorough testing prior to clinical use. The first step that 
can provide useful information is in vitro testing. In vitro testing is frequently used 
to detect potential toxic and carcinogenic effects of a new material33. However, 
no in vitro cell culture system is able to mimic the tissue response. Therefore, the use 
of animal models is inevitable. Animal studies are also useful to test the histocom­
patibility and functionality of a specific implant, as besides the tissue response, 
animal models allow the evaluation of implants in loaded or unloaded conditions. 
In clinical situations dental and orthopedic implants are subjected to functional 
loading. If loading aspects need to be evaluated, an animal model is required that 
reflects well the complex environment in clinical applications, in order to evaluate 
the osteogenic response at the bone-implant interface under the influence of 
loading (e.g. intra-oral implantation models17,35,2. In situations, in which the goal 
is solely to evaluate the biological response to the implant, a non-loading animal 
model is sufficient (e.g. intramedullary model18,39). It should be emphasized,
however, that despite the fact that the biological conditions in animals more 
closely resemble the mechanical and physiological situation in humans, these will 
never be able to fully represent the clinical situation.
Currently, numerous animal models are available for testing the biological perfor­
mance of newly developed implants. However, as the range of existing animal 
models is rather wide, the selection of an adequate and suitable model is 
complex. When choosing an animal model, one should realize that the healing 
response within different animals and tissues can vary significantly, implying that 
thorough knowledge of the biological and physiological characteristics of the 
species is essential. Consequently, care must be taken regarding the selection of 
an appropriate animal model and implantation site to obtain reliable data3. The 
selection of a suitable implantation model largely depends on whether its 
anatomical and physiological characteristics meet the research demands. For 
example, when placing implants into the rabbit tibial or femoral bone, the implant 
dimensions are limited to a diameter of about 3.75 mm and a length of 8.0 mm, 
in view of the risk of inducing a pathological fracture30,44,21. Consequently, 
evaluation of the biological performance of dental implants, having diameters 
ranging from 2.8 to 6.0 mm and a length between 7.0 and 15.0 mm is generally 
performed in larger animals, such as dogs, sheep and goats6,20,38. With respect to 
physiological characteristics, it is known that the metabolic and bone healing 
properties in rats as well as in rabbits are significantly different from those in human 
bone, which makes the extrapolation of the obtained results difficult4,33. Further­
more, for an accurate judgment of the biological behaviour of implants, the 
animal experiments should be designed correctly and statistical analysis should be 
comparative24. In an ideal study design, all test variables are positioned in one 
animal, thereby making comparisons within one animal feasible, as such, deleting 
the effect of the animal itself. Moreover, the costs to acquire and care for the 
animals is an important factor that needs to be considered when deciding on the 
species of animal and a particular model. Although no single animal model will 
fully meet the requirements, there is always need for refinements in order to 
approximate the perfect model as much as possible. Finally, authorities on animal 
welfare are also becoming increasingly critical. Performing animal experiments
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requires approval of a committee dedicated to animal welfare and ethical issues 
related to that. These authorities urge the scientific community to improve the 
quality of the experimental design and to search for alternatives where possible 
according to their ground rules: replacement, reduction, and refinement (three R's). 
This implies that researchers should (i) look for alternative techniques, such as in 
vitro cell culture models, cadaveric specimens or computer simulations that can 
'replace' animals or at least use animals that are phylogenetically lower, (ii) 
'reduce' the number of animals required, and (iii) 'refine' the experimental method 
used by reducing the ethical costs in terms of painful or stressful procedures4. In 
view of the aforementioned, a new model for objective standardized evaluation 
of the bone response to implants is presented using the iliac crest in goats. This 
implantation model is supposed to conform to the requirements of (i) anatomical 
and physiological similarity to humans, (ii) balancing of experimental influences 
(implantation sites), (iii) appropriate size for the number and size of implants chosen, 
and (iv) cost-effectiveness. To verify the assumptions made on the iliac crest model, 
its feasibility was determined regarding anatomy and implant positioning using 
two cadaveric specimens, and the bone structure was evaluated and compared 
with that of the goat femoral condyle. Additionally, the validity of the model was 
tested by performing an in vivo goat study. This paper will present the iliac crest 
implantation model as an alternative to other models.
CURRENTLY AVAILABLE AN IM A L MODELS
To determine to what extent the iliac crest implantation model is a useful and 
potentially more appropriate or justified alternative for the already existing animal 
models, the following section will summarize the most commonly used models 
for bone-implant interactions, which are: (i) tibia, and (ii) femoral condyle.
Tibia
The tibia has been extensively used as the location for implant placement in rats, 
guinea pigs, rabbits, minipigs, dogs, goat and sheep. W ith respect to the surgical 
approach, the skin incision made to approach the tibial bone, can be located on
either the medial or the lateral side of the tibia. Generally, implants can be placed 
bilaterally in both tibiae, allowing each animal to serve as its own control. Regarding 
bone remodeling rates, extrapolation of results obtained in rats as well as in guinea 
pigs, is limited33. W ith increasing animal size, implant size also increases: for rats:
1.0 to 1.9 mm (diameter), 2.0 to 2.5 mm (length)25,53, guinea pigs: 1.8 and 2.0 
mm (diameter), 5.0 to 7.0 mm (length)16,15, rabbits: 3.0 to 3.75 mm (diameter),
8.0 mm (length)30,44,21, for minipigs: 4.1 mm (diameter), 10.0 mm (length)7,8, for 
dogs: 4.0 to 6.0 (diameter), 6.0 to 18.0 mm (length)14,12,45. for goats: 3.8 to 
4.6 mm (diameter), 10.0 to 13.0 mm (length)51,36,41, for sheep: 6.0 to 6.5 mm 
(diameter), 15.0 to 18.0 (length)46,47. Besides variations in implant dimensions, 
the number of available implantation sites also differs significantly between 
animal species. In rats and guinea pigs for example, only one implant site per limb 
has been reported. In rabbits, two implants can be placed44. Minipigs, dogs and 
goats offer four implant sites, whereas in sheep even five implant sites are 
available47,46. A summary of the aforementioned data with respect to implant 
dimensions and available implant sites per animal are given in Table 1.
141
Table 1. Currently available animal models for the evaluation of biological 
responses to dental implants, categorized for species, implant dimensions and 
num ber of implants placed per animal.
Animal model Implant dimensions (mm)
Diameter Length
No. implants 
placed per 
animal References
Tibia Rat
Guinea pig 
Rabbit
1.0 - 1.9
1.8 - 2.0
3.0 - 3.75
2.0 - 2.5
5.0 - 7.0 
8.0
1
1
2
Wermelin et al. 2008; Kajiwara et 
al. 2005
De Smet et al. 2006; De Smet et al. 
2008
He et al. 2009; Meirelles et al. 
2008; Susin et al. 2008
Minipig 4.1 10.0 4 Buchter et al. 2005a; 2005b
Dog 4.0 - 6.0 6.0 - 18.0 4
Coelho et al. 2009; Suzuki et al. 
2009; Cook et al. 1992
Goat 3.8 - 4.6 10.0 - 13.0 4
Vercaigne et al. 1998b; Shalabi et 
al. 2007; Schierano et al. 2005
Sheep 6.0 - 6.5 15.0 - 18.0 5 Svehla et al. 2000; 2002
Femoral condyle Rat
Rabbit
Dog
1.75 - 3.0 
3.25 - 3.75 
6.0
3.5 - 5.0
4.0 - 7.0
9.0 - 16.0
1
2
2
Schouten et al. 2009a; Peter et al. 
2006
Klokkevold et al. 2001; Susin et al. 
2008
Lind et al. 1996a; 1996b; Thomas 
et al. 1985
Sheep 3.0 - 13.0 5.0 - 130.0 2
Stadelmann et al. 2008; Heimann 
et al. 2004;
Goat 3.6 - 9.0 8.0 - 10.0 3
Schouten et al. 2008; Caulier et al. 
1995; Nikolidakis et al. 2009; 
Clemens et al. 1998; Hulshoff et al. 
1997
142
Ch
ap
te
r 
6 
No
ve
l 
im
pl
an
ta
tio
n 
m
od
el
 f
or
 e
va
lu
at
io
n 
of 
the
 
bo
ne
 
he
al
in
g 
re
sp
on
se
 
to 
de
nt
al
 i
m
pl
an
ts
Femoral condyle
Another frequently used implantation site for implant evaluation is the femoral 
condyle. A variety of implants can be placed in the femoral condyle, such as 
rods22,43,39,40, plugs29,11, and also screws10,28,23,26,38,44,32, are commonly implanted 
in the femoral condyle of rats, rabbits, dogs, goats and sheep. Both surgical approach 
and exact implantation site can vary between experiments. The most common 
approach involves a longitudinal incision over the medial or lateral surface of the 
femoral condyle, allowing placement of the implant in a perpendicular direction 
to the long axis of the femur29,34,32. Alternatively, one can start with a medial 
parapatellar incision, followed by lateral dislocation of the patella and maximal 
flexion of the knee joint to allow implantation at the bottom of the femoral condyle 
(i.e. the area that is in almost constant contact with the tibial plateau39). The first 
approach, i.e. the medial or lateral approach, offers space for more than one implant 
per condyle, though the maximum number of implants to be placed differs between 
animal species. In rats, only one implant can be placed per condyle34,39. The 
placement of two implants per site is possible in rabbits26, and sheep43, whereas 
in goats as much as three implants per condyle can be placed38, resulting in a 
maximum of six implants per animal. For the second approach, i.e. the parapatellar 
approach, only one implant per condyle can be placed, irrespective of the animal 
species used. Except for number of implants per site, also the diameter (dm) and 
length (l) of the implant matters, i.e. 1.75 to 3.0 mm (dm) and 3.5 to 5.0 mm (l) 
in rats, 3.25 to 3.75 (dm) and 4.0 to 7.0 mm (l) in rabbits, 6.0 mm (dm) and 9.0 
to 16.0 mm (l) in dogs, 3.6 to 9.0 mm (dm) and 8.0 to 10.0 mm (l) in goats and
3.0 to 13 mm (dm) and 5.0 to 130 mm (l) in sheep (Table 1). Regarding the femora 
in animals, implant placement is not only limited to the condyles, but studies have 
also been reported on using a transcortical approach, which allows for example 
in dogs, the placement of 5 implants per femur of 6 mm in diameter and 18 mm 
in length48,14.
A  NOVEL IM PLAN TATION MODEL TO TE ST  
THE BO NE-IM PLANT INTERFACE: THE GOAT 
ILIAC CREST
In clinical practice, harvesting iliac bone grafts for the reconstruction of bone 
defects is a common procedure. Inspired by this, Anderson et al., validated the 
iliac wing as a suitable bicortical critical size defect model for evaluation of the 
bone response to biodegradable bone substitutes with a diameter of 17 mm5.
Since then, only two additional studies, one in goats27 and one in rabbits19 were 
published, using the same critical sized iliac crest defect model as described by 
Anderson et al. for testing bone substitutes.
Based on the results of the aforementioned studies and the continuous need to 
refine animal models, the present study focused on the ability to place dental 
implants mono-cortically, i.e. inserting implants on top of the iliac crest down into 
the trabecular bone of the os ileum. This method has, as far as the authors know, 
never been described before.
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First, the iliac crests of two goat cadavers were studied with respect to anatomy 
and implant positioning. Additionally, the bone structure was evaluated and 
compared with that of the goat femoral condyle. Secondly, the model was vali­
dated by performing an in vivo experiment.
Feasibility of the iliac crest as implantation model
Anatomy
As the anatomy of the iliac crest resembles more or less an hourglass, the width 
of the iliac wing measured ranged from 0.9 to 1.3 cm on the medial side, 0.7 to
1.0 cm on the lateral side and 0.6 to 0.8 cm in between. The total length of the 
iliac crest varied between 3.8 and 4.5 cm (Figure 1).
Positioning the implants
Based on the anatomical dimensions, it was judged that in each iliac crest five 
dental implants with a diameter of about 4 mm and a length of 13 mm can be 
placed mono-cortically. Ultimately, respecting an inter-implant distance of about
144
Ch
ap
te
r 
6 
No
ve
l 
im
pl
an
ta
tio
n 
m
od
el
 f
or
 e
va
lu
at
io
n 
of 
the
 
bo
ne
 
he
al
in
g 
re
sp
on
se
 
to 
de
nt
al
 i
m
pl
an
ts
4 mm, a maximum of 10 implant sites per goat are available (Figures 2 and 3A). 
As an alternative, the implants can also be placed bicortically, resulting in four 
available implant sites (Figure 3B).
Fig. 1. Representation of the anatomical dimensions of the left iliac wing. The diameter varies along the iliac wing 
from 0.9 to 1.3 cm on the medial side, 0.6 to 0.8 cm on the inner side and 0.7 to 1.0 cm on the lateral side.
Bone structure
To determine the bone structure of both the iliac crest and femoral condyle, micro­
computed tomography (micro-CT) imaging was performed. Before scanning, 
small bone blocks were dehydrated in ethanol 7 0 %  and wrapped in Parafilm® 
(SERVA Electrophoresis GmbH, Heidelberg, Germany) to prevent drying during 
scanning. For a 3D analysis, the specimens were placed vertically onto the sample 
holder of a micro-CT imaging system (Skyscan 1072 desktop X-ray Micro­
tomography System; Skyscan, Kontich, Belgium). Subsequently, a high resolution 
scan was recorded at a 30-|_im-voxel resolution. Then, using Nrecon V1.4 (Skyscan, 
Kontich, Belgium), a cone beam reconstruction was performed on the projected 
files. Finally, a 3D-reconstruction of the implant was obtained (3D creator software; 
Skyscan, Kontich, Belgium). For both the iliac crest and femoral condyle, an area
Fig. 2. Schematic representation of the pelvic of the goat. The numbered cavities represent the 5 available im­
plant sites in the iliac crest.
Fig. 3. A. Representation of five available monocortical implantation sites in the right iliac wing of a goat. In the 
middle three bone cavities were already three dental implants placed. B. Bi-cortical implantation of four dental 
implants in the left iliac wing of a goat.
of interest (5.0 x 5.0 mm) was defined, that corresponded to the site of implant 
placement, i.e. where the major part of the implant would be situated after 
implantation. Additionally, bone volume fractions (bone volume/total volume) 
were determined in the area of interest.
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For the iliac crest, micro-CT images showed a well-defined trabecular structure, 
with the trabeculae oriented perpendicular to the outside borders and in a long­
itudinal direction in the centre of the iliac crest (Figure 4A-D), presenting a bone 
volume fraction of 21.7%. W ith respect to the bone structure in the femoral 
condyle, a more compact trabecular network with less defined trabeculae was 
observed, showing a bone volume fraction of 57.4% (Figure 4E-H).
Validation of the iliac crest implantation model using an in vivo 
study
After evaluation of the feasibility of the model, an in vivo study was performed 
in four female Saanen goats (average age: 26-30 months; mean body weight: 
50-60 kg), using similar dental implants as used in the cadavers. The detailed 
biological data of this in vivo study will be published separately.
First, each animal was immobilized in a ventral position, the pelvic areas were 
shaved and the anatomical structures were marked. A transverse skin incision was 
made, starting at the intermediate zone of the iliac crest (i.e. half way the posterior 
superior iliac spine and anterior superior iliac spine), subsequently processing 
towards the anterior superior iliac spine (i.e. from medial to lateral) on both sides 
of the vertebral column. The incision was continued through the underlying 
tissue layers down to the periosteum. Hereafter, the periosteum was undermined 
and lifted aside, exposing the iliac crest. For statistical reasons, in each iliac wing only 
four implants (Dyna Dental Engineering BV, Bergen op Zoom, the Netherlands) were 
inserted, resulting in eight implant sites per goat (Figure 5). Subsequently, the soft 
tissue layers and skin were closed with resorbable sutures (Vicryl® 4-0, Ethicon 
Products, Amersfoort, the Netherlands). To reduce post-operative pain, Finadyne® 
was administered for 2 days postoperatively. After six weeks of implantation, all 
four goats were euthanized with an overdose of Nembutal®, and the specimens 
were processed for histological analysis.
Histological preparations
After euthanasia of the animals, the iliac crests were harvested, excess tissue was 
removed and the specimens were fixed in 10%  neutral buffered formalin solution
and dehydrated gradually in ethanol solutions from 70 to 100%. Subsequently, the 
specimens were embedded in methyl methacrylate (MMA). Following polymeriza­
tion, non-decalcified, 10-|_im-thick, longitudinal sections of the implants were 
prepared (at least three of each implant), using a modified sawing microtome 
technique49, and subsequently stained with methylene blue and basic fuchsin.
Fig. 4. A+E. Two-dimensional cone beam reconstructed micro-CT image representing the trabecular bone structure 
in the iliac crest (A) and femoral condyle (E). B-H. Three-dimensional reconstructed micro-CT image of the iliac 
crest (B-D) and femoral condyle (F-H). Represented is an area of interest (5.0 x 5.0 mm), corresponding to the part 
of the iliac crest where the screw-shaped part of the implant would be situated after implantation. B-C. Represent 
a top (B), front (C), and side view (D) of the iliac crest, showing a well-defined trabecular structure. (F-H). Represent 
a top (F), front (G), and side view (H) of the femoral condyle, showing a compact trabecular network.
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Fig. 5. A-B. Representation of the right iliac wing showing four implant sites (A), and the implanted dental im­
plants, with an inter-implant distance of 1.0 cm (B). In all animals, the top of the iliac crest was covered with a 
cartilaginous layer, which was shifted aside during surgical preparation (see arrows).
General observations experimental animals
Throughout the experimental period, all four goats remained in good health and 
recovered successfully from the surgery. No postoperative bleeding, wound healing 
complications or bone fractures were observed. After six weeks, all dental implants 
were still in situ (i.e. surrounded by bone), and no signs of inflammation or adverse 
tissue reactions were observed.
Descriptive histological evaluation
For a qualitative analysis of the bone response around the implants, histological 
evaluation was carried out using a light microcope (Axio Imager Microscope Z1, 
Carl Zeiss Micro imaging GmbH, Gottingen, Germany. Light microscopic exami­
nation of methylene blue/basic fuchsin stained sections of the implants and 
surrounding tissue demonstrated variable amounts of bone inside and on top of 
the threads of the implants. The bone consisted of a well-defined trabecular 
network in the centre of the iliac crest, with the trabeculae oriented perpendicular 
to the long axis of the implants. At the borders of the iliac crest, the bone appeared 
to be more compact, resembling cortical bone. An unexpected observation was the 
presence of a cartilaginous growth plate at the top of the iliac crest (Figure 6).
1 4 9
Fig. 6 . A. Histological representation of a dental implant inserted into the iliac crest of a goat after 6 weeks of 
implantation, showing a well-defined trabecular structure of the iliac bone and the presence of a cartilaginous 
growth plate at the top of the iliac crest.
DISCUSSION
The aim of this study was to determine the feasibility and viability of the iliac crest 
in goats as a new implantation model, in order to serve as a promising alternative 
to the already existing models. First, the iliac crests of two goats were studied ex 
vivo with respect to anatomy and implant positioning. Additionally, the bone 
structure was evaluated and compared with the femoral condyle. Thereafter, an 
in vivo experiment was performed to validate the suitability of the iliac crest model 
for evaluation of the in vivo bone response to dental implants. The results of the 
present study show that by means of a rather simple, safe and reproducible surgical
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procedure, the iliac crest in goats can be approached and allows implantation of 
up to five dental implants per iliac crest. As such, and more specifically due to 
the symmetry of the iliac crest and hence the possibility to use this model in a 
bilateral set-up, statistical comparisons between groups on either side of the iliac 
crest can be performed, which considerably reduces the use of laboratory animals 
and associated costs. In conclusion, the iliac crest model presented foresees in the 
primary goal of animal experiments in implantology, i.e. achieving reliable data on 
the biological performance of implants. Additionally, these biological data can be 
obtained using less experimental animals, and hence lesser costs.
Surgical approach
As the long-term clinical success of dental and orthopedic implants is still 
highly influenced by their physicochemical surface characteristics, research in the 
biomedical field is still focusing on implant surface modification to optimize the 
biological response. To study the biological response at the bone-implant interface, 
the femoral condyle model still is the most frequently used implantation model. 
Therefore, in the following discussion the femoral condyle model is used as a 
reference for comparison with the newly presented iliac crest implantation model. 
Regarding the surgical approach, for both the medial and lateral femoral condyle 
model, locating the flat surface of the condyle suitable for implant placement is 
rather difficult. Moreover, in cases of bilateral implantation, i.e. operating both 
hind limbs, positioning of the animal in such a way that both condyles are easily 
approached, is very complex, nearly always resulting in repositioning of the 
animal during surgery, which is rather inconvenient and time-consuming29,1 1,32. 
As demonstrated in the present study, the iliac crest implantation model does not 
entail these limitations. Animals can be immobilized in a ventral position, exposing 
both iliac crests at the same time. The anatomical dimensions of the iliac crest are 
easily recognized, making determination of the exact incision location rather simple. 
During the surgical procedure, no vital structures will be encountered and, as the 
iliac crest is fully exposed, the surgeon has a clear view where to create the bone 
cavities and place the implants. In view of this, the surgical procedure related to 
the iliac crest implantation model can be considered (i) simple, (ii) reproducible,
and (iii) safe. Even more important is the resultant short operating time, which 
leads to a short period of anesthesia and thereby a quick recovery of, and less 
stress for the animals.
The validation of the iliac crest implantation model showed no postoperative 
complications. In literature, also no long-term complications are described for the 
femoral condyle model. However, for the short-term, occasionally transient swollen 
knees were observed due to edema or hematoma. Therefore, the Experimental 
Animal Ethical Committee from the Radboud University Medical Center (Nijmegen, 
the Netherlands) recently decided that bilateral implantation in the femoral condyles 
of goats is prohibited for future studies.
Anatomy, implant positioning and bone structure
Its large body size makes the goat highly suitable for implantation of multiple 
implants or implants of considerable size. When the femoral condyle model is 
chosen, literature describes models in which a maximum of three implants per 
condyle can be placed38,32. Because of the spheric aspect of the condyle, care 
must be taken during implantation to prevent contact between apical parts of the 
implants, consequently limiting the length of the implants. The results obtained 
in the present study showed that a maximum of five dental implants with a 
diameter of 4.2 mm could be placed in each iliac wing, resulting in 10 implant 
sites per goat. The implants were placed parallel to each other, on top of the iliac 
crest, between the outer and inner cortical layer of the os ileum. Consequently, 
the iliac crest model does not have restrictions regarding implant length. Besides 
goats, the iliac crest implantation model could also be used in alternative animal 
species, such as rabbits, mini pigs, dogs and sheep. The ultimate use of the 
iliac crest model in these species, however, requires feasibility studies before 
experimental use. Furthermore, due to differences in animal body size, implant 
diameters and the number of implants that can be placed, will differ accordingly. 
For extrapolation of biological data, physiological similarities between the animal 
model and humans are required. In view of that, literature reports that goats have 
a metabolic and bone remodeling rate similar to that of humans42. Qualitative anal­
ysis of the bone structure in the goat iliac crest showed a well-defined trabecular
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structure, with a different orientation of the trabeculae in the center of the iliac 
crest compared with the peripheral borders. Evaluation of the histological 
sections revealed that the trabecular network in the centre of the goat iliac crest 
had a rather porous architecture, which was objectified by micro-CT analysis, 
showing also a rather low bone volume fraction (21.7%). Micro-CT as well as 
histological analysis of the goat femoral condyle showed a less defined, but more 
compact trabecular network compared to the iliac crest. This was objectified by a 
two-fold bone volume fraction compared with the iliac crest (57.4%). A previous 
study by Stadelmann, in which the bone volume faction of goat iliac crest biopsies 
was determined, corroborates these findings, as they found a bone volume fraction 
of 1 9 % 43. The fact that the bone volume fraction in the iliac crest is substantially 
lower than in the femoral condyle, makes the iliac crest highly suitable for testing 
the bone-implant interface in low quality bone.
It should be emphasized that in this study, only models that evaluate the bone 
implant interface in an unloaded situation were addressed. If loading aspects 
also need to be taken into account, intra-oral implantation models are preferred. 
Numerous load-bearing model set-ups have been performed in, for example, 
dogs, goats and monkeys10,50,9,52,13,37. A disadvantage related to these studies, 
however, is the fact that they are more expensive: the placement of implants 
needs to be preceded by molar extraction and subsequent healing.
Statistical evaluation
In the in vivo experiment described in the present study, the bone response to two 
experimental groups was evaluated and therefore four dental implants were 
placed in each iliac crest. Placing only four implants was preferred over placing 
five implants, as it allows statistical comparisons of both groups within one side 
and one animal ('paired left' and 'paired right), instead of between opposing 
sides within one animal ('paired left-right'), resulting in a higher statistical power. 
An experimental model should be designed in such a way that data can be com­
pared within one animal and preferably within either side of the animal. Despite 
these precautions, due to external influences, such as (i) the health and general 
condition of the animal (quality of the bone), (ii) local differences between implant
sites (trabecular bone, cortical bone), and (iii) surgical technique, still variations 
might occur. To balance/minimize such influences, specific randomization schemes 
can be applied for allocation of the implants. In the in vivo study performed in the 
present study, implants were distributed over the animals according to a Latin Square 
Randomization scheme31,24, which is a randomization scheme that guarantees 
control over experimental variation depending on implant location. Figure 7A. 
displays the distribution of the implants of the two different experimental groups in 
the right and left iliac crest of two goats. Figure 7B, C and D display the distribution 
of implants for different experimental designs, showing the suitability of the iliac 
crest implantation model in various situations.
Fig. 7. Schematical representation of various Latin Square Randomization Schemes for two different experimental 
groups distributed over the left and right iliac wing of a goat (A-B). A. Representation of the distribution of the im­
plants in the in vivo study evaluating two different experimental groups and 1 implantation period. B. Distribution 
of implants of 3 experimental groups and 1 implantation period. C. Distribution of implants of 4 experimental 
groups and 1 implantation period. D. Distribution of implants of 2 experimental groups and 2 implantation periods.
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The fact that the bilateral use of the femoral condyle model is prohibited by the 
Experimental Animal Ethical Committee of the Radboud University Nijmegen 
Medical Center, increases the value of the bilateral iliac crest implantation model 
to a high extent, also from a statistical point of view.
In summary, the iliac crest is presented as a new implantation model suitable for 
evaluation of the osteogenic response to implant materials. It was demonstrated 
that in terms of surgical approach, anatomy, and implant positioning, the iliac 
crest is advantageous over the femoral condyle model. By a relatively simple, safe, 
fast and reproducible procedure, bone defects were created in the iliac crest of 
goats allowing qualitative and quantitative analysis of large implants. Due to the 
ease of handling, the resultant pain and stress for the animals were rather low, 
and the recovery of the animals quick. Moreover, it was demonstrated that the 
goat iliac crest model allows the implantation of a maximum of 10 implants per 
animal and due to the bilateral implantation scheme, statistical comparisons can 
be performed using paired analysis on either side of the iliac crest, resulting in a 
very high statistical power. Consequently, by using the goat iliac crest as a model 
for the evaluation of the osteogenic response to implants, a reduced number of 
animals is needed for biological evaluation, making this model very promising for 
future use in in vivo experiments.
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INTRODUCTION
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The long-term clinical success of orthopedic and dental implants is highly influenced 
by their physicochemical surface characteristics, since the overall tissue response 
(i.e. adsorption of proteins, cell adhesion and spreading) responsible for optimal 
anchoring of the implant into the native bone tissue, takes place at the surface of 
the implant1,2. Consequently, research is increasingly focusing on the modification 
of implant surfaces to improve the properties of a bulk material and thereby 
enhancing the biological healing response into the desired direction. These implant 
surface modifications can rely on either chemical or topographical alterations, or 
a combination thereof3.
Already various reports have claimed a positive correlation between implant 
micro/nano surface roughness and interfacial strength, which can, for example, be 
measured by removal torque testing4-6. In addition, a faster rate and higher de­
gree of bone formation has been reported for roughened surfaces7-10. Regarding 
surface chemistry, bioactive materials, such as calcium phosphate (CaP) ceramics, 
have been routinely applied as thin coatings onto metallic implant materials 
(mostly titanium, Ti), as these ceramics are too brittle for use as bulk material under 
loaded conditions. The excellent biological properties of CaP ceramics can be 
exploited in combination with the mechanical strength of metallic materials in 
such coated implants11-14.
Since the introduction of CaP-coatings, these ceramics have proved to be 
osteoconductive15,16, to improve implant fixation17, to increase bone-to-implant 
contact18,19 and to facilitate the bridging of gaps up to 1.0 mm20,21. Various 
techniques have been used to deposit CaP-coatings onto implant surfaces, of 
which plasma-spraying is still the most widely used14,22,23. Despite positive results 
regarding the osteoconductive and bone-bonding behavior of plasma-sprayed 
coatings24,25, this deposition technique is only capable of producing coatings with 
a minimal thickness of 30 |_im, thereby introducing the risk of coating delamination. 
Additionally, incorporation of organic biomolecules (e.g. growth factors) to further 
enhance the biological activity of the CaP-coatings has been hampered due to the 
extremely high temperatures during the plasma-spray process. To overcome this
limitation, to electrospraying of suspensions of nano-sized crystalline CaP particles 
was recently suggested to enable the deposition of nanometer thin CaP films at 
low temperatures26. As in these suspensions CaP crystals have already been formed 
prior to spraying, high temperatures during coating deposition and additional 
heat-treatments to crystallize the ceramic are bypassed. Moreover, nanometer 
thin coatings will reduce the risk of coating delamination related to the micro­
meter thick plasma-sprayed coatings. Also, from a biological point of view, there 
is increasing interest in the use of CaP nanoparticles (nano-CaP) for orthopedic 
and dental applications, as they resemble the nano-crystalline nature of bone 
mineral, increase osteoblast adhesion27 and improve osteogenic behaviour28. To 
date, it has been shown that CaP particle size is directly related to the bioactive 
properties of CaP29,30. Although these results are promising, in vivo experiments 
are needed to obtain conclusive data on the capacity of nanometer-thick electro­
sprayed CaP-coatings to enhance the osteogenic response.
Consequently, the current study aimed at evaluating the mechanical properties 
and in vivo response of electrosprayed nano-CaP-coated implants using a goat 
implantation model. For this purpose, nano-CaP-coatings were deposited onto 
cylindrical screw-type (St) implants and implanted bilaterally into the iliac crest of 
goats for 6 weeks. Grit-blasted, acid-etched (GAE) implants served as controls. 
Insertion and removal torque values were determined for bone implants at implant 
placement and retrieval, respectively. Further, the osteogenic response was evalu­
ated qualitatively (histology) and quantitatively (histomorphometry).
M A T E R IA L S  A N D  M ETHODS
M aterials
Helix® dental implants, made of titanium alloy (Ti-6AL-4V), and grit-blasted and 
acid-etched (GAE) to obtain a rough surface (roughness Ra: 1.3 -  1.4 |_im), were 
provided by Dyna Dental Engineering BV (Bergen op Zoom, the Netherlands). 
These cylindrical Screw-type (St) implants were based on a root shape core and a 
straight self-tapping thread, measuring 13 mm in length and 4.2 mm in diameter.
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Commercially available nanoCaP suspensions were acquired from Berkeley (Berkeley 
Advanced Biomaterials Inc., Berkeley, CA, USA).
Im plant preparation and cleaning
Prior to coating deposition, all St- implants were cleaned ultrasonically in 10% nitric 
acid (15 min), acetone (15 min) and isopropanol (15 min) and thereafter air-dried.
C o atin g  deposition
For coating deposition at low temperatures, nano-CaP suspensions containing 
nano-sized crystalline carbonate apatite particles were used, as reported previous­
ly28. Commercially available ethanol-based CaP suspensions (Berkeley Advanced 
Biomaterials Inc.) were diluted in 100% ethanol (10:90 vol.%) prior to electro­
spraying. To deposit the nano-CaP-coatings a commercially available vertical ESD 
set-up (Advanced Surface Technology, Bleiswijk, the Netherlands), as described by 
De Jonge et al.31 was used. The St-implants were coated in two runs (in turns of 
180°) of 5 min each to obtain complete coverage. Standardized conditions 
were respected: relative humidity of 15%, substrate holder temperature of 40°C, 
a nozzle-to-substrate distance of 40 mm, a liquid flow rate of 0.15 ml/h, and an 
applied voltage of 8-10.5 kV.
C o atin g  characterization
Coating thickness
The thickness of the deposited nanoCaP-coating, corresponding to an electro­
spray deposition time of 5 min, was determined by Atomic Force Microscopy 
(AFM; Multimode Nanoscope Ilia, USA). For this purpose, silicon wafers were 
used, which were for one half coated with nanoCaP, while the other half was left 
uncoated. Subsequently, the wafers were scanned at the non-coated/coated 
boundaries in tapping mode at a rate of ~1 Hz using 100 |_im long silicon cantile­
vers (NSG10, NT-MDT, Russia) with average nominal resonant frequencies of 250 
kHz, spring constants of 15 N/m and a tip radius of curvature of < 10 nm. To an-
alyze the height difference between the silicon wafer and the coating, which cor­
responds to the coating thickness, nanoscope imaging software (version 6.13rl,
Veeco) was used.
Coating morphology
Scanning electron microscopy (SEM; Jeol 6310, Tokyo, Japan) was performed to 
examine the surface morphology of the implants of both experimental groups 
(GAE and nano-CaP).
Coating surface roughness
Average surface roughness values (Ra) were determined for both experimental 
groups (GAE and nano-CaP) using a Universal Surface Tester (UST; Innowep, Wurz­
burg, Germany).
Coating adhesion upon implant insertion in artificial bone
To evaluate the adhesion of nano-CaP-coatings to the St-implants, biomedical
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test blocks (Sawbones®; Pacific Research Laboratories Inc., Washington, DC, USA) 
were used as artificial bone model. These test blocks offer uniform and consistent 
mechanical properties that eliminate the variability encountered when using ca­
daver bones. The test blocks consisted of solid, rigid polyurethane foam 
with a density of 0.48 g/cm3 covered with a 1 mm thick fiber-filled epoxy sheet, 
corresponding to human cancellous and cortical bone, respectively. In accordance 
with the manufacturer's recommendations, drill holes with a diameter of 4.0 mm 
were made in the test blocks using a dental drill (KaVo EWL Dental GmbH, Biber- 
ach, Germany) at a rotational speed of 2000 rpm under continuous cooling. Sub­
sequently, the St-implants were installed. In order to prevent damage to 
the coating upon explantation by means of unscrewing, the test blocks were 
cross-sectioned and the implants removed. In this way, the test procedure closely 
resembles the clinical situation, in which implants are left in situ after installation.
After explantation, the implants were carefully brushed to remove adherent poly­
urethane foam fragments. Subsequently, the nano-CaP-coatings were thoroughly 
inspected using SEM. The amount of nano-CaP-coating remaining on the implant
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surface was quantified using the ortho-cresolphthalein complexone method 
(OCPC) . In brief, the implants were incubated overnight in 1 ml 0.5 N acetic acid 
on a shaker table. For analysis, 300|_il work reagent was added to aliquots of 10|_il 
of sample or standard in a 96-wells plate. The plate was incubated for 10 minutes 
at room temperature, after which the plate was read at 570 nm. Serial dilutions 
of CaC l2 (0 - 100|jg/ml) were used to produce a standard curve. As received, 
nano-CaP-coated implants were used as controls.
Experim ental anim al groups
In the present study, St-implants were placed in the iliac crest of four goats. Two 
experimental groups were used:
1. Grit-blasted and acid-etched (GAE)
2. GAE + nanoCaP
Sterility of the substrates was obtained by autoclavating.
Surgical procedure
Four healthy female Saanen goats with an average age of 26-30 months and a 
mean body weight of 50-60 kg were selected. All in vivo work was conducted in 
accordance with ISO standards and protocols of the Radboud University Nijmegen 
Medical Center, Nijmegen, the Netherlands. National guidelines for care and 
use of laboratory animals were obeyed and approval of the Radboud University 
Experimental Animal Ethical Committee was obtained (RUDEC 2008-189). The 
St-implants were inserted into trabecular bone in the iliac crest, as described by 
Schouten et al.32. Preoperatively, all animals received subcutaneous injections of 
the prophylactic antibiotic Albipen® (Albipen 15%, 3 ml/50 kg pre-operative and 
Albipen LA, 7.5 ml/50 kg for 3 days post-operative, Intervet BV, Boxmeer, the 
Netherlands) to reduce the risk of peri-operative infection. Surgery was performed 
under general inhalation anesthesia and sterile conditions. Anesthesia was induced 
by an intravenous injection of Pentobarbital®, after which the goats were intubated 
and connected to an inhalation ventilator with a constant volume of a mixture 
of nitrous oxide, isoflurane, and oxygen. After intubation, the incision sites and 
surrounding areas were shaved, washed and disinfected with povidone-iodine.
For insertion of the St-implants, each animal was immobilized in a prone 
position. A  transverse skin incision was made, starting at the intermediate zone 
of the iliac crest (i.e. half way the posterior superior iliac spine and anterior 
superior iliac spine), subsequently processing towards the anterior superior iliac 
spine (i.e. from medial to lateral) on both sides of the vertebral column (Figure 1). 
The incision was continued through the underlying tissue layers down to the 
periosteum. Hereafter, the periosteum was undermined and lifted aside, fully 
exposing the iliac crest. Subsequently, cavities were created with a 2.0 mm pilot 
drill, which were gradually widened using drills of increasing size until the final 
diameter of 4.0 mm was reached. Drilling was performed using a dental bur 
(Elcomed 100, W&H Dental werk Burmoos, Austria) with low rotational drill 
speeds (1200 rpm) and continuous external cooling with saline solution. In each 
iliac wing, 4 implant locations were created with an inter implant distance of 
about 1 cm (Figure 1). After preparation, the implant locations were irrigated and 
the implants inserted manually. For each iliac wing insertion torque values (torque- 
in) were measured for two implants using a Digital® torque gauge instrument 
(model MGT 50, MARK-10 Corporation, New York, USA). In total, 32 St-implants 
(16 implants per experimental group) were implanted into 4 goats. Following 
statistical randomization, the implants were clustered in groups of two implants 
(GAE vs. nano-CaP-coated). After implant placement, the soft tissue layers 
and skin were closed with resorbable sutures (Vicryl® 4-0, Ethicon Products, 
Amersfoort, the Netherlands). To reduce post-operative pain, Finadyne® was 
administered for 2 days postoperatively. After six weeks of implantation, all four 
goats were euthanized with an overdose of Nembutal®.
Im plant retrieval
Immediately after sacrificing the animals, the implants with surrounding tissues 
were explanted and excess tissue was removed. Half of the specimens (16 
specimens; 8 nano-CaP and 8 GAE controls) were stored on ice for subsequent 
mechanical testing (torque-out). The remaining specimens for histological analysis 
(16 specimens; 8 nano-CaP and 8 GAE controls) were fixed in 10% neutral buffered 
formalin solution for further histological processing.
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Fig. 1. Schematic representation of the pelvis of the goat. The numbered cavities represent the four implant 
locations in the iliac crest.
M echanical testing
Torque-testing
Torque-out values, i.e. the value necessary to remove the implant from the bone 
specimen, were determined using the Digital® torque gauge instrument (MARK-10 
Corporation, New York, NY, USA). Therefore, the specimens were embedded in 
a mold with gypsum and placed in a jig, which formed part of a tensile bench 
(Figure 2). As such, to each implant a controlled, gradually increasing, rotational 
force (displacement 0.5 mm/min) was applied until implant loosening. The peak 
force measured at implant loosening was scored as the torque-out value. 
Following the torque measurements, the specimens were fixed in 10% neutral 
buffered formalin solution, dehydrated in a graded series of ethanol and embedded 
in methyl methacrylate (MMA). After polymerization, non-decalcified, longitudinal 
sections of the implants were prepared and stained with methylene blue and basic 
fuchsin and examined using a light microscope. The histological sections were 
examined to determine the fracture plane of the mechanically tested implants.
Fig. 2. Representation of the torque removal set-up. A. After harvesting the bone specimens, containing one St- 
implant each, were embedded in a mold with gypsum. B. For determination of the torque-out value the mold was 
placed in a jig, which is part of a tensile bench. Subsequently, a controlled, gradually increasing, longitudinal force 
was applied via the tensile bench to each implant until it loosened. The peak force measured at implant loosening 
was scored as the torque-out value.
Histological preparations
After fixation in 10% neutral buffered formalin solution, the specimens for histo­
logical processing were dehydrated gradually in ethanol solutions from 70%  to 
100% and subsequently embedded in MMA. Following polymerization, non-de- 
calcified, 10-|_im-thick longitudinal sections of the implants were prepared (at least 
3 for each implant) using a modified sawing microtome technique33 and subse­
quently stained with methylene blue and basic fuchsin.
Histological and histom orphom etrical evaluation
To evaluate the bone response around the implants, histological evaluation was 
carried out using a light microcope (Axio Imager Microscope Z1, Carl Zeiss Micro 
imaging GmbH, Gottingen, Germany) equipped with a computer-based image 
analysis system (Leica Qwin Pro-image analysis software; Leica Imaging Systems, 
Cambridge, UK) to perform histomorphometrical analyses. Quantitative measure­
ments were conducted for three different sections per specimen, on each side of the 
two-dimensional histological image (at magnification 31.5x), resulting in a total 
of six measurements per specimen. Bone-implant contact (BC) and peri-implant 
bone volume (BV) were the parameters as assessed. BC was calculated as the 
percentage of implant surface in direct contact with bone, without any fibrous
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tissue interposition. To determine the peri-implant BV, three regions of interest 
(ROI) were set along the long axis of the implant for each individual sample, starting 
at the first coronal screw thread of the St-implants (Figure 3). The inner, middle and 
outer zone was marked, with a standardized length of 4000 |_im and a height of 500 
l_im. BV was defined as the percentage of the total ROI occupied by bone tissue.
Fig. 3. Schematic representation of the quantification of bone contact (BC) and bone volume (BV) for histomor- 
phometrical analysis. BC was calculated as the percentage of implant surface (4000 pm) which is in direct contact 
with bone. To determine the amount of peri-implant bone volume, three ROI were set for each individual sample 
along the length of the implant, starting at the first coronal screw thread of the St-implants. An inner, middle and 
outer zone were marked, with a standardized length of 4000 pm and a width of 500 pm. The peri-implant bone 
volume was defined as the percentage of the total area of interest in which bone was present.
Statistical analysis
All measurements were statistically evaluated using SPSS, version 16.0 (SPSS Inc., 
Chicago, Illinois USA). For comparison of torque-in and torque-out values for the 
GAE vs. the nano-CaP-coated implants, paired t-tests were used. Paired t-tests 
were also used to test the differences between the two experimental groups 
for BC, BV and the three individual BV zones (inner, middle and outer). Statistical 
significancy was set at a probability (p) value: p < 0.05.
R ESU LT S
Electrosprayed coatings
Surface characterization
Figure 4  displays SEM images of the GAE (Figure 4A and B) and electrosprayed 
nano-CaP-coated St-implant surfaces (Figure 4C and D). The GAE implants showed 
a rough surface appearance in accordance with the surface treatment. The nano­
CaP-coating showed a rough, porous network of densely packed nano-CaP 
particles distributed over the entire implant surface. At higher magnification 
(Figure 4D), the nano-CaP-coatings appeared to have granular depositions of 
different sizes 'on top of' and 'in between' the porous network.
The thickness of the coatings was measured using partially coated silicon wafers, 
which were subjected to AFM. Results obtained with AFM elucidated an electro­
sprayed nano-CaP-coating thickness of ~400 ± 50 nm.
The results of the surface roughness measurements using UST showed an average
171
surface roughness value (Ra) of 1.33 ± 0.01 for GAE surfaces and 1.28 ± 0.10 for 
nano-CaP-coated surfaces.
Implantation of St-implants in artificial bone
Results obtained with the OCPC method demonstrated that 64.4%  ± 4.0 of the 
calcium in the nano-CaP-coatings remained on the implant surface after implantation 
in artificial bone. Furthermore, evaluation of the morphological appearance of 
the electrosprayed nano-CaP-coatings before and after implantation in the arti­
ficial bone using SEM, showed that the implant surface was still completely 
covered with the nano-CaP-coatings after implantation (data not shown).
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172 Fig. 4. Scanning electron microscopy (SEM) images of an GAE implant surface (A-B), and a nanoCaP-coated implant 
surface (C-D). Original magnifications: 500x (A-C); 2.000x (B-D).
In-vivo implantation experiment
G eneral observations on experim ental anim als
Throughout the experimental period, all four goats remained in good health 
and did not show any postoperative wound healing complications. After six 
weeks, a total of 32 implants were retrieved; all 32 St-implants were still in situ 
(i.e. surrounded by bone). Macroscopically, the implants remained intact and no 
inflammatory signs or adverse tissue reactions were observed.
Torque-testing
During removal torque testing, one nano-CaP-coated St-implant appeared to 
be loosened and was therefore excluded from the torque-out measurements. The 
results of the insertion (torque-in) and removal torque (torque-out) measurements 
for both experimental groups (GAE and nano-CaP-coated) are depicted in Figure
5 and Table 1. Mean torque-in values were 32.1 and 32.8 N/cm for GAE and 
nanoCaP-coated implants respectively. Mean torque-out values after 6 weeks of 
implantation were 42.8 and 36.8 N/cm for GAE and nanoCaP-coated implants, 
respectively. Regarding the mean difference in torque-in values for the two exper­
imental groups, no significant differences were observed. Similarly, no significant 
differences were observed for the torque-out values for the GAE and nano-CaP- 
coated groups. Additionally, torque-in and torque-out values for each individual 
group were analyzed and also did not show significant differences.
Light microscopic examination of the fracture plane of specimens subjected to 
torque testing, showed similar results for the GAE and nano-CaP-coated implants. 
After 6 weeks of implantation, the fracture plane was observed to be located at 
the implant-coating interface (Figure 6).
173
Fig. 5. Results of the torque-testing showing mean values ± SD (N/cm) for both experimental groups regarding 
insertion (torque-in) and removal (torque-out) torque values.
Table  1. M ean values ±  SD  (N/cm) and the o utco m e o f the statistical analyses fo r 
both experim ental gro u p s regard ing  insertion (torque-in) and rem oval (torque-out) 
torque values.
_______________________ GAE________ NanoCaP-coated p-value______
Torque-in 32.06 ± 8.85 32.77 ± 12.37 p  = 0.90 
Torque-out_________ 42.80 ± 20.87 36.81 ± 14.62___________ p = 0.54
a One nano-CaP-coated implant appeared to be loosened upon removal torque testing and was 
therefore excluded from analysis.
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Fig. 6 . Histological sections of a Screw-type (St) implant coated with a nano-CaP-coating after mechanical torque 
testing (A+B). After 6 weeks implantation, the fracture plane was observed to be located at the implant-coating in­
terface (see arrows). Magnification A  (31.5x); B (126x).
Descriptive histological evaluation
Light microscopic examination of methylene blue/basic fuchsin stained sections 
of the retrieved specimens demonstrated variable amounts of bone inside and 
on top of the threads of the St-implants (Figure 7). All implants were inserted 
for the major part into trabecular bone. No apparent differences between the 
two experimental groups were observed. On more detailed observation, it was ob­
served that generally for all St-implants, irrespective of surface modification, the pe­
ripheral pitch of the threads was in close contact with the surrounding bone tis­
sue. Moreover, it was observed that the bone, present in the pitch, was 
conducting along the implant surface into the threads. A  striking observation in 
various sections was the presence of a cartilaginous growth plate at the top of the 
iliac crest, from which in some cases an intervening fibrous tissue layer was con­
ducting along the implant surface.
Fig. 7. Representative histological sections of St-implants after 6 weeks of implantation in the crista iliaca of 
goats. A-B: GAE; C-D: nano-CaP-coated implants (Magnification A,C: (31.5x); B,D: (126x)).
H istom orphom etrical analysis
Mean data regarding BC and BV measurements and the outcome of statistical 
analyses between the experimental groups for the three peri-implant zones (inner, 
middle and outer) are depicted in Figure 8 and Table 2 .
Bone contact (Figure 8A): overall data for bone-implant contact did not show 
significant differences between the GAE (23.2% ) and the nano-CaP-coated 
group (23.0%).
Bone volume (Figure 8B): regarding overall bone volume, no significant differences 
were observed between the GAE (40.9%) and the nano-CaP-coated group 
(38.8%). Additionally, the bone volume values for the different peri-implant zones
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(inner, middle and outer) showed no significant differences between the GAE 
(43.3%; 42.1%; 37.5%) and the nano-CaP-coated group (41.5%; 38.6%; 36.2%).
GAE NanoCaP-coated
GAE NanoCaP-coated
Fig. 8 . Results of histomorphometrical analyses of St-implants inserted in the crista iliaca of goats. Bone-implant 
contact (A) and bone volume values (B), specified for the three different peri-implant zones (inner, middle and 
outer) after 6 weeks of implantation, are displayed for both experimental groups (GAE and nano-CaP-coated). 
No interaction between the experimental groups and different peri-implant zones were found.
Table  2. M ean, m ean d ifferen ce  ±  SD and the o utco m e of the  statistical analyses 
fo r the variab les: Bone co n ta ct (B C), Bone vo lu m e (BV), and the d ifferent peri- 
im plant zo n e s  (inner, m iddle and outer).
Histomorphometry
Mean
Mean
difference p-value
Overall Bone contact GAE
NanoCaP-coated
23.16 ± 6.58 
23.00 ± 6.89 0.16 ± 6.87 p = 0.95
Overall Bone volume GAE
NanoCaP-coated
40.93 ± 7.93 
38.77 ± 8.71 2.16 ± 6.25 p = 0.36
Bone volume 
Inner GAE
NanoCaP-coated
43.30 ± 9.15 
41.50 ± 7.06 1.76 ± 6.92 p = 0.50
Middle GAE
NanoCaP-coated
42.10 ± 8.41 
38.60 ± 10.79 3.45 ± 9.64 p = 0.35
Outer GAE
NanoCaP-coated
37.50 ± 9.14 
36.20 ± 9.58 1.26 ± 8.63 p = 0.69
DISCUSSIO N
The current study was initiated to evaluate the mechanical properties and the in 
vivo bone response to electrosprayed nano-CaP-coated implants compared with 
GAE implant surfaces, using the iliac crest of goats as an implantation model. The 
results of the present study show that electrosprayed nano-CaP coatings perform 
to a comparable extent to GAE implants, both with respect to implant fixation 
and bone healing response.
C o atin g  properties
The electrospray deposition technique, as used for the deposition of nano-CaP 
coatings in the present study, is a so-called line-of-sight deposition technique. For 
deposition and characterization of the coatings on the dental implants used in 
the present study several practical issues are involved. First, determination of 
coating thickness directly on the implant surface was impossible due to (i) the 
pre-existing surface roughness resulting from the grit blasting and acid etching 
procedure, (ii) the three-dimensional configuration of the implants and (iii) the 
presence of screw threads on the implant surface. Consequently, coating thickness 
was determined using a validated model system (unpublished results) in which 
planar silicon wafers serve as model substrates for coating deposition. Second, 
complete surface coverage of a three-dimensional dental implant by the electrospray 
deposition technique can only be achieved by either continuous rotation of the 
implant during coating deposition or performing multiple coating deposition 
runs, as in the present study. Although the authors are aware of the fact that the 
option of continuous rotation of the implant during coating deposition is preferable 
for homogeneous coating thickness over the entire implant surface, the experi­
mental set-up of the electrospray equipment lacks a rotational implant holder. 
Consequently, the dental implants were coated in two runs that resulted in complete 
surface coverage by nano-CaP, as was seen by electron microscopy.
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M echanical testing
Torque-out tests determine the force that is needed to loosen implants from their 
surrounding bone, which is indicative of the bone-implant interface strength34. 
The present study showed similar mean torque values for the nano-CaP-coated and 
GAE implants, with high variation (i.e. standard deviation) within each individual 
group. The high intra-group variation most likely resulted from variations in implant 
location within the iliac crest, used for reasons of statistical randomization. It is 
straightforward to hypothesize that in this way location-dependent effects are 
minimized, albeit that variations in torque values increase due to slight differences 
in the anatomical surrounding of the implants. From a mechanical point of view this 
lack of difference can be explained by the comparable surface roughness values 
for both experimental groups (Ra _ 1.3 lm). However, in addition to surface rough­
ness, surface composition plays a major role in obtaining an optimal bone-implant 
interface35,36. Surprisingly addition of the nano-CaP coating did not result in an 
improvement in bone bonding. The reasons for this lack of a beneficial effect of 
the nano-CaP could be multiple. Outsiders might speculate that detachment of 
the coating upon insertion is a likely cause. However, indirect evidence exists that 
contradicts such speculations. Several studies showed that thin nanosized CaP 
coatings, up to 400 nm, mainly consist of poorly crystalline particles28,37,38. As 
coating crystallinity and mechanical strength are positively related, nanometer 
thin electrosprayed CaP coatings need a certain degree of crystallinity in order to 
ensure interfacial adhesion to the substrate and sufficient mechanical strength of 
the applied coating upon implantation39. However, as shown in the assay using 
artificial bone, the nanometer thin CaP coatings did show sufficient adhesion 
strength to withstand the shear and compressive forces upon implantation, as 
expressed by a coating retention of ~64% . Another speculative reason for the 
lack of an additional favorable effect of the nano-CaP coating might be fast dis­
solution of the coating. It has been reported by Wolke et al. that the dissolution 
behavior of coatings is determined by the degree of coating crystallinity, i.e. a 
lower degree of crystallinity causes a higher dissolution rate40. In view of this, it 
can be hypothesized that in the current study dissolution of the coating occurred 
before it had a chance to influence the bone healing response. Dissolution of CaP
ceramic coatings can be enhanced by the local bone conditions after creation of 
the wound bed, which is associated with a decrease in pH40. In view of this, coating 
dissolution as a possible cause for the lack of a significant effect cannot be ruled 
out and needs to be addressed in future experimental work on electrosprayed 
nano-CaP coatings. A  final explanation might be that, within the context of the 
experimental model used, addition of the nano-CaP coating could not improve 
the already excellent biological effect induced by a GAE surface alone. This phe­
nomenon will be thoroughly addressed in the next paragraph.
In vivo evaluation
With respect to bone contact and bone volume, no significant differences were 
found for the GAE and nano-CaP-coated implants after 6 weeks implantation in 
the iliac crest. These results indicate that electrosprayed nano-CaP coatings are 
able to improve the bone response to a comparable extent to the GAE control 
implants. Evidently, adding a nano-CaP coating has, within the restrictions of this 
experimental model, no additional value. The beneficial effect on peri-implant 
bone formation of calcium phosphate coatings on titanium implants has been 
confirmed in numerous studies12,22. To overcome drawbacks, such as delamination 
of coating fragments resulting in failure of the implant41-43, the electrostatic spray 
deposition technique was introduced, which allows the production of nanometer 
thin coatings28,44,45. The results obtained in the present study have demonstrated 
that the addition of a nanometer thin CaP coating did not significantly enhance 
bone healing around St implants compared with GAE implant surfaces. This 
observation corroborates published data comparing acid-etched surfaces with 
CaP-coated surfaces46 and GAE surfaces with CaP-coated surfaces47. In contrast 
to these findings, a recently published study by Schouten et al. demonstrated that 
when using an intramedullary gap healing model, the presence of a nano-CaP 
coating significantly improved bone-implant contact after 4 weeks implantation 
compared with GAE surfaces45. This biological response proves that nano-CaP 
coatings are able to enhance the osteogenic response in cases of non-intimate 
bone-implant contact. The authors hypothesize that these contradictory results 
are due to the applied study design. In the current study the St implants (diameter
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4.2 mm) were inserted into a pre-drilled cavity measuring 4.0 mm in diameter, 
according to the manufacturer's instructions. Using this press fit surgical approach 
small bone fragments are loosened due to shear forces at the bone-implant inter­
face and subsequently pressed in between the trabecular voids and screw threads 
during implant placement. As a result of this translocation of bone fragments 
new peri-implant bone formation is initiated and implant stability enhanced48,49. 
The intimate bone contact achieved by the press fit surgical approach in this 
study apparently overshadowed the effect of the nano-CaP coating. This is in 
contradiction to compromised situations in which imperfect implant-tissue 
contact is obtained upon implantation. The latter was shown by Conner et al., 
who showed in a canine model that hydroxyapatite-coated implants significantly 
enhanced bone contact compared with acid-etched surfaces in the case of a 
non-intimate bone-implant contact (gap 2 mm), whereas no significant differences 
were observed in the case of intimate bone-implant contact at the time of 
implant placement46.
CONCLUSION
The present study has demonstrated that electrosprayed nano-CaP coatings evoke 
a similar bone response to GAE implants in the case of press fit implant place­
ment. Also, equal torque values were observed for the two experimental groups. 
The authors hypothesize that the previously demonstrated additional effect of 
nano-CaP coating was overshadowed by the optimal peri-implant osseous 
environment in the present experiment, created by the press fit surgical approach.
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SU M M A R Y  AN D  A D D R E SS  TO THE A IM S
I General introduction
Due to the increasing life-expectancy of the population, the need for prostheses 
and implants to overcome the skeletal problems associated with deteriorating, 
failing or malfunctioning body parts is growing at a rapid rate. Consequently, 
extensive research has been performed in order to improve and optimize implant 
technology, resulting in an increase of the long-term clinical success rates. However, 
the more useful a technology, the more rapidly are its limits challenged. Therefore, 
the use of implants in more challenging situations drives the need for continuing 
refinements.
Successful integration of an implant into its biological surroundings highly depends 
on implant properties (e.g. material, design), the interaction between the implant 
surface and the surrounding bone tissue (e.g. surface characteristics) and the 
medical condition of the recipient (e.g. bone quality and quantity). In view of this, 
the general aim of the research described in this thesis was to optimize the biologi­
cal healing response after implant placement. In order to improve the biological 
response, the effects of different implant geometries were exploited as well as the 
application of different biologically active implant coatings. Additionally, the value 
of different analysis techniques for studying peri-implant bone responses were 
evaluated.
II Effects of im plant geom etry and surface m odifications on 
peri-im plant bone responses
Despite the high success rates in oral implantology, the desire to use oral implants 
in more challenging clinical situations drives the need for continuing refinements 
in implant design and surface properties. In chapter II, a comparative study design 
was set up, using two geometrically different implant types, i.e. screw-type (St) and 
push-in type (Pi), in order to evaluate the effect of implant geometry on peri-implant 
bone response. Furthermore, the potential beneficial effect of an electrosprayed 
CaP-coating, either or not enriched with TGF-B1 (1.0 |jg), on the osteogenic 
response was examined. Implants were inserted into the femoral condyles of
goats and evaluated after 12 weeks of implantation using qualitative (histology 
and fluorochrome labeling) as well as quantitative (histomorphometry) analysis 
techniques. Histomorphometrical analysis of bone-implant contact (BIC) data 
revealed that, with respect to implant design, St implants showed an overall supe­
rior biological healing response compared to Pi implants. Considering surface 
modification, the deposition of an electrosprayed CaP-coating onto implants 
significantly increased the amount of BIC for both implant types. Additional 
enrichment of the CaP-coating with TGF-B1 did not significantly affect peri- 
implant bone response. The results of this study indicated that a substantial 
improvement of the osteogenic response to titanium implants can be obtained by 
the deposition of an electrosprayed CaP-coating. The enrichment of the coating 
with TGF-b1, however, only had a marginal effect.
III Q uantitative assessm ent of peri-im plant bone responses 
using tw o  d ifferent analysis techniques: h istom orphom etry 
and m icro-com puted to m o grap hy
Subsequently, in chapter III, the same comparative study design was used, together 
with the same dental implant types (St and Pi) to evaluate peri-implant bone volume 
(BV) around implants, under the influence of variations in implant design and surface 
modification (as studied in the previous chapter). Additionally, the interchangeable 
value of two analysis techniques, i.e. conventional histomorphometry vs. micro­
computed tomography (micro-CT) were studied. After 12 weeks of implantation 
in a goat femoral condyle model, peri-implant bone responses were evaluated 
in three different zones (inner: 0-500|jm; middle: 500-1000|jm; and outer: 
1000-1500|jm) around the implant. Results indicated superiority of conventional 
histomorphometry over micro-CT, as the latter was hampered by deficits in the 
discrimination of implant material from tissue at the implant/tissue interface. 
More remoted from this interface (i.e. beyond 500 |_im), both analysis techniques 
can be regarded as complementary. Histomorphometrical analysis showed an 
overall higher BV around St compared to Pi implants, but no effects of surface 
modification were observed. St implants showed lowest BVs in the outer zone, 
whereas inner zones were lowest for Pi implants. These results implicated that for
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Pi implants bone formation started from two different directions (contact- and 
distance osteogenesis). In contrast, for St implants it was concluded that the 
undersized implantation technique and associated loosening of bone fragments 
during implant placement compressed the zones for contact and distant osteo­
genesis, thereby improving bone volume at the interface significantly.
IV In vivo bioactivity of D N A-based coatings
In implantology research, it has been heavily documented that the deposition of 
ceramic materials onto implant surfaces, such as CaPs, favors early bone responses. 
The coating techniques used to deposit these CaP-coatings, however, entail some 
important limitations, such as high deposition and post-treatment temperatures and 
the inability to coat complex three-dimensional substrates. As DNA-based coatings 
do not entail these limitations, a study was performed in which the potential in vivo 
bioactivity of these coatings was evaluated (Chapter IV). DNA-based coatings, 
either or not pre-treated in simulated body fluid (SBF), were generated onto Ti 
cylinders using the layer-by-layer (LbL) deposition technique, with bis-ureido- 
surfactant (BUS) as the cationic component and DNA as the anionic component. 
Non-coated implants and CaP sputter-coated implants served as negative and 
positive controls, respectively. For a period of 1 and 4 weeks, implants were placed 
in the femoral condyles of rats, after which for each implant BIC and BV values 
were determined histomorphometrically. The results of this study showed that 
DNA-based coatings, either or not pretreated in SBF, and CaP-coatings increased 
the BIC after 1 week compared to non-coated controls. Four weeks of implantation 
further increased BIC for non-coated controls, SBF pre-treated DNA coatings and 
CaP-coatings, whereas DNA-coated implants showed no additional effect. Bone 
volume measurements did not show any significant differences between the 
individual experimental implant groups at both 1 and 4 weeks post-implantation. In 
conclusion, this study demonstrated that DNA-based coatings are histocompatible 
and favor early bone responses. Furthermore, SBF-pretreated DNA-based coatings 
were found to increase both early as well as late peri-implant bone responses.
V  In vivo bone responses to electrosprayed A LP- and A LP -C aP  
com posite coatings
As the role of ceramic coatings is relatively passive owing to their surface-restriction, 
which only allows interaction with the biological environment via direct contact 
at the bone-implant interface, the metalloenzyme alkaline phosphatase (ALP) has 
recently been proposed as an implant coating material in order to improve the 
biological performance of orthopedic and dental implants. The idea behind using 
ALP-based coatings as an alternative to conventional ceramic coatings is based on 
the fact that ALP plays an important role in the physiological biomineralization 
process. In chapter V, the in vivo bone response to electrosprayed coatings, con­
sisting of ALP, CaP or a combination thereof (composite coating: ALP+CaP) com­
pared to non-coated controls (gritblasted and acid etched) was evaluated. Im­
plants were inserted intramedullary and bilaterally into the femurs of rats. 
After 1 and 4 weeks, bone responses were evaluated qualitatively (histology) as well 
as quantitatively (histomorphometry). The results of this study showed that all 
electrosprayed coatings (ALP, CaP, ALP+CaP) significantly improved osteoconduction 
compared to non-coated controls after 4 weeks of implantation, without significant 
differences among these coated groups. Consequently, the results indicated that 
ALP-coatings improve the osteogenic response to a comparable extent as CaP­
coatings or an ALP+CaP composite coating. In conclusion, the current study proved 
that ALP-coatings have potential as bone implant coatings, though long-term 
data remain to be obtained. From a clinical perspective, it was observed that the 
process of osteoconduction is related to positional determinants, which needs to 
be taken into account when analyzing data on bone response.
VI Validation of a novel im plantation model for evaluation of 
bone healing responses: the goat iliac crest
Numerous animal models are currently available for testing the biological perfor­
mance of newly-developed dental and orthopedic implants. However, as the range 
of existing animal models is rather wide, the selection of a suitable model is 
complex. Based on the continuous need to refine animal models, chapter VI
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presents a new model for objective and standardized evaluation of the bone 
response to bone implants using the iliac crest in goats. The iliac crest implantation 
model is based on the ability to place implants mono-cortically, i.e. inserting implants 
on top of the iliac crest down into the trabecular bone of the os ileum. First, the 
feasibility of this model was determined using two cadaveric specimens regarding 
anatomy and implant positioning. Additionally, the bone structure was evaluated 
and compared to that of the goat femoral condyle. Secondly, the validity of the 
model was tested by performing an in vivo study. The results of this validation 
showed that by means of a rather simple, safe, fast and reproducible surgical 
procedure, the iliac crest in goats can be approached and allows the implantation 
of up to five dental implants per iliac crest. Due to the bilateral implantation 
possibility, statistical comparisons between groups on either side of the goat 
can be performed, resulting in an increased statistical power and consequently a 
reduction in the number of animals needed to obtain statistically significant data. 
Furthermore, it was demonstrated that in terms of surgical approach, anatomy, 
and implant positioning, the iliac crest is the preferred model over the femoral 
condyle model. Consequently, the iliac crest implantation model is suitable for 
evaluation of the osteogenic response to bone implant materials and represents a 
justified and deliberate alternative to the already existing animal models.
VII M echanical properties of and in vivo bone responses to 
electrosprayed CaP-nanoparticle  coatings
Recent trends in clinical implantology include the use of endosseous dental 
implant surfaces embellished with nano-sized modifications. The final study 
presented in chapter VII was initiated to evaluate the mechanical properties as 
well as the potential beneficial effects of electrosprayed CaP-nanoparticle coated 
(nanoCaP) implants on the in vivo osteogenic response with grit-blasted, acid-etched 
(GAE) implant surfaces as controls. For this purpose, nanoCaP-coatings were 
deposited on St implants and implanted into the iliac crest of goats for 6 
weeks. In addition to histological and histomorphometrical analysis, insertion 
torque and removal torque values were measured at implant placement and 
retrieval, respectively. Evaluation of the obtained results showed similar insertion
and removal torque values for nanoCaP-coated and GAE control implants, with 
for each individual group no statistically significant increase in torque value during 
the implantation period. In view of BIC and peri-implant BV measurements, no 
significant differences were found between nanoCaP-coated and GAE implants 
after 6 weeks of implantation. In conclusion, this study demonstrated that in 
situations in which implants are placed in a non-compromised situation using 
a standard press-fit implantation strategy, electrosprayed nanoCaP-coatings 
perform to a comparable extent as GAE implants, both with respect to implant 
fixation and bone healing response.
CLOSING R E M A R K S  AN D  FU TU RE 
P E R S P E C T IV E S
Years of fundamental and applied research have led to the development and 
commercial exploitation of over 1300 implant designs. Due to the high implant 
success rates in dentistry (up to 99% ) and the broad diversity of available implants, 
each with their own specific characteristics, clinicians have the possibility to select 
the most appropriate design for each clinical situation, resulting in a wide appli­
cation of implants in medical and dental surgery. Since the application of implants 
is so successful, there is now a tendency towards the use of implants in more 
challenging situations, such as in patients with compromised medical conditions 
(e.g. osteoporosis, metabolic disorders (Diabetes Mellitus), status after irradiation 
therapy). Therefore, still more basic knowledge is needed to further refine and 
optimize the biological healing response to implants.
In this thesis, research efforts focused on the use of different implant designs with 
a wide variation of surface modifications in order to optimize the interaction 
between implants and the surrounding bone. Based on the obtained data, it can 
be concluded that the addition of organic and/or inorganic biomedical coatings 
plays an important role in the bone healing response around implants, as these 
coatings have proven to enhance the peri-implant bone responses. These positive 
results, however, cannot only be described to hardware effects.
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One of the other contributing elements for implant success, which is often underes­
timated, is surgical technique. The surgical implant procedure is a sensitive technique 
that focuses on minimizing damage to the host tissues (e.g. contaminants, surgical 
trauma, thermal injury). The use of sterile operating conditions, relatively low drill 
speed (max 2.000 rpm), appropriate drill sharpness and design, and adequate 
cooling of the surgical site are considered to be a prerequisite for implant success, 
as excessive surgical trauma and thermal injury may lead to osteonecrosis and 
fibrous encapsulation of the implant, often resulting in implant failure1,2. Even 
more important elements for implant success are variations in insertion modality 
and operative fit. Initial implant stability and continuous apposition to host bone 
are vital for fixation of the implant3. In clinical situations, however, operative fit is 
often compromised, as it is technically difficult to drill bone precisely to provide 
an exact fit for the implant. In this thesis, it has been demonstrated that using an 
undersized surgical approach, i.e. preparing an implant receptor site that is 
smaller in diameter than the implant to be placed, induces a high primary implant 
stability and consequently a favorable biological healing response. Implant 
designs that do not allow undersized placement, but need a press-fit approach 
(e.g. cylindrical implants) will face implant-bone interface gaps. For these situations, 
in which imperfect implant tissue contact is obtained upon implantation, it has 
been demonstrated that the presence of an organic and/or inorganic biomedical 
coating can induce gap bridging, up to 1.0 mm,
Another important issue that needs to be addressed is the fact that, though clini­
cians are always aiming for the most optimal treatment in each individual patient, 
reality learns that not always the best implant system option is chosen. One of the 
features responsible for this fact, is the wide availability of implants in different 
shapes, sizes, lengths, and widths made of a variety of materials with different 
surface treatments. A  wide range of options is good from a general point of view, 
but it complicates the clinician's task of selecting the most appropriate implant 
system. In addition, due to the rapid rate at which new techniques are developed 
and exploited, clinicians are not always aware of the existence and possibilities 
of new systems, which might give better results than the techniques which 
have already been used for years. However, if clinicians are aware of these new
techniques, it is still the question whether they will actually start using these new 
devices, as (i) they are usually very loyal to the company which is already supplying 
them for years, (ii) the availability of new products is often a problem, (iii) the 
costs of a new product are usually higher due to the necessary long-term preclinical 
and clinical scientific research prior to exploitation, and (iv) new products do not 
automatically guarantee a significantly better performance.
Considering the financial aspects as a determining factor in choosing the best 
option in a particular situation, there is still a lot of debate on the use of growth 
factors to enhance the bone healing response around implants. Based on extensive 
scientific literature it can be concluded that growth factors in general and the 
transforming growth factor-B superfamily (e.g. TGF- B, BMP) in particular are able 
to promote bone formation and bone repair. Despite these positive reports, howev­
er, only a few products (e.g. rhBMP-2 for spinal surgery, and OP-1 for non-unions 
of tibia after trauma) have so far reached the clinic. A  reason for this somewhat 
disappointing result is most probably to be found in the intrinsic nature of these 
molecules in combination with the high costs. Growth factors are by nature short­
lived signals, implying the need for a matrix to allow for an adequate controlled 
slow release of the growth factor. At present, the ideal system for sustained delivery 
of osteogenic growth factors is not available yet, resulting in the use of relatively 
high doses, which makes the application of growth factors very expensive and 
increases the risk of unwanted side-effects due to their potential to induce an 
immune response. Therefore, it should be emphasized that not all promising 
results obtained in scientific research, can be extrapolated to a clinical situation.
A  final issue regarding the optimization of the biological healing response to 
implants, concerns the use of new and innovative techniques. Especially in the 
dental field, the use of cone-beam computed tomography (CBCT) has become 
an important tool in dental implant planning. By using this technique, a three 
dimensional (3D) representation of the maxillofacial skeleton can be obtained prior 
to treatment and by using appropriate software planning programs the optimal 
location, (i.e. the location with the highest bone quality and where no important 
anatomical structures are located (e.g. nerves), and most suitable implant, with
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the most optimal length and width dimensions can be determined. Using this 
technique allows the clinician to virtually treat the patient prior to implantation, 
giving insight into the outcome of using different surgical options. As this technique 
is still very new, the procedures utilized to assess and analyze the obtained data 
are not yet fully understood, but this technique might be a useful contribution in 
controlling the peri-implant bone healing response.
The exploitation of new techniques falls or stands with the interest and possi­
bilities of a company to commercialize the product. Scientific results can be highly 
promising, still it is possible that companies do not want to produce and market 
the new technique. This defensive character can be based on (i) high costs related 
to the development of the new product, (ii) or the fact that exploitation of the 
new product might endanger the market potential of already marketed products 
of this company, thereby creating a competitor of their own product.
The continuing search for new techniques to further optimize and refine the 
peri-implant bone response should not only be directed towards hardware and 
surface modifications, but should also focus on a continuous optimization of 
the surgical skills and clinical experience of the operator (e.g. one operator and 
standardized operating conditions). Emphasize should therefore be directed towards 
a successful combination of optimal biomaterial characteristics and clinical expertise.
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SA M EN V A TTIN G  EN EVALUATIE VAN  DE 
D O ELSTELLIN G EN
I A lgem en e inleiding
Door de toegenomen levensverwachting van de wereldbevolking, stijgt de vraag 
naar prothese chirurgie en implantologie om met behulp van deze nieuwe 
technieken een oplossing te kunnen bieden in situaties waarin de kwaliteit van 
bijvoorbeeld botweefsel onvoldoende is of tand- of gewrichtsfuncties verloren 
zijn gegaan. Als gevolg hiervan is jarenlang intensief onderzoek verricht met als 
doel het optimaliseren van het gebruik van implantaten, wat heeft geleid tot een 
enorme stijging van de klinische succespercentages op de lange termijn. Echter, 
hoe meer een techniek word toegepast, des te sneller worden de grenzen bereikt. 
Wanneer dus de vraag naar het gebruik van implantaten in meer uitdagende 
situaties toeneemt, zal de techniek ook verder verfijnd dienen te worden. 
Succesvolle integratie van een implantaat in het omliggende weefsel hangt 
grotendeels af van de eigenschappen van het implantaat (bijv. type materiaal en 
design), de interactie van het aangrenzende botweefsel met het oppervlak van 
het implantaat (bijv. oppervlakte-eigenschappen) en de medische conditie van de 
patiënt (bijv. leeftijd, metabole aandoeningen en daaruit volgende effecten op 
botweefsel). Met dit in het achterhoofd was het algemene doel van het onderzoek 
beschreven in het onderhavige proefschrift, het optimaliseren van de biologische 
weefselreactie na plaatsing van een implantaat. Om de biologische weefselrespons 
te bevorderen is onderzoek gedaan naar het effect van verschillende implantaat 
typen, evenals het aanbrengen van verschillende biologisch actieve coatings als 
deklagen op implantaten. Tevens is gekeken naar de waarde van verschillende 
analyse-technieken voor het beoordelen van de peri-implantaire botreactie.
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II Effect van im plantaat geom etrie en oppervlakte-e igenschappen 
op de peri-im plantaire botreactie
Ondanks de hoge succespercentages binnen de orale implantologie, vraagt de 
behoefte om tandheelkundige implantaten in de meer uitdagende situaties te 
gebruiken, om een steeds verdere verfijning van implantaat design en oppervlakte- 
eigenschappen. In hoofdstuk II is een vergelijkende studie uitgevoerd, waarin 
twee verschillende implantaat typen (schroefvormig, St; cilindrisch, Pi) werden 
vergeleken om het effect van implantaat geometrie op de peri-implantaire 
botreactie te kunnen beoordelen. Tevens is gekeken naar het potentieel positieve 
effect van een met behulp van de electrospray depositietechniek (ESD) aangebrachte 
calciumfosfaat (CaP) coating, al dan niet verrijkt met transforming growth factor 
61 (TGF-61; 1,0 Mg), op de botvorming. Hiervoor werden implantaten geplaatst 
in de femorale condyle van geiten en geëvalueerd na een implantatieperiode van 12 
weken met behulp van zowel kwalitatieve (histologie en fluorochroom labeling) als 
kwantitatieve (histomorfometrie) analyse-technieken. Histomorfometrische analyse 
van bot-implantaat-contact (BIC) liet een superieure biologische genezingsreactie 
zien van schroefvormige implantaten ten opzichte van cilindrische implantaten. 
Gelet op het effect van oppervlakte-modificatie, bleek de aanwezigheid van een 
met behulp van de ESD-techniek aangebrachte CaP coating voor beide implantaat 
typen een significante toename van het BIC op te leveren. Additionele toevoeging 
van TGF-61 had voorts geen positief effect op de peri-implantaire botreactie. Samen­
vattend heeft deze studie laten zien dat implantaat-geometrie (in combinatie met 
plaatsingstechniek) een dominante rol speelt in de inheling van botimplantaten 
en dat een substantiële toename van de botvorming rondom titanium implantaten 
kan worden verkregen door het aanbrengen van een CaP-coating. De verrijking van 
deze CaP-coating met de groeifactor TGF-61 had echter slechts een marginaal 
effect.
III Q uantitatieve analyse van de peri-im plantaire botreactie 
gebru ikm akend van tw ee verschillende analyse-technieken: 
histom orfom etrie en m icro-com puted tom ograp hy
In hoofdstuk III is dezelfde studie opzet gebruikt als beschreven in hoofdstuk II, 
waarbij werd gekeken naar de invloed van implantaat geometrie en oppervlakte- 
modificatie op het peri-implantaire botvolume. Tevens werd onderzoek gedaan 
naar de uitwisselbaarheid van twee verschillende analyse-technieken, te weten 
conventionale histomorfometrie versus micro-computed tomography (micro-CT). 
Na een implantatieperiode van 12 weken in de femorale condyle van geiten, 
werd de peri-implantaire botreactie gemeten in drie verschillende zones rondom 
het implantaat: binnen (0-500|_im), midden (500-1000|_im) en buiten (1000-1500 
Mm). De verkregen resultaten toonden dat conventionele histomorfometrie superieur 
is ten opzicht van micro-CT, aangezien de betrouwbaarheid van laatstgenoemde 
techniek werd beperkt door het gebrek aan onderscheidend vermogen ter plaatse 
van de implantaat/weefsel overgang. Echter, gelet op de resultaten verkregen in de 
zone vanaf 500Mm rond het implantaat, kunnen de technieken worden beschouwd 
als complementair. Histomorfometrische analyse liet een algeheel hoger botvolume 
(BV) zien rond schroefvormige implantaten ten opzichte van cilindrische implan­
taten. Er werd echter geen effect gezien van de verschillende oppervlaktemodi- 
ficaties. De schroefvormige implantaten lieten de laagste hoeveelheid BV zien 
in de buitenste zone, terwijl de cilindrische implantaten juist in de binnenste 
zone de laagste hoeveelheid BV lieten zien. Concluderend impliceren de ver­
kregen resultaten dat rondom cilindrische implantaten de nieuwvorming van 
bot begint in twee verschillende richtingen ('contact' en 'distance osteogenesis'). 
Voor de schroefvormige implantaten geldt juist dat een 'undersized' chirurgische 
benadering en daarmee samenhangend het optreden van losse botdeeltjes tijdens 
de plaatsing van het implantaat, als het ware de twee zones van 'contact' en 
'distance osteogenesis' in elkaar perst en daarmee het botvolume ter plaatse van 
de implantaat/weefsel overgang significant doet toenemen.
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IV In-vivo bioactiviteit van D N A -co atin gs
Binnen de implantologie is reeds veelvuldig beschreven dat het aanbrengen van 
keramische deklagen op het implantaatoppervlak, zoals bijv. CaP, een stimulerende 
werking heeft op de nieuwvorming van botweefsel. De huidige, beschikbare 
depositie-technieken voor het aanbrengen van deze CaP-coatings hebben echter 
beperkingen, zoals het gebruik van een hoge temperatuur zowel tijdens depositie 
als nabehandeling en het twee-dimensionale depositie-vlak, waardoor complexe 
(evt. poreuze) driedimensionale substraten moeilijk of niet volledig gecoat kunnen 
worden. Aangezien het aanbrengen van DNA-coatings middels Layer-by-Layer (LbL) 
depositie deze beperkingen niet heeft, werd een studie uitgevoerd waarin de 
potentiële in vivo bioactiviteit van deze coatings werd geëvalueerd (Hoofdstuk 
IV). DNA-coatings (met of zonder voorbehandeling in 'Simulated Body Fluid', SBF) 
werden gegenereerd op titanium (Ti) cilinders met behulp van de LbL-depositie. 
Hierbij werd afwisselend een positief (bis-ureido-surfactant; BUS) en negatief 
(DNA) geladen polyelectrolyt afgezet, hetgeen leidt tot een gelaagde coating. 
Ongecoate implantaten en implantaten met een CaP sputter coating dienden 
achtereenvolgens respectievelijk als negatieve en positieve controle. Gedurende 
een periode van 1 en 4 weken werden implantaten geplaatst in de femorale 
condylen van ratten, waarna per implantaat BIC en BV werden bepaald met be­
hulp van histomorfometrie. De resultaten van deze studie toonden een toename 
van BIC na 1 week in de DNA-coating groep, al dan niet ondergedompeld in SBF, en 
de CaP-coating groep in vergelijking met de ongecoate groep. Een implantatie- 
periode van 4 weken liet een verdere toename van BIC zien in de in SBF-voor- 
behandelde groep, de CaP-coating groep en de ongecoate groep, terwijl de 
DNA-coating groep geen toename liet zien. BV metingen lieten geen significant 
verschil zien tussen de groepen onderling alsook tussen de verschillende implan- 
tatieperioden (1 vs. 4 weken). Samenvattend heeft deze studie bewezen dat 
DNA-coatings weefselcompatibel zijn en een positief effect hebben op de vroege 
botreactie. Bovendien is aangetoond dat DNA-coatings met voorbehandeling in 
SBF een positief effect hebben op zowel de vroege als de late botreactie.
V  In vivo botreactie op A LP en A LP -C aP  com posiet coatingen
Aangezien keramische coatings een relatief passieve rol vervullen, waarbij ze een 
directe binding kunnen aangaan met botweefsel, is recent het enzym alkalische 
fosfatase (ALP) geïntroduceerd als oppervlakte-actieve coating om de biologische 
respons rondom orthopedische en tandheelkundige implantaten te bevorderen. 
Het idee achter het gebruik van ALP-coatings als een alternatief voor conventionele 
keramische coatings is gebaseerd op het feit dat ALP een belangrijke rol speelt in 
het fysiologische mineralisatie proces van harde weefsels. In hoofdstuk V wordt 
de in vivo botreactie op, met behulp van de ESD-techniek gegenereerde coatings 
bestaande uit ALP, CaP of een combinatie van beide (ALP+CaP), vergeleken met 
ongecoate controles (gezandstraald en geëtst). Implantaten werden hiertoe 
intramedullair en bilateraal geplaatst in de femurs van ratten. Na een periode van 
1 en 4 weken werd de botreactie zowel kwalitatief (histologie) als kwantitatief 
(histomorfometrie) geëvalueerd. De resultaten van deze studie lieten zien dat alle 
gecoate implantaten (ALP, CaP en ALP+CaP) een significante toename van de 
botgeleiding veroorzaken in vergelijking met de ongecoate implantaten na een 
implantatieperiode van 4 weken. Tussen de groepen onderling werden geen 
significante verschillen gevonden. Deze studie is derhalve indicatief voor een 
bot-stimulerende capaciteit van ALP-coatings vergelijkbaar met die van de CaP­
coatings of de composiet coatings (ALP+CaP). Concluderend heeft deze studie 
bewezen dat ALP-coatings potentie hebben voor toepassing op botimplantaten. 
Lange termijn resultaten dienen echter nog te worden verkregen. Vanuit een klinisch 
perspectief dient bovendien te worden vermeld, dat in deze studie is waargenomen 
dat het proces van botgeleiding gerelateerd is aan positionele determinanten.
VI Validatie van een nieuw  im plantatiem odel voor de evaluatie 
van botgenezingsreacties: de crista iliaca van de geit
Momenteel is een verscheidenheid aan diermodellen beschikbaar om de biologische 
eigenschappen van nieuwe tandheelkundige en orthopedische implantaten te 
testen. Juist vanwege dit breed scala aan diermodellen, is de keuze voor een 
geschikt model niet altijd eenvoudig. Op basis van de continue drang naar het 
verder optimaliseren van een diermodel, is in hoofdstuk VI een nieuw model
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geobjectiveerd voor evaluatie van de botreactie rondom implantaten, gebruik­
makend van de crista iliaca in geiten. Dit implantatie model biedt de mogelijkheid 
om implantaten monocorticaal te plaatsen, dat wil zeggen, plaatsing van implan­
taten met slechts eenmaal penetratie door een dichte laag botweefsel (corticaal 
bot). Allereerst is met behulp van twee kadavers de toepasbaarheid van het model 
getest. Vervolgens is de botstructuur beoordeeld en vergeleken met de femoral 
condyl van de geit. Hierna is de validiteit van het model getest door het uitvoeren 
van een in vivo studie. De resultaten van deze experimenten lieten zien dat op 
een relatief eenvoudige en snelle wijze de crista iliaca chirurgisch benaderd kan 
worden en ruimte biedt voor het plaatsen van 5 tandheelkundige implantaten in 
monocortical positie. Daarnaast biedt het model de mogelijkheid tot het bilateraal 
plaatsen van implantaten, waardoor de power van de statistische vergelijkingen 
groter wordt en het aantal dieren noodzakelijk voor het verkrijgen van significante 
data afneemt. Tenslotte werd in deze studie aangetoond dat qua chirurgische 
benadering, anatomie en implantaat-positionering, de crista iliaca de voorkeur 
verdiend boven het femorale condyl model en dat hiermee een uitstekend model
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is gevonden als alternatief voor de reeds bestaande modellen.
VII M echanische e igenschappen van een in vivo botreactie op 
n ano C aP-co atings
Recente ontwikkelingen binnen de implantologie omvatten het gebruik van 
tandheelkundige implantaten voorzien van nanometer-dunne coatings. Derhalve 
beoogde hoofdstuk VII de evaluatie van zowel mechanische eigenschappen als 
potentieel positieve effecten van nanometer-dunne CaP-coatings (nanoCaP) op 
de in vivo botrespons in vergelijking met gezandstraalde en geëtste implantaten. 
Hiertoe werden nanoCaP-coatings gegenereerd op schroefvormige implantaten, 
welke werden geplaatst in de crista iliaca van geiten voor een periode van 6 weken. 
Naast de gebruikelijke analyse technieken (histologie en histomorfometrie) 
werden eveneens mechanische testen meegenomen, waarin zowel de torque-in 
als de torque-out waardes werden bepaald. Evaluatie van de verkregen data toonde 
gelijke torque-in en torque-out waardes voor nanoCaP-coatings en controle im­
plantaten. Ten aanzien van BIC en BV werden geen significante verschillen gevonden
tussen beide groepen na een implantatieperiode van 6 weken. Concluderend 
toont deze studie dat in situaties waarin implantaten geplaatst worden in bot van 
mindere kwaliteit en gebruik gemaakt wordt van de standaard 'press-fit' implan­
tatie techniek, nanoCaP-coatings op gelijkwaardig niveau presteren als controle 
implantaten, zowel ten aanzien van implantaat fixatie alsook botgenezingsreactie.
SLO T O PM ER K IN G EN  EN 
T O E K O M ST P E R SP E C T IE F
Jarenlang onderzoek heeft geresulteerd in de ontwikkeling en commerciële 
exploitatie van meer dan 1300 implantaat designs. Als gevolg van de hoge 
succespercentages (± 99% ) en de diversiteit van de beschikbare implantaten, elk 
met zijn eigen specifieke karakteristieken, hebben clinici de gelegenheid om voor 
iedere situatie het meest geschikte design te kiezen, resulterend in een brede 
toepassing van implantaten binnen medische en tandheelkundige disciplines.
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Aangezien het plaatsen van implantaten zo succesvol is, is men steeds meer 
geneigd ook patiënten met een slechtere algehele conditie te behandelen (bijv. 
osteoporose, metabolische aandoeningen, status na bestraling). Derhalve bestaat 
nog steeds de noodzaak tot het vergaren van kennis omtrent het verder optima­
liseren van de biologische weefselreactie na plaatsing van een implantaat.
In onderhavig proefschrift waren de onderzoeken met name gericht op het 
gebruik van verschillende implantaat typen met een diversiteit aan oppervlakte- 
modificaties. Op basis van de verkregen data kan worden geconcludeerd dat de 
toevoeging van organische en/of anorganische biomedische coatings een zeer 
belangrijke rol kan spelen in de botreactie rondom implantaten. De in dit proefschrift 
beschreven positieve weefselreacties zijn echter niet alleen toe te schrijven aan de 
invloed van de 'hardware'.
Een andere factor die een belangrijke rol speelt in implantaatsucces en die veelal 
wordt onderschat, is de chirurgische techniek. De chirurgische implantatietechniek 
dient zorgvuldig toegepast te worden teneinde slechts minimale weefselschade 
te veroorzaken (bijv. contaminatie, chirurgisch trauma en thermale schade). Het
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gebruik van steriele omstandigheden, relatief lage boorsnelheden (max. 2.000rpm), 
adequate boorscherpte, -design en koeling van het wondbed worden beschouwd 
als een voorwaarde voor implantaatsucces. Het is immers bekend dat excessieve 
weefselschade als gevolg van chirurgisch trauma of hyperthermie kunnen leiden 
tot botnecrose en fibreuze kapselvorming rondom implantaten, veelal resulterend 
in implantaat falen. Andere factoren die een rol spelen in het implantaatsucces 
zijn variaties in de techniek van plaatsing en 'operative fit'. Primaire stabiliteit en 
continue appositie van het omliggende botweefsel zijn vitaal voor een sterke 
verankering van het implantaat. In klinische situaties is de 'operative fit' echter 
vaak verre van optimaal, aangezien het technisch lastig is om het boorgat precies 
op maat voor het implantaat te boren. In dit proefschrift is aangetoond dat het 
gebruik van de 'undersized' techniek, dat wil zeggen het creëren van een boorgat 
met een diameter kleiner dan de diameter van het implantaat, een relatief hoge 
primaire stabiliteit oplevert, resulterend in een gunstige biologische weefselreactie. 
Implantaat typen die geen 'undersized' plaatsingstechniek behoeven, maar middels 
de 'press-fit' techniek geplaatst dienen te worden (bijv. cilindrische implantaten)
202
hebben vaak te maken met het optreden van een kloof ('gap') tussen het implantaat 
en omliggend botweefsel. Voor deze situaties, waarin geen perfect, initieel contact 
is tussen botweefsel en implantaat is aangetoond dat de aanwezigheid van een 
organische en/of anorganische coating in staat is deze kloof tot een maximum 
van 1,0 mm te overbruggen.
Een ander belangrijk aspect is het feit dat clinici in theorie altijd zullen proberen 
voor de patiënt de meest optimale behandeling te kiezen, maar daar in de praktijk 
toch niet altijd voor kiezen. Een van de redenen waarom de praktijk nogal eens 
afwijkt van de theoretische keuze voor een implantaat is het breed scala aan 
beschikbare implantaten. Over het geheel genomen heeft een groot aanbod aan 
implantaten de voorkeur, maar het compliceert daarentegen ook het maken van 
de juiste keuze. Door de snelle ontwikkelingen is de clinicus niet altijd meer op de 
hoogte van de mogelijkheden van een systeem. Daarnaast is het ook altijd de 
vraag of clinici überhaupt wel open staan voor nieuwe systemen, aangezien ze 
vaak erg loyaal zijn aan de firma waarmee ze al jaren werken en het systeem 
waarmee ze bekend zijn. Daarbij komt dat de levering van een nieuw systeem
vaak beperkt is, het nogal eens met hoge kosten gepaard gaat en het de vraag is 
of het wel automatisch betere resultaten oplevert.
Ten aanzien van de financiële aspecten als bepalende factor in het maken van 
een keuze voor een implantaat in een bepaalde situatie, bestaat nog altijd veel 
discussie over het gebruik van groeifactoren om de botreactie rondom implantaten 
te bevorderen. Op basis van uitvoerig onderzoek kan worden geconcludeerd dat 
groeifactoren in het algemeen en de TGF-B superfamilie (bijv. TGF- B's en BMP's) 
in het bijzonder in staat zijn botvorming en het herstel van botweefsel te 
bevorderen. Ondanks de positieve resultaten, bestaat op dit moment slechts 
een beperkt aantal producten, dat een toepassing heeft gevonden in de kliniek 
(bijv. rhBMP-2 voor wervelkolom chirurgie en OP-1 voor non-unions of tibia na 
trauma). De reden voor deze ietwat teleurstellende resultaten is waarschijnlijk toe 
te schrijven aan het intrinsieke karakter van deze moleculen in combinatie met de 
hoge kosten. Groeifactoren zijn van nature nogal 'short-lived' en vereisen daarom 
de toevoeging van een matrix om te kunnen voorzien in een gecontroleerde release 
van de groeifactor. Op dit moment is er nog geen ideaal systeem waarmee een
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gereguleerde afgifte van groeifactoren kan worden bewerkstelligd. Hierdoor dienen 
relatief hoge doseringen te worden gebruikt, waardoor de toepassing van groei­
factoren zeer kostbaar wordt en het risico op ongewilde bijwerkingen toeneemt.
Om deze reden dient te worden benadrukt dat niet alle veelbelovende resultaten 
verworven met wetenschappelijk onderzoek ook daadwerkelijk kunnen worden 
geëxtrapoleerd naar de kliniek.
Een laatste kwestie betreffende het optimaliseren van de biologische weefselrespons 
rondom implantaten, betreft het gebruik van nieuwe innovatieve technieken.
Met name binnen de tandheelkunde is het gebruik van de 'cone-beam computed 
tomography (CBCT) een belangrijk instrument geworden. Met behulp van deze 
techniek kan een driedimensionale representatie van de kaak en het aangezicht 
worden gemaakt voorafgaand aan de behandeling. Met de juiste software kan 
dan eveneens de optimale locatie (bijv. plaats met de beste kwaliteit bot en waar 
geen belangrijke anatomische structuren lopen, zoals zenuwen) en het meest 
geschikte implantaat met de juiste afmetingen worden bepaald. Deze techniek 
stelt de clinicus in de gelegenheid om de patiënt voorafgaand aan de plaatsing
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van het implantaat virtueel te behandelen. Hiermee kan inzicht worden verkregen 
in het resultaat van verschillende operatieve opties. Aangezien deze techniek nog 
erg nieuw is, wordt momenteel nog volop gewerkt aan een systeem om de 
verkregen data ook op de juiste manier te analyseren, maar het moge duidelijk 
zijn dat de ontwikkeling van deze nieuwe techniek een zinvolle bijdrage kan gaan 
leveren aan het controleren van de peri-implantaire botreactie.
De exploitatie van een nieuwe techniek valt of staat met de interesse van een 
bedrijf en de mogelijkheden om het product ook daadwerkelijk op de markt te 
brengen. Ondanks het feit dat wetenschappelijk data soms zeer hoopgevend lijken, 
gebeurt het vaak dat bedrijven er geen heil in zien. Deze defensieve opstelling 
kan gebaseerd zijn op de hoge kosten gepaard gaande met de ontwikkeling van 
een idee tot een commercieel verkoopbaar product, of het feit dat het nieuwe 
product het marktaandeel van reeds bestaande producten kan bedreigen.
De continue zoektocht naar nieuwe technieken die de peri-implantaire botreactie 
verder kunnen optimaliseren zou niet alleen gericht moeten zijn op hardware en 
oppervlakte-modificaties, maar moet ook gericht zijn op het optimaliseren van de
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chirurgische vaardigheden en klinische ervaringen van de chirurg (bijv. 1 chirurg 
en gestandaardiseerde operatie omstandigheden). De nadruk moet daarom meer 
gelegd worden op een succesvolle combinatie van optimale karakteristieken van 
het biomateriaal in combinatie met klinische expertise.
a c k n o w l e d g e m e n t s  (d a n k w o o r d )
Net als bij de auteurs van een artikel, staat ook in een proefschrift het belangrijkste 
achterin! Had echter niet gedacht dat het zo lastig zou zijn om deze laatste pagina's 
te vullen. Desalniettemin, wil ik heel graag van de gelegenheid gebruik maken 
om via deze weg iedereen die op enigerlei wijze betrokken is geweest bij de 
totstandkoming van mijn proefschrift te bedanken en daarbij natuurlijk een paar 
mensen in het bijzonder.
Prof. P.H.M. Spauwen, het zit erop! Twaalf jaar geleden was onze eerste kennis­
making en werd ik mede door uw enthousiasme gegrepen door het vak. Twee 
jaar later kwam ik bij u terug voor een wetenschappelijke stage, wat uitmondde 
in een extra onderzoek bij de afdeling Biomaterialen en waarmee de basis werd 
gelegd voor het huidige proefschrift. Zo werd ik de 6e en tevens laatste promoven­
dus in de Biomaterialen-Plastische onderzoekslijn. Ik kan niet nalaten te zeggen 
hoe ontzettend jammer ik het vind, dat u echter niet degene zult zijn van wie ik
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straks het vak ga leren. De manier waarop u patiënten bejegent, uw discretie en 
integriteit, maar vooral de interesse die u altijd toonde in de persoon achter de 
arts, zijn voor mij een inspirerend voorbeeld geweest. Met de afronding van mijn 
proefschrift, komt ook een einde aan uw Radboud avontuur. Ik wens u het 
allerbeste samen met uw vrouw in Wenen en ik hoop dat we zo nu en dan nog 
eens samen een Jagermeister kunnen drinken.
Prof. Jansen. Met name in het begin van mijn promotietraject ben jij als directe 
supervisor een zeer belangrijke factor geweest in het opstarten en sturen van het 
onderzoek. Later droeg je geleidelijk aan het stokje over aan Gert en Jeroen, maar 
bleef toch altijd op de achtergrond aanwezig om er voor te zorgen dat we wel 
de juiste koers bleven varen. Dank voor je doeltreffendheid, helderheid en in het 
bijzonder de snelheid waarop je altijd reageerde.
Dr. G.J. Meijer, beste Gert. Precies halverwege mijn promotietraject voegde jij je 
bij onze afdeling en werd ik jou eerste promovendus. In het begin was het voor
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ons beiden best een beetje zoeken, maar gaandeweg het onderzoek raakten 
we steeds beter op elkaar ingespeeld wat resulteerde in een zeer prettige 
samenwerking. Bedankt voor al je uitleg over de 'orkestbak'en ben blij dat je me 
hebt geholpen de juiste 'flow' te vinden om dit proefschrift af te ronden!
Dr. J.J.J.P. van den Beucken, lieve Jeroen. Bij jou ging het eigenlijk precies ander­
som. Was jij in het begin vooral degene met wie ik gezellige koffie-uurtjes in de 
koffiekamer, bij Blixem of het DE-cafe doorbracht. Zo werd jij later juist de drijvende 
kracht achter mijn onderzoek, en heb jij er mede voor gezorgd dat dit boekje uit­
eindelijk tot stand is gekomen. Als geen ander was jij in staat om mij precies op 
de juiste momenten weer de goede kant op te sturen. Ik kan dan ook niet in 
woorden uitdrukken hoe zeer ik waardeer wat je allemaal voor me hebt gedaan.
Mijn paranimfen, Lise en Wouter. Lieve Lise, wie had gedacht dat wij zulke 
goede vriendinnen zouden worden. Jij in het begin zeker niet..:)!. Mede dankzij 
jou denk ik met veel plezier terug aan de afgelopen 4 jaar. De dagelijkse ritjes
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naar de tandheelkunde, de vele drankjes die we samen gedronken hebben, 
je altijd vermakelijke verhalen, maar vooral je positieve instelling zullen mij altijd 
bij blijven. Bedankt dat je er altijd voor me was op de momenten dat het onderzoek 
even niet zo lekker ging. Jammer genoeg ben je nu even niet meer zo dichtbij, 
maar ik hoop dat we in de toekomst onze intensieve vriendschap weer kunnen 
oppakken! Lieve Woutje, jij bent en blijft mijn beste maatje. Bijna niemand staat 
zo dicht bij mij als jij en heeft aan 1 woord genoeg om te begrijpen wat ik bedoel, 
echt te bizar af en toe. Zo grappig ook dat we echt steeds voor dezelfde dingen 
kiezen. Heel veel succes met de laatste loodjes van jouw proefschrift en ik hoop 
dat we over een paar jaar niet alleen onze vriendschap maar ook onze patiënten 
delen!
Lieve onderzoekers en medewerkers van de afdeling Parodontologie en Bio­
materialen. Heb het altijd heel bijzonder gevonden dat zo'n grote club met 
zo veel verschillende achtergronden en nationaliteiten zo ontzettend hecht en 
gezellig kan zijn. I want to thank you all for your collegiality, helping hand and 
sociability. I really miss your company and especially the always entertaining coffee
breaks! Natasja, bedankt voor al je hulp bij de verwerking van mijn samples. Vincent, 
dank voor alle technische ondersteuning en het vermogen om voor ieder probleem 
weer een oplossing te vinden. Daniel, bedankt voor alle gezellige uurtjes op de 
kamer en je hulp bij de dierstudies. Joop, was iedereen maar zo oprecht als jij, 
dank voor alles. Mati en Floor, you both have become more than just colleagues.
Anja, wat jammer dat we de 4 jaar niet samen af hebben kunnen maken, maar 
ontzettend bedankt voor de leuke herinneringen van de eerste 2 jaar.
Ook dank voor de samenwerking met de afdeling Nucleaire Geneeskunde, en in 
het bijzonder Dr. Boerman, Annemarie en Huub. Helaas hebben de eindeloze 
labelingsexperimenten niet mogen resulteren in een wetenschappelijk artikel.
Richard, bedankt voor de gezellige DE-momentjes. Kunnen we binnenkort eindelijk 
eens die fles champagne opentrekken!
De uitvoering van de experimenten beschreven in dit proefschrift zouden niet 
mogelijk zijn geweest zonder de deskundige assistentie van de biotechnici van 
het dierenlaboratorium: Geert, Debby, Kay, Ilona, Aglaja, Daphne, Alex, Wilma,
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Jeroen, Conrad en Hennie. Veel dank voor jullie samenwerking en flexibiliteit.
Alle (voormalig) stafleden en (voormalig) assistenten van de plastische chirurgie, 
waaronder Pieter, Rita, Henriette, Johan, David, Stijn, Jan, Erwin, Dr. Boode en Dr. 
van Tintelen, Ed, Ghita, Esther, Xander, Michiel, Maarten, Bas, Diederik, Quinten,
Bram, Ewa, Mirjam, Margot en Inge. Dank voor de aangename klinische afwisseling, 
met name in het begin van mijn onderzoekstraject. Alle secretaresses en poli- 
dames, in het bijzonder Daisy en Francisca, ontzettend bedankt voor jullie hulp 
en betrokkenheid. Lieve Dilian, wat ben je toch een goed mens. Hoop dat we 
binnenkort weer samen poli's kunnen doen. Lieve Alex, dank voor je vriendschap 
en je adviezen op klinisch gebied.
Lieve Oud-Ko-raad genootjes, Irene, Jente, Loes en Niels. Als derde in de rij, wil 
ook ik jullie bedanken voor alle gezellige avondjes. Vind het erg bijzonder dat 
ondanks alle drukke agenda's, promoties, babies, tentamens etc. het ons al die 
jaren nog steeds gelukt is om contact te houden. Op naar de volgende 7 jaar en 
een 4e promotie.. Jente, ben jij de volgende.:)
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Lieve Syl, nog 2 jaar en dan kunnen we al ons 3e lustrum vieren. Bedankt voor je 
vriendschap door de jaren heen, de onvergetelijke avonden in Anneke, Bas en de 
Compagnie en de leuke tripjes die we gemaakt hebben. Ik bewonder je lef en 
doorzettingsvermogen en ben ontzettend blij met je ontwerp voor mijn kaft! Ons 
eerste gezamenlijke boek is klaar, zou 'de twee godinnen in Frankrijk' er dan toch 
ooit nog van komen.
Lieve Anne-Margot, jou wil ik bedanken voor onze bijzondere vriendschap. Ik heb 
veel bewondering voor de manier waarop jij je altijd vol overgave in een nieuw 
avontuur stort en keer op keer in staat bent daar iets goeds uit te halen. Ik wens 
je veel succes met je vooruitstrevende onderzoek en de keuzes die je nog moet 
gaan maken.
Dr. Wegdam, bedankt voor de onvergetelijke tijd in Ghana en de bijzondere 
vriendschap die we nu delen.
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Lieve Go, ontzettend veel dank voor alle gezellige etentjes en glaasjes amaretto 
in 'De Deut', 'De Nar', 't Keershuys' etc. Jij zorgt er ieder keer weer voor dat ik 
aan het eind van de avond volledig ontspannen en vrolijk naar huis ga. Hoop dat 
er nog heel veel van dit soort avondjes zullen volgen!
Lieve (oud) hockeyteamgenootjes. Hoe belangrijk jullie zijn als uitlaatklep op de 
dinsdagavond en zondag! Dank voor jullie niet aflatende belangstelling en steun.
Tenslotte wil ik mijn vrienden in Nijmegen en daarbuiten, Lau, Marielle, Ties, Nienke, 
Sanne, Rolo, Ka-Chun, Sas, Mi, Marc, Maud, Ier, Nielske, Dennis, Bis en Roos (succes 
met jouw laatste loodjes) bedanken voor jullie niet aflatende belangstelling. Door 
alle drukte rondom promotie en opleiding heb ik de afgelopen jaren veel te weinig 
tijd in onze vriendschap kunnen investeren. Toch weet ik dat de vriendschap met 
jullie zo hecht is, dat het altijd wel goed zit, ook al heb ik jullie een tijd niet 
gezien.
Lieve mama, papa en Minnie, bedankt voor jullie onvoorwaardelijke steun 
gedurende al die jaren en het feit dat jullie altijd grenzeloos voor mij klaar staan. 
Al van jongs af aan hebben jullie mij een stabiele basis meegegeven en me alle 
vrijheid gegeven om me zo breed mogelijk te ontwikkelen. Zo fijn dat ik altijd op 
jullie kon terugvallen als ik het even niet meer zag zitten of gewoon advies nodig 
had. Zonder jullie had ik dit allemaal niet voor elkaar kunnen krijgen. Tinus, met mijn 
zusje samen hebben jullie Tim en Thijntje, twee zonnetjes, die het familieleven 
helemaal een feest maken.
Tot slot, lieve Alexander. De afgelopen jaren waren voor jou niet altijd even 
makkelijk met zo'n drukke en soms wat gestresste vrouw thuis. Ik ben je ontzettend 
dankbaar voor je geduld en steun. Iedere keer denk ik weer nu gaat het echt 
rustiger worden, maar of dat ooit gaat gebeuren kan ik je helaas niet beloven!
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Chirurgie. De eerste kennismaking met de Plastische Chirurgie vond plaats in 
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In september 2009 werd gestart met de vooropleiding Algemene Chirurgie in het 
Rijnstate Ziekenhuis te Arnhem (opleider dr. M.M.PJ. Reijnen). De specialisatie tot 
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